
<html lang="en"     class="pb-page"  data-request-id="537fb3fe-c2cf-4b52-b57e-32e9b96b6765"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.9b00350;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2019.62.issue-9"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma" /></meta><meta name="dc.Creator" content="Christopher R. M.  Asquith" /></meta><meta name="dc.Creator" content="Kaleb M.  Naegeli" /></meta><meta name="dc.Creator" content="Michael P.  East" /></meta><meta name="dc.Creator" content="Tuomo  Laitinen" /></meta><meta name="dc.Creator" content="Tammy M.  Havener" /></meta><meta name="dc.Creator" content="Carrow I.  Wells" /></meta><meta name="dc.Creator" content="Gary L.  Johnson" /></meta><meta name="dc.Creator" content="David H.  Drewry" /></meta><meta name="dc.Creator" content="William J.  Zuercher" /></meta><meta name="dc.Creator" content="David C.  Morris" /></meta><meta name="dc.Description" content="We describe the design of a set of inhibitors to investigate the relationship between cyclin G associated kinase (GAK) and epidermal growth factor receptor (EGFR) in chordoma bone cancers. These co..." /></meta><meta name="Description" content="We describe the design of a set of inhibitors to investigate the relationship between cyclin G associated kinase (GAK) and epidermal growth factor receptor (EGFR) in chordoma bone cancers. These co..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 11, 2019" /></meta><meta name="dc.Type" content="rapid-communication" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b00350" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00350" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b00350" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b00350" /></link>
        
    
    

<title>Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b00350" /></meta><meta property="og:title" content="Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0006.jpeg" /></meta><meta property="og:description" content="We describe the design of a set of inhibitors to investigate the relationship between cyclin G associated kinase (GAK) and epidermal growth factor receptor (EGFR) in chordoma bone cancers. These compounds were characterized both in vitro and using in cell target engagement assays. The most potent chordoma inhibitors were further characterized in a kinome-wide screen demonstrating narrow spectrum profiles. While we observed a direct correlation between EGFR and antiproliferative effects on chordoma, GAK inhibition appeared to have only a limited effect." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b00350"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b00350">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b00350&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b00350&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b00350&amp;href=/doi/10.1021/acs.jmedchem.9b00350" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 4772-4778</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b00508" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Brief Article</span><a href="/doi/10.1021/acs.jmedchem.9b00559" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Christopher R. M. Asquith</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher R. M. Asquith</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div><div class="loa-info-affiliations-info">Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div></div><span class="conrtib-corresp"><strong>*</strong>For C.R.M.A.: phone, (919) 962-5349; e-mail, <a href="/cdn-cgi/l/email-protection#caa9a2b8a3b9e4abb9bbbfa3bea28abfa4a9e4afaebf"><span class="__cf_email__" data-cfemail="0b6863796278256a787a7e627f634b7e6568256e6f7e">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+R.+M.++Asquith">Christopher R. M. Asquith</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kaleb M. Naegeli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kaleb M. Naegeli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UNC Catalyst for Rare Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kaleb+M.++Naegeli">Kaleb M. Naegeli</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael P. East</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael P. East</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+P.++East">Michael P. East</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tuomo Laitinen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tuomo Laitinen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, 70211 Kuopio, Finland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tuomo++Laitinen">Tuomo Laitinen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tammy M. Havener</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tammy M. Havener</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UNC Catalyst for Rare Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tammy+M.++Havener">Tammy M. Havener</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Carrow I. Wells</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Carrow I. Wells</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Carrow+I.++Wells">Carrow I. Wells</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4799-6792" title="Orcid link">http://orcid.org/0000-0003-4799-6792</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gary L. Johnson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gary L. Johnson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gary+L.++Johnson">Gary L. Johnson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David H. Drewry</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David H. Drewry</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+H.++Drewry">David H. Drewry</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5973-5798" title="Orcid link">http://orcid.org/0000-0001-5973-5798</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">William J. Zuercher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">William J. Zuercher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div><div class="loa-info-affiliations-info">Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=William+J.++Zuercher">William J. Zuercher</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9836-0068" title="Orcid link">http://orcid.org/0000-0002-9836-0068</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">David C. Morris</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David C. Morris</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">UNC Catalyst for Rare Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</div></div><span class="conrtib-corresp"><strong>*</strong>For D.C.M.: phone, +1 (919) 445-2750; e-mail, <a href="/cdn-cgi/l/email-protection#4622273023682b2934342f350633282568232233"><span class="__cf_email__" data-cfemail="1672776073387b7964647f655663787538737263">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+C.++Morris">David C. Morris</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2910-7544" title="Orcid link">http://orcid.org/0000-0002-2910-7544</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00350&amp;href=/doi/10.1021%2Facs.jmedchem.9b00350" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 4772–4778</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 11, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 February 2019</li><li><span class="item_label"><b>Published</b> online</span>11 April 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 May 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b00350" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00350</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4772%26pageCount%3D7%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristopher%2BR.%2BM.%2BAsquith%252C%2BKaleb%2BM.%2BNaegeli%252C%2BMichael%2BP.%2BEast%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D9%26contentID%3Dacs.jmedchem.9b00350%26title%3DDesign%2Bof%2Ba%2BCyclin%2BG%2BAssociated%2BKinase%2B%2528GAK%2529%252FEpidermal%2BGrowth%2BFactor%2BReceptor%2B%2528EGFR%2529%2BInhibitor%2BSet%2Bto%2BInterrogate%2Bthe%2BRelationship%2Bof%2BEGFR%2Band%2BGAK%2Bin%2BChordoma%26numPages%3D7%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4778%26publicationDate%3DMay%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b00350"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1551</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b00350" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design of a Cyclin G Associated Kinase (GAK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Set to Interrogate the Relationship of EGFR and GAK in Chordoma&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;R. M. Asquith&quot;},{&quot;first_name&quot;:&quot;Kaleb&quot;,&quot;last_name&quot;:&quot;M. Naegeli&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;P. East&quot;},{&quot;first_name&quot;:&quot;Tuomo&quot;,&quot;last_name&quot;:&quot;Laitinen&quot;},{&quot;first_name&quot;:&quot;Tammy&quot;,&quot;last_name&quot;:&quot;M. Havener&quot;},{&quot;first_name&quot;:&quot;Carrow&quot;,&quot;last_name&quot;:&quot;I. Wells&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;L. Johnson&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;H. Drewry&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;J. Zuercher&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;C. Morris&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;4772-4778&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b00350&quot;},&quot;abstract&quot;:&quot;We describe the design of a set of inhibitors to investigate the relationship between cyclin G associated kinase (GAK) and epidermal growth factor receptor (EGFR) in chordoma bone cancers. These compounds were characterized both in vitro and using in cell target engagement assays. The most potent chordoma inhibitors were further characterized in a kinome-wide screen demonstrating narrow spectrum profiles. While we observed a direct correlation between EGFR and antiproliferative effects on chordoma, GAK inhibition appeared to have only a limited effect.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00350&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00350" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00350&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00350" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b00350&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00350" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b00350&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b00350&amp;href=/doi/10.1021/acs.jmedchem.9b00350" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b00350" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b00350" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00350&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b00350%26sid%3Dliteratum%253Aachs%26pmid%3D30973735%26genre%3Darticle%26aulast%3DAsquith%26date%3D2019%26atitle%3DDesign%2Bof%2Ba%2BCyclin%2BG%2BAssociated%2BKinase%2B%2528GAK%2529%252FEpidermal%2BGrowth%2BFactor%2BReceptor%2B%2528EGFR%2529%2BInhibitor%2BSet%2Bto%2BInterrogate%2Bthe%2BRelationship%2Bof%2BEGFR%2Band%2BGAK%2Bin%2BChordoma%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D9%26spage%3D4772%26epage%3D4778%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290795" title="Quinolines">Quinolines</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/jmcmar.2019.62.issue-9/20190509/jmcmar.2019.62.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/medium/jm-2019-003508_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00350&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We describe the design of a set of inhibitors to investigate the relationship between cyclin G associated kinase (GAK) and epidermal growth factor receptor (EGFR) in chordoma bone cancers. These compounds were characterized both in vitro and using in cell target engagement assays. The most potent chordoma inhibitors were further characterized in a kinome-wide screen demonstrating narrow spectrum profiles. While we observed a direct correlation between EGFR and antiproliferative effects on chordoma, GAK inhibition appeared to have only a limited effect.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44541" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44541" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chordomas are rare tumors arising along the bones of the central nervous system and spine with invasive and metastatic potential driven by the notochord transcription factor brachyury.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Largely due to the sensitive tissues affected, treatment of chordoma is challenging. The first line of treatment is generally radical resection with complementary proton therapy. Recurrent or metastatic disease is often fatal, as surgical and chemotherapeutic options are limited. Improved chordoma therapies will require a deeper understanding of the oncogenesis of chordomas and the molecular biology of the tumors.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a></div><div class="NLM_p">One promising chemotherapeutic avenue in chordoma is inhibition of the epidermal growth factor receptor (EGFR).<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> EGFR and its ligand, EGF, are highly expressed in chordomas, and copy number gains of EGFR occur in 40% of chordomas.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Compounds that inhibit EGFR have shown efficacy against independently derived chordoma cell lines and murine xenograft models.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> These results have led to clinical evaluation of the irreversible EGFR inhibitor afatinib for patients with EGFR-expressing tumors.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> EGFR inhibitors are not expected to be effective against all chordomas. For example, one patient-derived chordoma cell line overexpresses EGFR but exhibits marked resistance to EGFR inhibitors due to high levels of activated MET.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Hence there is need for chemotherapeutic targets beyond EGFR.</div><div class="NLM_p">EGFR inhibitors based on the anilino-quin(az)oline scaffold often carry concurrent cyclin G associated kinase (GAK) inhibitory activity, and modulation of either of these kinases may affect the expression/activity of the other.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> The quinazoline-based clinical kinase inhibitors gefitinib, erlotinib, afatinib, and vandetanib have activity in chordoma cell lines (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> These drugs were designed to target EGFR and show similar or higher affinity for GAK and several other kinases, making them ineffective tools for direct interrogation of EGFR and GAK biology. We were interested in separation of the activities of both GAK and EGFR to assess the potential of GAK as a therapeutic target for chordoma either as a single target or in combination with EGFR inhibition.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/medium/jm-2019-003508_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previously reported inhibitors of GAK and EGFR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00350&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46064" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46064" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">We first selected a set of literature inhibitors that covered a cross section of quinoline/quinazoline EGFR chemical space (Supporting Information, (SI), <a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">Figure S1</a>). The compounds and a pyrrolo[2,1-<i>f</i>][1,2,4]triazine (BMS 690514) were screened directly against two chordoma cell lines, U-CH1 and U-CH2 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), the latter of which is notably less sensitive to EGFR inhibitors.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The combination of the literature kinase cross-screening and chordoma cellular results enabled us to identify several kinases, including GAK as targets of interest, with EGFR and GAK the most prevalent across the series of inhibitors (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">Table S1</a>).<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14 ref15">(9−15)</a> There was not a linear relationship between EGFR and/or GAK inhibition and antiproliferative effects.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Literature Inhibitors Screening and Reported Activities</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn2" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center">U-CH1</th><th class="colsep0 rowsep0" align="center">U-CH2</th><th class="colsep0 rowsep0" align="center">EGFR<a class="ref internalNav" href="#t1fn3" aria-label="b">b</a><i>K</i><sub>D</sub> (nM)</th><th class="colsep0 rowsep0" align="center">GAK<a class="ref internalNav" href="#t1fn3" aria-label="b">b</a><i>K</i><sub>D</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">BMS 690514</td><td class="colsep0 rowsep0" align="center">0.53</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">220</td><td class="colsep0 rowsep0" align="center">0.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">sapitinib (AZD8931)</td><td class="colsep0 rowsep0" align="center">0.42</td><td class="colsep0 rowsep0" align="center">5.7</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 4.0<a class="ref internalNav" href="#t1fn1" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">poziotinib</td><td class="colsep0 rowsep0" align="center">0.11</td><td class="colsep0 rowsep0" align="center">8.1</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dacomitinib</td><td class="colsep0 rowsep0" align="center">0.05</td><td class="colsep0 rowsep0" align="center">2.7</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 6.0<a class="ref internalNav" href="#t1fn1" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">canertinib</td><td class="colsep0 rowsep0" align="center">0.08</td><td class="colsep0 rowsep0" align="center">17</td><td class="colsep0 rowsep0" align="center">0.19</td><td class="colsep0 rowsep0" align="center">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bosutinib</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="center">36</td><td class="colsep0 rowsep0" align="center">35</td><td class="colsep0 rowsep0" align="center">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">neratinib</td><td class="colsep0 rowsep0" align="center">5.5</td><td class="colsep0 rowsep0" align="center">2.4</td><td class="colsep0 rowsep0" align="center">1.1</td><td class="colsep0 rowsep0" align="center">250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">saracatinib</td><td class="colsep0 rowsep0" align="center">4.3</td><td class="colsep0 rowsep0" align="center">28</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 66<a class="ref internalNav" href="#t1fn1" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pelitinib (EKB-569)</td><td class="colsep0 rowsep0" align="center">0.09</td><td class="colsep0 rowsep0" align="center">1.6</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 39<a class="ref internalNav" href="#t1fn1" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">tesevatinib (XL-647)</td><td class="colsep0 rowsep0" align="center">0.15</td><td class="colsep0 rowsep0" align="center">1.1</td><td class="colsep0 rowsep0" align="center">IC<sub>50</sub> = 0.30<a class="ref internalNav" href="#t1fn1" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vandetanib</td><td class="colsep0 rowsep0" align="center">1.0</td><td class="colsep0 rowsep0" align="center">4.2</td><td class="colsep0 rowsep0" align="center">9.5</td><td class="colsep0 rowsep0" align="center">86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">afatinib</td><td class="colsep0 rowsep0" align="center">0.10</td><td class="colsep0 rowsep0" align="center">6.4</td><td class="colsep0 rowsep0" align="center">0.30</td><td class="colsep0 rowsep0" align="center">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">gefitinib</td><td class="colsep0 rowsep0" align="center">1.4</td><td class="colsep0 rowsep0" align="center">23</td><td class="colsep0 rowsep0" align="center">1.0</td><td class="colsep0 rowsep0" align="center">13</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn2"><div class="footnote" id="t1fn2"><sup><sup>a</sup></sup><p class="last">Standard mean (n = 1−3 see SI for errors).</p></div><div class="footnote" id="t1fn3"><sup><sup>b</sup></sup><p class="last">Literature reported values.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13 ref14 ref15">(9−15)</a></p></div><div class="footnote" id="t1fn1"><sup><sup>c</sup></sup><p class="last">Enzyme assay IC<sub>50</sub></p></div></div></div><div class="NLM_p">The different and sometimes broad kinome inhibition profiles possessed by each inhibitor was a confounding factor in establishing the molecular basis for the cellular activity. There appeared to be a trend between inhibiting GAK or EGFR and effects on the U-CH1 cell line. In several cases, potent EGFR inhibition led to a strong response in U-CH1 with a generally weaker response in U-CH2. The effects of GAK inhibition were less clear, but BMS-690514 showed moderate potency against U-CH1 with relatively weak EGFR activity and a potent GAK profile with a >700-fold window over EGFR.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> BMS-690514 had five other kinases with <i>K</i><sub>D</sub> < 225 nM, including RET, ABL2, SIK2, ABL1, PRKD2, and TNK2. The inhibition of any of these kinases, alone or in combination, could be responsible for the growth phenotype observed in U-CH1, confounding the interpretation of the result.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">We sought to determine the effect of both GAK and EGFR inhibition utilizing the 4-anilino-quin(az)oline scaffold. Molecular modeling of the scaffold in GAK and EGFR (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A–D) showed an ability to increase selectivity for EGFR over GAK by utilizing the deeper hydrophobic pocket of EGFR not present in GAK (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">Figures S2–S6</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/medium/jm-2019-003508_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design strategy for GAK/EGFR inhibitors: (A) Erlotinib docked in GAK (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y8D">4Y8D</a>) and (B) <b>3</b> docked in GAK (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y8D">4Y8D</a>) and (C) lapatinib docked in EGFR (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XKK">1XKK</a>) and (D) <b>15</b> docked in EGFR (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XKK">1XKK</a>) demonstrating the hydrophobic pocket (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">SI</a> for detailed images).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00350&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We synthesized compounds <b>1</b>–<b>16</b>, <b>18</b>, and <b>19</b> through nucleophilic aromatic displacement of 4-chloroquin(az)olines (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>) to furnish the products in good yields (52–89%). The only low yielding analogue was the trifluoromethyl quinazoline (<b>2</b>), which was consistent with previous reports and likely arose from attenuation of aniline nucleophilicity by the powerful electron withdrawing effect of the trifluoro group.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/medium/jm-2019-003508_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Procedure</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00350&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We designed the compounds to exploit the structure–activity relationships between GAK and EGFR within the quin(az)oline scaffold. We first screened the compounds in heterogeneous assays for GAK and EGFR binding involving displacement of kinase protein from an immobilized inhibitor. Then to assess the in-cell target engagement, compounds were assessed in a GAK nanoBRET assay for the ability of the compound to displace a fluorescent tracer molecule from the ATP binding site of full length GAK protein <i>N</i>-terminally fused with NanoLuc luciferase (Nluc) transiently expressed in HEK293T cells. The tracer molecule and fusion protein are able to generate an observable bioluminescence resonance energy transfer (BRET) signal, when they are in proximity and without a bound inhibitor.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> EGFR cellular activity was assessed using an EGFR phosphorylation assay in the human epidermoid carcinoma cell line A431. This cell line endogenously expresses a high level of EGFR, and stimulation of these cells with human epidermal growth factor (EGF) results in receptor tyrosine autophosphorylation (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. GAK and EGFR in Vitro and in Cell Biochemical Characterization</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/medium/jm-2019-003508_0005.gif" alt="" id="GRAPHIC-d7e795-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">EGFR<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><i>K</i><sub>D</sub> (nM)</th><th class="colsep0 rowsep0" align="center">GAK<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a><i>K</i><sub>D</sub> (nM)</th><th class="colsep0 rowsep0" align="center">in cell<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a> EGFR IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">NanoBRET<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a> GAK IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>1</b></td><td class="colsep0 rowsep0" align="center">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">CH</td><td class="colsep0 rowsep0" align="center">3,4,5-(OMe)<sub>3</sub></td><td class="colsep0 rowsep0" align="center"><50% @ 1 μM<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></td><td class="colsep0 rowsep0" align="center">31<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></td><td class="colsep0 rowsep0" align="center">>50000</td><td class="colsep0 rowsep0" align="center">170</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>2</b></td><td class="colsep0 rowsep0" align="center">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">3,4,5-(OMe)<sub>3</sub></td><td class="colsep0 rowsep0" align="center">6100<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></td><td class="colsep0 rowsep0" align="center">190<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></td><td class="colsep0 rowsep0" align="center">>50000</td><td class="colsep0 rowsep0" align="center">60% @ 5 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>3</b></td><td class="colsep0 rowsep0" align="center">Br</td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">CH</td><td class="colsep0 rowsep0" align="center">3,4,5-(OMe)<sub>3</sub></td><td class="colsep0 rowsep0" align="center"><50% @ 1 μM<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></td><td class="colsep0 rowsep0" align="center">1.9<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></td><td class="colsep0 rowsep0" align="center">>50000</td><td class="colsep0 rowsep0" align="center">48</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>4</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">CH</td><td class="colsep0 rowsep0" align="center">3,4,5-(OMe)<sub>3</sub></td><td class="colsep0 rowsep0" align="center">410</td><td class="colsep0 rowsep0" align="center">2.9<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></td><td class="colsep0 rowsep0" align="center">27000</td><td class="colsep0 rowsep0" align="center">23</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>5</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">3,4,5-(OMe)<sub>3</sub></td><td class="colsep0 rowsep0" align="center">22</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="center">5400</td><td class="colsep0 rowsep0" align="center">350</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>6</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">C–CN</td><td class="colsep0 rowsep0" align="center">3,4,5-(OMe)<sub>3</sub></td><td class="colsep0 rowsep0" align="center">7.4</td><td class="colsep0 rowsep0" align="center">0.42</td><td class="colsep0 rowsep0" align="center">7100</td><td class="colsep0 rowsep0" align="center">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>7</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">CH</td><td class="colsep0 rowsep0" align="center">3-ethynyl</td><td class="colsep0 rowsep0" align="center">0.27</td><td class="colsep0 rowsep0" align="center">7.6</td><td class="colsep0 rowsep0" align="center">42</td><td class="colsep0 rowsep0" align="center">500</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>8</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">3-ethynyl</td><td class="colsep0 rowsep0" align="center">0.55</td><td class="colsep0 rowsep0" align="center">6.8</td><td class="colsep0 rowsep0" align="center">19</td><td class="colsep0 rowsep0" align="center">72</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>9</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">C–CN</td><td class="colsep0 rowsep0" align="center">3-ethynyl</td><td class="colsep0 rowsep0" align="center">1.8</td><td class="colsep0 rowsep0" align="center">2.6</td><td class="colsep0 rowsep0" align="center">61</td><td class="colsep0 rowsep0" align="center">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>10</b></td><td class="colsep0 rowsep0" align="center">6,7-(OCH<sub>2</sub>CH<sub>2</sub>OMe)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">6,7-(OCH<sub>2</sub>CH<sub>2</sub>OMe)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">3,4,5-(OMe)<sub>3</sub></td><td class="colsep0 rowsep0" align="center">53</td><td class="colsep0 rowsep0" align="center">150</td><td class="colsep0 rowsep0" align="center">2400</td><td class="colsep0 rowsep0" align="center">2600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">erlotinib</td><td class="colsep0 rowsep0" align="center">6,7-(OCH<sub>2</sub>CH<sub>2</sub>OMe)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">6,7-(OCH<sub>2</sub>CH<sub>2</sub>OMe)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">3-ethynyl</td><td class="colsep0 rowsep0" align="center">0.70<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></td><td class="colsep0 rowsep0" align="center">3.1<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">910</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>11</b></td><td class="colsep0 rowsep0" align="center">6,7-(OCH<sub>2</sub>CH<sub>2</sub>OMe)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">6,7-(OCH<sub>2</sub>CH<sub>2</sub>OMe)<sub>2</sub></td><td class="colsep0 rowsep0" align="center">CH</td><td class="colsep0 rowsep0" align="center">3-ethynyl</td><td class="colsep0 rowsep0" align="center">390</td><td class="colsep0 rowsep0" align="center">1200</td><td class="colsep0 rowsep0" align="center">340</td><td class="colsep0 rowsep0" align="center">4200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>12</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">CH</td><td class="colsep0 rowsep0" align="center">3-Br</td><td class="colsep0 rowsep0" align="center">58</td><td class="colsep0 rowsep0" align="center">240</td><td class="colsep0 rowsep0" align="center">170</td><td class="colsep0 rowsep0" align="center">510</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>13</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">3-Br</td><td class="colsep0 rowsep0" align="center">0.32<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></td><td class="colsep0 rowsep0" align="center">29<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></td><td class="colsep0 rowsep0" align="center"><15</td><td class="colsep0 rowsep0" align="center">260</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>14</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">C–CN</td><td class="colsep0 rowsep0" align="center">3-Br</td><td class="colsep0 rowsep0" align="center">2.4</td><td class="colsep0 rowsep0" align="center">12</td><td class="colsep0 rowsep0" align="center">90</td><td class="colsep0 rowsep0" align="center">130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>15</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">CH</td><td class="colsep0 rowsep0" align="center">3-Cl, 4-OCH<sub>2</sub>(3-F-Ph)</td><td class="colsep0 rowsep0" align="center">32</td><td class="colsep0 rowsep0" align="center">>10000</td><td class="colsep0 rowsep0" align="center">1700</td><td class="colsep0 rowsep0" align="center">22% @ 5 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>16</b></td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">OMe</td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">3-Cl, 4-OCH<sub>2</sub>(3-F-Ph)</td><td class="colsep0 rowsep0" align="center">1.3</td><td class="colsep0 rowsep0" align="center">5000</td><td class="colsep0 rowsep0" align="center"><15</td><td class="colsep0 rowsep0" align="center">12% @ 5 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">lapatinib</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">3-Cl, 4-OCH<sub>2</sub>(3-F-Ph)</td><td class="colsep0 rowsep0" align="center">11<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></td><td class="colsep0 rowsep0" align="center"><50% @ 1 μM<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></td><td class="colsep0 rowsep0" align="center">21</td><td class="colsep0 rowsep0" align="center">0% @ 5 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17</b></td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">CH</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"><50% @ 1 μM<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></td><td class="colsep0 rowsep0" align="center"><50% @ 1 μM<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></td><td class="colsep0 rowsep0" align="center">>50000</td><td class="colsep0 rowsep0" align="center">0% @ 5 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>18</b></td><td class="colsep0 rowsep0" align="center">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">CH</td><td class="colsep0 rowsep0" align="center">3,4,5-(OMe)<sub>3</sub></td><td class="colsep0 rowsep0" align="center"><50% @ 1 μM<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></td><td class="colsep0 rowsep0" align="center">7.1 μM<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></td><td class="colsep0 rowsep0" align="center">2200</td><td class="colsep0 rowsep0" align="center">7% @ 5 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>19</b></td><td class="colsep0 rowsep0" align="center">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="center">H</td><td class="colsep0 rowsep0" align="center">CH</td><td class="colsep0 rowsep0" align="center">3,4,5-(OMe)<sub>3</sub></td><td class="colsep0 rowsep0" align="center"><50% @ 1 μM<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></td><td class="colsep0 rowsep0" align="center"><50% @ 1 μM<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></td><td class="colsep0 rowsep0" align="center">>50000</td><td class="colsep0 rowsep0" align="center">0% @ 5 μM</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">gefitinib</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">N</td><td class="colsep0 rowsep0" align="center">4-F, 3-Cl</td><td class="colsep0 rowsep0" align="center">1.0<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></td><td class="colsep0 rowsep0" align="center">13<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></td><td class="colsep0 rowsep0" align="center"><15</td><td class="colsep0 rowsep0" align="center">420</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">DiscoverX binding assay (<i>n</i> = 2).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">ProQinase In-cell assay (<i>n</i> = 1).</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">NanoBRET (<i>n</i> = 1–3)</p></div></div></div><div class="NLM_p">Compound <b>1</b> was previously identified as a narrow spectrum inhibitor of GAK with only three other off-targets having <i>K</i><sub>D</sub> < 1 μM in a kinome-wide screen and a negligible affinity for EGFR at 1 μM.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18−20)</a> The corresponding quinazoline (<b>2</b>) had a 6-fold drop off in vitro and a 26-fold drop off in cells against GAK but a corresponding increase in EGFR biochemical activity.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Compound <b>3</b>, in which the trifluoromethyl of <b>1</b> was replaced by bromine, was highly selective, with only RIPK2 as an off-target across the kinome and a small increase in GAK cellular potency.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Previous reports suggested the activity of the quin(az)oline can be independently modulated for both GAK and EGFR while maintaining a narrow spectrum profile across the kinome. The switch to the 6,7-dimethoxy substitution (<b>4</b>) showed potent GAK activity both biochemically and in cells.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> However, <b>4</b> possessed previously uncharacterized EGFR activity albeit with a 140-fold window in vitro and only limited cell activity. The quinazoline (<b>5</b>) and 3-cyanoquinoline (<b>6</b>) both showed improved potency with both GAK and EGFR with <b>6</b> showing low single-digit nanomolar potency in cells against GAK. <b>6</b> is the most potent GAK inhibitor reported to date.</div><div class="NLM_p">The switch to the <i>meta</i>-acetylene (<b>7</b>–<b>9</b>) across the same range of hinge-binding motif maintained GAK activity but significantly increased the potency of cellular target engagement against EGFR by more than 100-fold across the three compounds. This trend was mirrored when extending the 6,7-dimethoxy substitution to the 6,7-dimethoxyethoxy seen in erlotinib. The matched pairs of <b>10</b>/erlotinib and <b>11</b>/erlotinib demonstrate a well of activity around the quinazoline of erlotinib. We observed a significant decrease in EGFR inhibition potency with the switch from quinazoline to quinoline which is consistent with most matched pairs in the series and consistent with a previous report on EGFR inhibition for <b>11</b>/erlotinib.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> However, the drop in GAK activity between erlotinib and <b>11</b> was more surprising and suggested a more complex structure–activity relationship when extending beyond small substitutions on the quino(az)oline ring system. Surprisingly erlotinib had a very weak GAK cellular engagement despite a single–digit nanomolar <i>K</i><sub>D</sub>.</div><div class="NLM_p">A switch to a <i>meta</i>-bromo (<b>12</b>–<b>14</b>) to increase the occupancy of the ATP binding pocket led to an observed decrease in GAK activity both biochemically and in cells. The EGFR activity in this series increased with cellular potency approaching single-digit nanomolar for <b>13</b>. This result demonstrated that GAK activity of the 4-anilino-quino(az)oline scaffold can be reduced while maintaining potency on other kinases. We then sought to exploit the lapatinib scaffold to remove GAK activity (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). We designed <b>15</b> and <b>16</b> using the lapatinib aniline portion as the “headgroup” while having a simple 6,7-dimethoxy substituted quinoline (<b>15</b>) or quinazoline (<b>16</b>). These compounds demonstrated very limited GAK activity but moderate potency on EGFR both biochemically and in cells. We also included several control compounds (<b>17</b>–<b>19</b>) to counteract the off-target RIPK2 activity associated with this series (<b>17</b>) and the controls (<b>18</b>,<b>19</b>) that showed only limited activity.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Gefitinib showed an activity profile similar to erlotinib and lapatinib in both U-CH1 and U-CH2. We then screened these compounds using two clinically relevant chordoma cell lines, with different clinical presentations (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Chordoma and Fibroblast Screening Results</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">U-CH1</th><th class="colsep0 rowsep0" align="center">U-CH2</th><th class="colsep0 rowsep0" align="center">WS1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">33</td><td class="colsep0 rowsep0" align="center">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="center">50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="center">25</td><td class="colsep0 rowsep0" align="center">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="center">7.3</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">2.1</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">7.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">0.92</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">4.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="center">17</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="center">25</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">erlotinib</td><td class="colsep0 rowsep0" align="center">5.1</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">8.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="center">7.6</td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="center">3.6</td><td class="colsep0 rowsep0" align="center">7.9</td><td class="colsep0 rowsep0" align="center">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center">0.66</td><td class="colsep0 rowsep0" align="center">26</td><td class="colsep0 rowsep0" align="center">9.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center">8.8</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="center">2.6</td><td class="colsep0 rowsep0" align="center">2.9</td><td class="colsep0 rowsep0" align="center">8.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lapatinib</td><td class="colsep0 rowsep0" align="center">3.2</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="center">37</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">gefitinib</td><td class="colsep0 rowsep0" align="center">1.4</td><td class="colsep0 rowsep0" align="center">23</td><td class="colsep0 rowsep0" align="center">23</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Standard mean in (<i>n</i> = 1–3 see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">SI</a> for errors).</p></div></div></div><div class="NLM_p">We first screened the compounds containing the trimethoxy aniline (<b>1</b>–<b>3</b>) with in-cell GAK potency and no in-cell EGFR activity and found only a hint of inhibition on U-CH2 cell line with <b>1</b>. Increasing the potency on GAK with a change in substitution to 6,7-dimethoxy and a range of hinge binders (<b>4</b>–<b>6</b>) yielded a boost in potency on U-CH1 by more than 5-fold to single-digit micromolar for <b>5</b>, without increased toxicity in normal human skin fibroblast (WS1) cells.</div><div class="NLM_p">The <i>meta</i>-acetylenes (<b>6</b>–<b>9</b>) yielded a further potency boost, potentially due to the corresponding increase in EGFR activity. <b>7</b> and <b>8</b> showed some WS1 inhibition, with no activity on U-CH2. Interestingly the 3-cyano quinoline matched pair derivative (<b>9</b>) showed no toxicity on WS1 consistent with compound <b>6</b>. Combining the erlotinib quinazoline fragment with the trimethoxy aniline (<b>10</b>) showed limited activity on all cell lines. Erlotinib and the erlotinib quinoline derivative (<b>11</b>) had activity on all cell lines with some WS1 toxicity. However, there was only limited improvement in potency relative to <b>4</b> for both U-CH1 and U-CH2 and no improvement compared to both <b>7</b> and <b>8</b> for U-CH1.</div><div class="NLM_p">Installation of the <i>meta</i>-bromine on the 6,7-dimethoxy core (<b>12</b>–<b>14</b>) increased EGFR activity and proved to be the most effective set of compounds tested with the matched pair <b>12</b> and <b>13</b> showing that the quinoline (<b>12</b>) is favored for U-CH2 growth inhibition, and the quinazoline (<b>13</b>) is favored for U-CH1. <b>14</b> was considerably less active than <b>12</b> and <b>13</b>. Compound <b>13</b> was most potent compound tested against U-CH1 (IC<sub>50</sub> = 0.66 μM), but the more striking result was the EGFR inhibitor-resistant cell line U-CH2 showed relatively high sensitivity to <b>12</b>.</div><div class="NLM_p">The two lapatinib derivatives <b>15</b> and <b>16</b> containing the lapatinib aniline and the 6,7-dimethoxy core were designed to remove the influence of GAK inhibition from any phenotypic response. The quinoline (<b>15</b>) showed the highest potency against U-CH2 (IC<sub>50</sub> = 2.9 μM) with only limited toxicity. However, this compound showed weak EGFR activity in cells, confounding target identification. In contrast, <b>16</b> showed high cellular EGFR potency and only activity against U-CH1. As previously reported, lapatinib had low micromolar activity against U-CH1 and no activity against U-CH2 at the concentrations tested.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> We also observed WS1 toxicity with several compounds in the micromolar range. The RIPK2 control compound <b>17</b> with no GAK or EGFR activity had weak or no chordoma cell line inhibition as did <b>18</b> and <b>19</b>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Gefitinib was the only literature compound to show some activity on U-CH2 with a comparable profile to lapatinib on the other cell lines.</div><div class="NLM_p">The compounds that showed the highest efficacy against the U-CH2 cell line were then evaluated against five further patient-derived chordoma cell lines (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). The five cells lines showed varying inhibitor sensitivity, but all appeared less responsive than U-CH1, an observation consistent with previous reports (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Investigation of across Five Chordoma Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="5" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">name</th><th class="colsep0 rowsep0" align="center">U-CH7</th><th class="colsep0 rowsep0" align="center">UMChor1</th><th class="colsep0 rowsep0" align="center">CH22</th><th class="colsep0 rowsep0" align="center">U-CH12</th><th class="colsep0 rowsep0" align="center">U-CH14</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">24</td><td class="colsep0 rowsep0" align="center">12</td><td class="colsep0 rowsep0" align="center">33</td><td class="colsep0 rowsep0" align="center">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">14</td><td class="colsep0 rowsep0" align="center">13</td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">23</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">erlotinib</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">17</td><td class="colsep0 rowsep0" align="center">6.5</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="center">2.7</td><td class="colsep0 rowsep0" align="center">1.5</td><td class="colsep0 rowsep0" align="center">1.0</td><td class="colsep0 rowsep0" align="center">5.5</td><td class="colsep0 rowsep0" align="center">7.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">lapatinib</td><td class="colsep0 rowsep0" align="center">26</td><td class="colsep0 rowsep0" align="center">25</td><td class="colsep0 rowsep0" align="center">25</td><td class="colsep0 rowsep0" align="center">33</td><td class="colsep0 rowsep0" align="center">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">gefitinib</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td><td class="colsep0 rowsep0" align="center">>50</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Standard mean (<i>n</i> = 1–3 see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">SI</a> for errors)</p></div></div></div><div class="NLM_p">Compound <b>4</b> showed moderate activity across all cell lines consistent with the matched pair quinoline <b>7</b>. The switch to a quinazoline (<b>8</b>) produced quite a different profile with no activity against CH22, U-CH12, and U-CH14. Erlotinib was inactive up to 50 μM against all cell lines. The quinoline (<b>12</b>) displayed a similar profile to <b>8</b> with no activity against U-CH12, U-CH14, and U-CH7; with sensitivity against UMChor1 and CH22, with only UMChor1 consistent between both <b>8</b> and <b>12</b>. Compound <b>15</b> showed single- digit micromolar activity across all five cell lines and U-CH1 and U-CH2, with lapatinib showing a general >10-fold drop off in potency across the panel relative to U-CH1. Gefitinib only showed activity on the apparent most sensitive cell line UMChor1 despite moderate activity on U-CH1 and U-CH2.</div><div class="NLM_p">Having established activity in U-CH1 and U-CH2 cell lines, we next wanted to investigate downstream effects on EGFR (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Short-term compound treatment with <b>7</b> or <b>8</b> in U-CH1 and U-CH2 cells did not affect total EGFR levels; however, phosphorylated EGFR was reduced, indicative of reduced EGFR signaling, a phenotype consistent with the action of other EGFR inhibitors in chordoma.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> The reduction was quantified (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>) and showed that <b>8</b> was a more potent inhibitor than <b>7</b> of EGFR phosphorylation in chordoma cells (U-CH1 and U-CH2) supporting in the EGFR in-cell target engagement assay (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>) and the antiproliferative effect observed (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/medium/jm-2019-003508_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Western blot of p-EGFR (Y1068) and EGFR: Lane 1, untreated; lane 2, <b>7</b> (10 μM); lane 3, <b>7</b>(1 μM); lane 4, <b>8</b> (10 μM); lane 5, <b>8</b> (1 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00350&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Quantification of p-EGFR Reduction</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">U-CH1<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="rowsep1 colsep0" colspan="2" align="center">U-CH2<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">10 μM</th><th class="colsep0 rowsep0" align="center">1 μM</th><th class="colsep0 rowsep0" align="center">10 μM</th><th class="colsep0 rowsep0" align="center">1 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><b>7</b></td><td class="colsep0 rowsep0">60.8</td><td class="colsep0 rowsep0">0</td><td class="colsep0 rowsep0">71.3</td><td class="colsep0 rowsep0">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0"><b>8</b></td><td class="colsep0 rowsep0">100</td><td class="colsep0 rowsep0">63.4</td><td class="colsep0 rowsep0">100</td><td class="colsep0 rowsep0">100</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Percent signal remaining compared to untreated.</p></div></div></div><div class="NLM_p last">Compound <b>4</b> showed a narrow spectrum kinome profile. Only GAK and RIPK2 were bound by <b>4</b> as assessed by multiplexed kinase inhibitor bead set (MIBS) and quantitative mass spectrometry (MS) detection of kinase peptides.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The kinome selectivity profile of the other lead compounds (<b>7</b>, <b>8</b>, <b>12</b>, and <b>15</b>) displayed narrow spectrum kinome profiles on >300 wild-type kinases (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">14.1</a>). Compound <b>7</b> bound GAK, RIPK2, NEK1, and STRADA (LYK5), while <b>8</b> associated only with GAK and EGFR. Compound <b>12</b> had binding to GAK, EGFR, PKM, and BUB1, while <b>15</b> showed binding to EGFR, AURKB, MAP2K5, and NME2.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15153" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15153" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Chordoma is a difficult cancer to treat due to its slow growing nature and the integrated microenvironment surrounded by delicate tissues around the tumor. Chordomas have a high level of variance in presentation and susceptibility to treatment. This heterogeneity precludes a general approach to treatment and necessitates the need for personalization. EGFR inhibitors have been used to target chordomas, but the variation in efficacy across inhibitors is not presently understood and likely driven by off-target effects working additively or synergistically with EGFR inhibition. Conversely, the off-target kinases could also be limiting efficacy.</div><div class="NLM_p last">GAK is unlikely to be one of these targets with compound <b>3</b> and the corresponding controls (<b>18</b>,<b>19</b>) showing limited effect. However, as EGFR inhibition is increased the efficiency of the compounds also increases. Compound <b>13</b> is the most potent compound ever tested against U-CH1, which is likely due to high in-cell potency on EGFR. The matched pair compound <b>12</b> was a more significant result with increased potency on the U-CH2 cell line relative to <b>13</b>. However, compound <b>15</b>, a derivative of lapatinib demonstrated the most diverse inhibition profile across patient derived cell lines with marginal selectivity over normal human skin fibroblast (WS1) toxicity. This broad-spectrum anticancer activity against a panel of chordoma cell lines, despite being inactive in GAK assays and only weakly active in the cellular EGFR assay. Interestingly we observed that a switch between the quinazoline (<b>8</b>) and quinoline (<b>7</b>) produced a radically different profile with no activity against CH22, U-CH12, and U-CH14, highlighting the complexity of chordoma biology.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46878" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46878" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">This set of compounds provides a useful tool for the interrogation of GAK and EGFR and enables multipoint separation of their phenotypes. Profiling of the compounds with MIBS revealed that the compounds have a narrow kinome profile with GAK and EGFR likely the principal components of activity and biology observed.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37458" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37458" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Biology and Screening</h3><div class="NLM_p last">Chordoma cell lines were cultured as described previously (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">SI</a> for details). Screening was performed on multiple platforms (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">SI</a> for details).<a onclick="showRef(event, 'ref6 ref18'); return false;" href="javascript:void(0);" class="ref ref6 ref18">(6,18)</a></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> MIBS</h3><div class="NLM_p last">Kinome profiling was performed as previously described (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">SI</a> for details).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Computational Modeling</h3><div class="NLM_p last">Modeling was performed using Schrödinger Maestro software (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">SI</a> for details).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Chemistry</h3><div class="NLM_p last">Compounds <b>1</b>–<b>5</b>, <b>7</b>, <b>12</b>, <b>18</b>, and <b>19</b> were synthesized as previously reported, and <b>1</b>–<b>5</b>, <b>7</b>, <b>12</b>, <b>18</b>, and <b>19</b> were consistent with previous reports.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> Compound <b>17</b> was purchased from MedChemExpress (Monmouth Junction, NJ, USA). Compound characterization and spectra of <b>6</b>, <b>9</b>–<b>11</b>, <b>13</b>, <b>14</b>, and <b>16</b> and spectra of <b>8</b> and <b>15</b> are included in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">SI</a>. All compounds were >98% pure by <sup>1</sup>H/<sup>13</sup>C NMR and LCMS.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General Procedure for the Synthesis of 4-Anilinoquinolines</h3><div class="NLM_p">6-Bromo-4-chloroquinoline (1.0 equiv), 3,4,5-trimethoxyaniline (1.1 equiv), and <sup>i</sup>Pr<sub>2</sub>NEt (2.5 equiv) were suspended in ethanol (10 mL) and refluxed for 18 h. The crude mixture was purified by flash chromatography using EtOAc:hexane followed by 1–5% methanol in EtOAc. After solvent removal under reduced pressure, the product was obtained as a free following solid or recrystallized from ethanol/water. Compounds (<b>1</b>, <b>2</b>, <b>4</b>, <b>5</b>, <b>7</b>, <b>12</b>);<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (<b>3</b>, <b>18</b>, <b>19</b>).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> <i>N</i>-(3-Ethynylphenyl)-6,7-dimethoxyquinazolin-4-amine (<b>8</b>)</h4><div class="NLM_p last">Colorless solid (181 mg, 0.594 mmol, 89%); mp 237–239 °C. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.48 (s, 1H), 8.85 (s, 1H), 8.38 (s, 1H), 7.88 (t, <i>J</i> = 1.8 Hz, 1H), 7.79 (ddd, <i>J</i> = 8.1, 2.2, 1.1 Hz, 1H), 7.49 (t, <i>J</i> = 7.8 Hz, 1H), 7.40 (dt, <i>J</i> = 7.7, 1.3 Hz, 1H), 7.37 (s, 1H), 4.28 (s, 1H), 4.02 (s, 3H), 3.99 (s, 3H). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 158.1, 156.3, 150.2, 148.8, 137.4, 136.0, 129.2, 129.2, 127.6, 125.3, 122.0, 107.4, 104.1, 99.9, 82.9, 81.3, 57.0, 56.5. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>16</sub>N<sub>3</sub>O<sub>2</sub> 290.1293, found 306.1230. LC <i>t</i><sub>R</sub> = 3.41 min, >98% purity.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>N</i>-[3-Chloro-4-(3-fluorophenoxymethyl)phenyl]-6,7-dimethoxyquinolin-4-amine (<b>15</b>)</h4><div class="NLM_p last">Colorless solid (200 mg, 0.456 mmol, 68%); mp 244–246 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.78 (s, 1H), 8.32 (d, <i>J</i> = 6.9 Hz, 1H), 8.19 (s, 1H), 7.62 (d, <i>J</i> = 2.5 Hz, 1H), 7.61–7.21 (m, 6H), 7.26–7.11 (m, 1H), 6.64 (d, <i>J</i> = 6.9 Hz, 1H), 5.31 (s, 2H), 4.00 (s, 3H), 3.96 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 162.2 (d, <i>J</i> = 243.7 Hz), 154.5, 153.3, 152.2, 149.4, 139.8, 139.3 (d, <i>J</i> = 7.6 Hz), 135.2, 131.1, 130.6 (d, <i>J</i> = 8.4 Hz), 127.4, 125.7, 123.4 (d, <i>J</i> = 2.7 Hz), 122.2, 115.0, 114.8 (d, <i>J</i> = 20.9 Hz), 114.1 (d, <i>J</i> = 21.9 Hz), 111.5, 102.8, 99.8, 99.1, 69.5 (d, <i>J</i> = 1.9 Hz), 56.8, 56.1. HRMS <i>m</i>/<i>z</i> [M + H]<sup>+</sup> calcd for C<sub>24</sub>H<sub>21</sub>N<sub>2</sub>O<sub>3</sub>ClF 439.1225, found 439.1213. LC <i>t</i><sub>R</sub> = 5.28 min, >98% purity.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20"><a href="/doi/suppl/10.1021/acs.jmedchem.9b00350" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13131" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13131" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.9b00350" class="ext-link">10.1021/acs.jmedchem.9b00350</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures for the synthesis of intermediates together with biological data and associated errors, NMR conformation, and molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf">jm9b00350_si_001.pdf (8.0 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_002.csv">jm9b00350_si_002.csv (3.59 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b00350" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher R. M. Asquith</span> - <span class="hlFld-Affiliation affiliation">Structural
Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0162697368722f6072707468756941746f622f646574"><span class="__cf_email__" data-cfemail="44272c362d376a253735312d302c04312a276a212031">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David C. Morris</span> - <span class="hlFld-Affiliation affiliation">UNC
Catalyst for Rare Diseases, University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2910-7544" title="Orcid link">http://orcid.org/0000-0002-2910-7544</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7c181d0a195211130e0e150f3c09121f52191809"><span class="__cf_email__" data-cfemail="2e4a4f584b0043415c5c475d6e5b404d004b4a5b">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kaleb M. Naegeli</span> - <span class="hlFld-Affiliation affiliation">UNC
Catalyst for Rare Diseases, University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael P. East</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tuomo Laitinen</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, 70211 Kuopio, Finland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tammy M. Havener</span> - <span class="hlFld-Affiliation affiliation">UNC
Catalyst for Rare Diseases, University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Carrow I. Wells</span> - <span class="hlFld-Affiliation affiliation">Structural
Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4799-6792" title="Orcid link">http://orcid.org/0000-0003-4799-6792</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary L. Johnson</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmacology, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David H. Drewry</span> - <span class="hlFld-Affiliation affiliation">Structural
Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5973-5798" title="Orcid link">http://orcid.org/0000-0001-5973-5798</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William J. Zuercher</span> - <span class="hlFld-Affiliation affiliation">Structural
Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Lineberger
Comprehensive Cancer Center, University
of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9836-0068" title="Orcid link">http://orcid.org/0000-0002-9836-0068</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors approved of the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08222" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08222" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The SGC is a registered charity (no. 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z]. The UNC Catalyst for Rare Diseases is supported by UNC–CH and Eshelman Institute for Innovation. We thank Biocenter Finland/DDCB for financial support and the CSC-IT Center for Science Ltd. (Finland) for allocation of computational resources and Prof. Antti Poso (University of Eastern Finland) is thanked for informative discussions. We are grateful to the Chordoma Foundation for providing the cell lines and Dr. Brandie Ehrmann for LC-MS/HRMS support provided by the Mass Spectrometry Core Laboratory at the University of North Carolina at Chapel Hill. We also thank the team at ProQinase for their assistance and advice.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">GAK</td><td class="NLM_def"><p class="first last">cyclin G associated kinase</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">MIBS</td><td class="NLM_def"><p class="first last">multiplexed kinase inhibitor bead set</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16885" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16885" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 21 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">George, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bresson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froelich, S.</span></span> <span> </span><span class="NLM_article-title">Chordomas: A review</span>. <i>Neurosurg Clin N Am.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1016/j.nec.2015.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1016%2Fj.nec.2015.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=26141362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FgtVCquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=437-452&issue=3&author=B.+Georgeauthor=D.+Bressonauthor=P.+Hermanauthor=S.+Froelich&title=Chordomas%3A+A+review&doi=10.1016%2Fj.nec.2015.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Chordomas: A Review</span></div><div class="casAuthors">George Bernard; Bresson Damien; Herman Philippe; Froelich Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Neurosurgery clinics of North America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-52</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chordomas (CHs) are tumors with benign histopathology but exhibit aggressive clinical behavior with invasive and metastatic potential.  CHs are challenging tumors to treat, and there are still many questions especially about their optimum treatment.  Radical resection at first presentation should be applied on all CHs.  Complementary proton therapy irrespective of the quality of resection is now routinely proposed even if its efficacy is not clearly demonstrated in case of incomplete resection.  The future of CH treatment is certainly related to a better understanding of the molecular biology and oncogenesis of CHs and consequently to the development of efficient targeted chemotherapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtS4GCfwaGPsyail4HZd-ifW6udTcc2ea9iuHlUU2zXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FgtVCquw%253D%253D&md5=634ae823545d5798180ad85108ac6782</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.nec.2015.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nec.2015.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DB.%26aulast%3DBresson%26aufirst%3DD.%26aulast%3DHerman%26aufirst%3DP.%26aulast%3DFroelich%26aufirst%3DS.%26atitle%3DChordomas%253A%2520A%2520review%26jtitle%3DNeurosurg%2520Clin%2520N%2520Am.%26date%3D2015%26volume%3D26%26issue%3D3%26spage%3D437%26epage%3D452%26doi%3D10.1016%2Fj.nec.2015.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferraresi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoccali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marandino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidiri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salducca, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeuli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannarelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cognetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, R.</span></span> <span> </span><span class="NLM_article-title">Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">22</span>, <span class="refDoi"> DOI: 10.1186/1471-2407-10-22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1186%2F1471-2407-10-22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=20109225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A280%3ADC%252BC3c7js1Citw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=22&author=V.+Ferraresiauthor=C.+Nuzzoauthor=C.+Zoccaliauthor=F.+Marandinoauthor=A.+Vidiriauthor=N.+Salduccaauthor=M.+Zeuliauthor=D.+Giannarelliauthor=F.+Cognettiauthor=R.+Biagini&title=Chordoma%3A+clinical+characteristics%2C+management+and+prognosis+of+a+case+series+of+25+patients&doi=10.1186%2F1471-2407-10-22"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients</span></div><div class="casAuthors">Ferraresi Virginia; Nuzzo Carmen; Zoccali Carmine; Marandino Ferdinando; Vidiri Antonello; Salducca Nicola; Zeuli Massimo; Giannarelli Diana; Cognetti Francesco; Biagini Roberto</div><div class="citationInfo"><span class="NLM_cas:title">BMC cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Adequate surgery still remains the only curative treatment of chordoma.  Interesting clinical data on advanced disease with molecularly targeted therapies were reported.  METHODS:  We described the clinical outcome of a series of chordoma patients followed at Regina Elena National Cancer Centre of Rome from 2004 to 2008.  RESULTS:  Twenty-five consecutive patients with sacral (11 patients), spine (13 patients), and skull base (1 patient) chordoma went to our observation.  Six patients (24%) had primary disease, 14(56%) a recurrent disease, and 5(20%) a metastatic spreading.  Surgery was the primary option for treatment in 22 out of 25 patients.  Surgical margins were wide in 5 (23%) and intralesional in 17(77%) patients; 3 out of 4 in-house treated patients obtained wide margins.  After first surgery, radiotherapy (protons or high-energy photons) were delivered to 3 patients.  One out of the 5 patients with wide margins is still without evidence of disease at 20 months from surgery; 2 patients died without evidence of disease after 3 and 36 months from surgery.  Sixteen out of 17 (94%) patients with intralesional margins underwent local progression at a median time of 18 months with a 2-year local progression-free survival of 47%.  The 5-year metastasis-free survival rate was 78.3%.  Seventeen patients with locally advanced and/or metastatic disease expressing platelet-derived growth factor receptor (PDGFR) beta were treated with imatinib mesylate.  A RECIST stabilization of the disease was the best response observed in all treated cases.  Pain relief with reduction in analgesics use was obtained in 6 out of 11 (54%) symptomatic patients.  The 5- and 10-year survival rates of the entire series of patients were 76.7 and 59.7%, respectively.  CONCLUSIONS:  Despite progress of surgical techniques and the results obtained with targeted therapy, more effort is needed for better disease control.  Specific experience of the multi-disciplinary therapeutic team is, however, essential to succeed in improving patients' outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkUT6DwQ4W4sve_zCu79I8fW6udTcc2eatJNJNxl5Hubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7js1Citw%253D%253D&md5=4da42f86bedeb116a909fbac99b4c334</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-10-22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-10-22%26sid%3Dliteratum%253Aachs%26aulast%3DFerraresi%26aufirst%3DV.%26aulast%3DNuzzo%26aufirst%3DC.%26aulast%3DZoccali%26aufirst%3DC.%26aulast%3DMarandino%26aufirst%3DF.%26aulast%3DVidiri%26aufirst%3DA.%26aulast%3DSalducca%26aufirst%3DN.%26aulast%3DZeuli%26aufirst%3DM.%26aulast%3DGiannarelli%26aufirst%3DD.%26aulast%3DCognetti%26aufirst%3DF.%26aulast%3DBiagini%26aufirst%3DR.%26atitle%3DChordoma%253A%2520clinical%2520characteristics%252C%2520management%2520and%2520prognosis%2520of%2520a%2520case%2520series%2520of%252025%2520patients%26jtitle%3DBMC%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D22%26doi%3D10.1186%2F1471-2407-10-22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akhavan-Sigari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abili, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostertag, H.</span></span> <span> </span><span class="NLM_article-title">Expression of PDGFR-α, EGFR and c-MET in spinal chordoma: a series of 52 patients</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=24510991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A280%3ADC%252BC2cvjsFyjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=623-630&issue=2&author=R.+Akhavan-Sigariauthor=M.+Gaabauthor=V.+Rohdeauthor=M.+Abiliauthor=H.+Ostertag&title=Expression+of+PDGFR-%CE%B1%2C+EGFR+and+c-MET+in+spinal+chordoma%3A+a+series+of+52+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of PDGFR-α, EGFR and c-MET in spinal chordoma: a series of 52 patients</span></div><div class="casAuthors">Akhavan-Sigari Reza; Gaab Michael Robert; Rohde Veit; Abili Mehdi; Ostertag Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">623-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIM:  To investigate the expression of platelet-derived growth factor (PDGF) receptor-A (PDGFRα), epidermal growth factor receptor (EGFR) and c-Met in spinal chordoma.  To the authors' knowledge, little is known regarding the prognostic significance of receptor tyrosine kinase in spinal chordoma.  MATERIALS AND METHODS:  Using immunohistochemical techniques, the authors investigated PDGFR-α, EGFR and c-MET expression in 52 primary and 104 recurrent lesions, and compared these data with clinicopathological parameters.  RESULTS:  PDGFR-α, EGFR and c-MET were found to be expressed in 75.0%, 83% and 77% of primary, and in 97.0% of recurrent lesions in all investigated receptor tyrosine kinases.  Higher PDGFR-α and c-MET expression was found to be correlated with younger patient age.  Lesions with a higher expression of PDGFR-α demonstrated significantly higher EGFR scores in both primary and recurrent lesions compared to those with lower PDGFR-α expression.  In recurrent lesions, higher c-MET expression was found to be associated with significantly better prognosis than those with lower c-MET expression (p=0.033).  Lesions with a higher level of PDGFR-α expression were found to have significantly poorer prognosis than those with lower PDGFR-α expression (p=0.024).  Those patients with lower EGFR expression were found to have significantly better prognosis than those with higher EGFR expression (p=0.005).  CONCLUSION:  In the current study, c-MET expression in patients with spinal chordoma was found to be correlated with a younger patient age and a favorable prognosis.  Patients with a higher level of PDGFR-α and EGFR expression were found to have a significantly poorer prognosis than those with lower PDGFR-α and EGFR expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQszQcW9x3M6uWhZTslLrfffW6udTcc2eatJNJNxl5Hubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvjsFyjsg%253D%253D&md5=742c76c9ca2f9ea58e6273bf3dc5c2a3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkhavan-Sigari%26aufirst%3DR.%26aulast%3DGaab%26aufirst%3DM.%26aulast%3DRohde%26aufirst%3DV.%26aulast%3DAbili%26aufirst%3DM.%26aulast%3DOstertag%26aufirst%3DH.%26atitle%3DExpression%2520of%2520PDGFR-%25CE%25B1%252C%2520EGFR%2520and%2520c-MET%2520in%2520spinal%2520chordoma%253A%2520a%2520series%2520of%252052%2520patients%26jtitle%3DAnticancer%2520Res.%26date%3D2014%26volume%3D34%26issue%3D2%26spage%3D623%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magnaghi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salom, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amboldi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballinari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamborini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montagnoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raddrizzani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somaschini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosotti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orrenius, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stacchiotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacchi, A.</span></span> <span> </span><span class="NLM_article-title">Afatinib is a new therapeutic approach in chordoma with a unique ability to target EGFR and Brachyury</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">613</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-17-0324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1158%2F1535-7163.MCT-17-0324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=29237806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslKks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=603-613&issue=3&author=P.+Magnaghiauthor=B.+Salomauthor=L.+Cozziauthor=N.+Amboldiauthor=D.+Ballinariauthor=E.+Tamboriniauthor=F.+Gasparriauthor=A.+Montagnoliauthor=L.+Raddrizzaniauthor=A.+Somaschiniauthor=R.+Bosottiauthor=C.+Orreniusauthor=F.+Bozziauthor=S.+Pilottiauthor=A.+Galvaniauthor=J.+Sommerauthor=S.+Stacchiottiauthor=A.+Isacchi&title=Afatinib+is+a+new+therapeutic+approach+in+chordoma+with+a+unique+ability+to+target+EGFR+and+Brachyury&doi=10.1158%2F1535-7163.MCT-17-0324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury</span></div><div class="casAuthors">Magnaghi, Paola; Salom, Barbara; Cozzi, Liviana; Amboldi, Nadia; Ballinari, Dario; Tamborini, Elena; Gasparri, Fabio; Montagnoli, Alessia; Raddrizzani, Laura; Somaschini, Alessio; Bosotti, Roberta; Orrenius, Christian; Bozzi, Fabio; Pilotti, Silvana; Galvani, Arturo; Sommer, Josh; Stacchiotti, Silvia; Isacchi, Antonella</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">603-613</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Chordomas are rare bone tumors with no approved therapy.  These tumors express several activated tyrosine kinase receptors, which prompted attempts to treat patients with tyrosine kinase inhibitors.  Although clin. benefit was obsd. in phase II clin. trials with imatinib and sorafenib, and sporadically also with EGFR inhibitors, therapies evaluated to date have shown modest activity.  With the goal of identifying new drugs with immediate therapeutic potential for chordoma patients, we collected clin. approved drugs and other advanced inhibitors of MET, PDGFRβ, and EGFR tyrosine kinases, and assessed their antiproliferative activity against a panel of chordoma cell lines.  Chordoma cell lines were not responsive to MET and PDGFRβ inhibitors.  U-CH1 and UM-Chor1 were sensitive to all EGFR inhibitors, whereas the remaining cell lines were generally insensitive to these drugs.  Afatinib was the only EGFR inhibitor with activity across the chordoma panel.  We then investigated the mol. mechanisms behind the responses obsd. and found that the antiproliferative IC50s correlate with the unique ability of afatinib to promote degrdn. of EGFR and brachyury, an embryonic transcription factor considered a key driver of chordoma.  Afatinib displayed potent antitumor efficacy in U-CH1, SF8894, CF322, and CF365 chordoma tumor models in vivo.  In the panel analyzed, high EGFR phosphorylation and low AXL and STK33 expression correlated with higher sensitivity to afatinib and deserve further investigation as potential biomarkers of response.  These data support the use of afatinib in clin. trials and provide the rationale for the upcoming European phase II study on afatinib in advanced chordoma.  Mol Cancer Ther; 17(3); 603-13. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrafQ0pTf5v_rVg90H21EOLACvtfcHk0li7mY6VVRzbKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslKks7o%253D&md5=aecd84582cdf6f90be677bf8ca076b1f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-17-0324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-17-0324%26sid%3Dliteratum%253Aachs%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DSalom%26aufirst%3DB.%26aulast%3DCozzi%26aufirst%3DL.%26aulast%3DAmboldi%26aufirst%3DN.%26aulast%3DBallinari%26aufirst%3DD.%26aulast%3DTamborini%26aufirst%3DE.%26aulast%3DGasparri%26aufirst%3DF.%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DRaddrizzani%26aufirst%3DL.%26aulast%3DSomaschini%26aufirst%3DA.%26aulast%3DBosotti%26aufirst%3DR.%26aulast%3DOrrenius%26aufirst%3DC.%26aulast%3DBozzi%26aufirst%3DF.%26aulast%3DPilotti%26aufirst%3DS.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DSommer%26aufirst%3DJ.%26aulast%3DStacchiotti%26aufirst%3DS.%26aulast%3DIsacchi%26aufirst%3DA.%26atitle%3DAfatinib%2520is%2520a%2520new%2520therapeutic%2520approach%2520in%2520chordoma%2520with%2520a%2520unique%2520ability%2520to%2520target%2520EGFR%2520and%2520Brachyury%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26issue%3D3%26spage%3D603%26epage%3D613%26doi%3D10.1158%2F1535-7163.MCT-17-0324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siu, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzevick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettegowda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallia, G. L.</span></span> <span> </span><span class="NLM_article-title">Erlotinib inhibits growth of a patient-derived chordoma xenograft</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">11</span>), <span class="NLM_elocation-id">e78895</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0078895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1371%2Fjournal.pone.0078895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=24260133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVGmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&issue=11&author=I.+M.+Siuauthor=J.+Ruzevickauthor=Q.+Zhaoauthor=N.+Connisauthor=Y.+Jiaoauthor=C.+Bettegowdaauthor=X.+Xiaauthor=P.+C.+Burgerauthor=C.+L.+Hannauthor=G.+L.+Gallia&title=Erlotinib+inhibits+growth+of+a+patient-derived+chordoma+xenograft&doi=10.1371%2Fjournal.pone.0078895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Erlotinib inhibits growth of a patient-derived chordoma xenograft</span></div><div class="casAuthors">Siu, I.-Mei; Ruzevick, Jacob; Zhao, Qi; Connis, Nick; Jiao, Yuchen; Bettegowda, Chetan; Xia, Xuewei; Burger, Peter C.; Hann, Christine L.; Gallia, Gary L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e78895/1-e78895/8, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chordomas are rare primary bone tumors that occur along the neuraxis.  Primary treatment is surgery, often followed by radiotherapy.  Treatment options for patients with recurrence are limited and, notably, there are no FDA approved therapeutic agents.  Development of therapeutic options has been limited by the paucity of preclin. model systems.  We have established and previously reported the initial characterization of the first patient-derived chordoma xenograft model.  In this study, we further characterize this model and demonstrate that it continues to resemble the original patient tumor histol. and immunohistochem., maintains nuclear expression of brachyury, and is highly concordant with the original patient tumor by whole genome genotyping.  Pathway anal. of this xenograft demonstrates activation of epidermal growth factor receptor (EGFR).  In vitro studies demonstrate that two small mol. inhibitors of EGFR, erlotinib and gefitinib, inhibit proliferation of the chordoma cell line U-CH 1.  We further demonstrate that erlotinib significantly inhibits chordoma growth in vivo.  Evaluation of tumors post-treatment reveals that erlotinib reduces phosphorylation of EGFR.  This is the first demonstration of antitumor activity in a patient-derived chordoma xenograft model and these findings support further evaluation of EGFR inhibitors in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhQhcJFI7M7LVg90H21EOLACvtfcHk0lgpz7tA5RjFJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVGmsLc%253D&md5=15b6a4f4591f1067eab75b5c624e2783</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0078895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0078895%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DI.%2BM.%26aulast%3DRuzevick%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DConnis%26aufirst%3DN.%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DBettegowda%26aufirst%3DC.%26aulast%3DXia%26aufirst%3DX.%26aulast%3DBurger%26aufirst%3DP.%2BC.%26aulast%3DHann%26aufirst%3DC.%2BL.%26aulast%3DGallia%26aufirst%3DG.%2BL.%26atitle%3DErlotinib%2520inhibits%2520growth%2520of%2520a%2520patient-derived%2520chordoma%2520xenograft%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D11%26doi%3D10.1371%2Fjournal.pone.0078895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheipl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewry, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turlais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leite, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leithner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüderlein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guppy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amary, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirabosco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillay, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, A. M.</span></span> <span> </span><span class="NLM_article-title">EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>239</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1002/path.4729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1002%2Fpath.4729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=27102572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVWmu7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=239&publication_year=2016&pages=320-334&issue=3&author=S.+Scheiplauthor=M.+Barnardauthor=L.+Cottoneauthor=M.+Jorgensenauthor=D.+H.+Drewryauthor=W.+J.+Zuercherauthor=F.+Turlaisauthor=H.+Yeauthor=A.+P.+Leiteauthor=J.+A.+Smithauthor=A.+Leithnerauthor=P.+M%C3%B6llerauthor=S.+Br%C3%BCderleinauthor=N.+Guppyauthor=F.+Amaryauthor=R.+Tiraboscoauthor=S.+J.+Straussauthor=N.+Pillayauthor=A.+M.+Flanagan&title=EGFR+inhibitors+identified+as+a+potential+treatment+for+chordoma+in+a+focused+compound+screen&doi=10.1002%2Fpath.4729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen</span></div><div class="casAuthors">Scheipl, Susanne; Barnard, Michelle; Cottone, Lucia; Jorgensen, Mette; Drewry, David H.; Zuercher, William J.; Turlais, Fabrice; Ye, Hongtao; Leite, Ana P.; Smith, James A.; Leithner, Andreas; Moeller, Peter; Bruederlein, Silke; Guppy, Naomi; Amary, Fernanda; Tirabosco, Roberto; Strauss, Sandra J.; Pillay, Nischalan; Flanagan, Adrienne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">239</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">320-334</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">1096-9896</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Chordoma is a rare malignant bone tumor with a poor prognosis and limited therapeutic options.  We undertook a focused compd. screen (FCS) against 1097 compds. on three well-characterized chordoma cell lines; 154 compds. were selected from the single concn. screen (1 μm), based on their growth-inhibitory effect.  Their half-maximal effective concn. (EC50) values were detd. in chordoma cells and normal fibroblasts.  Twenty-seven of these compds. displayed chordoma selective cell kill and 21/27 (78%) were found to be EGFR/ERBB family inhibitors.  EGFR inhibitors in clin. development were then studied on an extended cell line panel of seven chordoma cell lines, four of which were sensitive to EGFR inhibition.  Sapitinib (AstraZeneca) emerged as the lead compd., followed by gefitinib (AstraZeneca) and erlotinib (Roche/Genentech).  The compds. were shown to induce apoptosis in the sensitive cell lines and suppressed phospho-EGFR and its downstream pathways in a dose-dependent manner.  Anal. of substituent patterns suggested that EGFR-inhibitors with small aniline substituents in the 4-position of the quinazoline ring were more effective than inhibitors with large substituents in that position.  Sapitinib showed significantly reduced tumor growth in two xenograft mouse models (U-CH1 xenograft and a patient-derived xenograft, SF8894).  One of the resistant cell lines (U-CH2) was shown to express high levels of phospho-MET, a known bypass signalling pathway to EGFR.  Neither amplifications (EGFR, ERBB2, MET) nor mutations in EGFR, ERBB2, ERBB4, PIK3CA, BRAF, NRAS, KRAS, PTEN, MET or other cancer gene hotspots were detected in the cell lines.  Our findings are consistent with the reported (p-)EGFR expression in the majority of clin. samples, and provide evidence for exploring the efficacy of EGFR inhibitors in the treatment of patients with chordoma and studying possible resistance mechanisms to these compds. in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTSrh0vHlqC7Vg90H21EOLACvtfcHk0lj5n9t8syrClg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVWmu7rI&md5=23ee7d42400eed728dc6232154a7a338</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fpath.4729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.4729%26sid%3Dliteratum%253Aachs%26aulast%3DScheipl%26aufirst%3DS.%26aulast%3DBarnard%26aufirst%3DM.%26aulast%3DCottone%26aufirst%3DL.%26aulast%3DJorgensen%26aufirst%3DM.%26aulast%3DDrewry%26aufirst%3DD.%2BH.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26aulast%3DTurlais%26aufirst%3DF.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DLeite%26aufirst%3DA.%2BP.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DLeithner%26aufirst%3DA.%26aulast%3DM%25C3%25B6ller%26aufirst%3DP.%26aulast%3DBr%25C3%25BCderlein%26aufirst%3DS.%26aulast%3DGuppy%26aufirst%3DN.%26aulast%3DAmary%26aufirst%3DF.%26aulast%3DTirabosco%26aufirst%3DR.%26aulast%3DStrauss%26aufirst%3DS.%2BJ.%26aulast%3DPillay%26aufirst%3DN.%26aulast%3DFlanagan%26aufirst%3DA.%2BM.%26atitle%3DEGFR%2520inhibitors%2520identified%2520as%2520a%2520potential%2520treatment%2520for%2520chordoma%2520in%2520a%2520focused%2520compound%2520screen%26jtitle%3DJ.%2520Pathol.%26date%3D2016%26volume%3D239%26issue%3D3%26spage%3D320%26epage%3D334%26doi%3D10.1002%2Fpath.4729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, L. E.</span></span> <span> </span><span class="NLM_article-title">Depletion of GAK/auxilin 2 inhibits receptor-mediated endocytosis and recruitment of both clathrin and clathrin adaptors</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">4311</span>– <span class="NLM_lpage">4321</span>, <span class="refDoi"> DOI: 10.1242/jcs.02548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1242%2Fjcs.02548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=16155256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCgt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2005&pages=4311-4321&author=D.+W.+Leeauthor=X.+Zhaoauthor=F.+Zhangauthor=E.+Eisenbergauthor=L.+E.+Greene&title=Depletion+of+GAK%2Fauxilin+2+inhibits+receptor-mediated+endocytosis+and+recruitment+of+both+clathrin+and+clathrin+adaptors&doi=10.1242%2Fjcs.02548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of GAK/auxilin 2 inhibits receptor-mediated endocytosis and recruitment of both clathrin and clathrin adaptors</span></div><div class="casAuthors">Lee, Dong-won; Zhao, Xiaohong; Zhang, Fang; Eisenberg, Evan; Greene, Lois E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4311-4321</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Cyclin G-assocd. kinase (GAK/auxilin 2), the ubiquitous form of the neuronal-specific protein auxilin 1, is an essential cofactor for the Hsc70-dependent uncoating of clathrin-coated vesicles.  We have now investigated the effect of knocking down GAK in HeLa cells by vector-based small hairpin RNA.  Functionally, depletion of GAK caused a marked decrease in internalization of both transferrin and epidermal growth factor and altered mannose 6-phosphate receptor trafficking, but had little effect on the recycling of transferrin receptor back to the plasma membrane.  Structurally, depletion of GAK caused a marked redn. in perinuclear clathrin assocd. with the trans-Golgi network and in the no. of clathrin-coated pits on the plasma membrane, and reduced clathrin exchange on the few clathrin-coated pits that remained.  Surprisingly, while clathrin depletion does not prevent adaptors from assembling on the membrane, depletion of GAK caused a dramatic redn. in AP2 and epsin on the plasma membrane and AP1 and GGA at the trans-Golgi network.  A similar effect was caused by expression of a dominant neg. Hsp70 mutant.  These results suggest that GAK, in conjunction with Hsc70, not only uncoats clathrin-coated vesicles and induces clathrin exchange on clathrin-coated pits, but also mediates binding of clathrin and adaptors to the plasma membrane and the trans-Golgi network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8IvRfVSaZT7Vg90H21EOLACvtfcHk0lj5n9t8syrClg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCgt7fK&md5=0172190491cf9b908e705e434b763d60</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1242%2Fjcs.02548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.02548%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DEisenberg%26aufirst%3DE.%26aulast%3DGreene%26aufirst%3DL.%2BE.%26atitle%3DDepletion%2520of%2520GAK%252Fauxilin%25202%2520inhibits%2520receptor-mediated%2520endocytosis%2520and%2520recruitment%2520of%2520both%2520clathrin%2520and%2520clathrin%2520adaptors%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2005%26volume%3D118%26spage%3D4311%26epage%3D4321%26doi%3D10.1242%2Fjcs.02548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. R.</span></span> <span> </span><span class="NLM_article-title">EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1852</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1540</span>– <span class="NLM_lpage">1549</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2015.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1016%2Fj.bbadis.2015.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=25912735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnt1ektrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1852&publication_year=2015&pages=1540-1549&issue=7&author=C.+H.+Yangauthor=H.+C.+Chouauthor=Y.+N.+Fuauthor=C.+L.+Yehauthor=H.+W.+Chengauthor=I.+C.+Changauthor=K.+J.+Liuauthor=G.+C.+Changauthor=T.+F.+Tsaiauthor=S.+F.+Tsaiauthor=H.+P.+Liuauthor=Y.+C.+Wuauthor=Y.+T.+Chenauthor=S.+F.+Huangauthor=Y.+R.+Chen&title=EGFR+over-expression+in+non-small+cell+lung+cancers+harboring+EGFR+mutations+is+associated+with+marked+down-regulation+of+CD82&doi=10.1016%2Fj.bbadis.2015.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82</span></div><div class="casAuthors">Yang, Chi-Hwa; Chou, Hsiao-Chin; Fu, Yu-Ning; Yeh, Chi-Ling; Cheng, Hui-Wen; Chang, Il-Chi; Liu, Ko-Jiunn; Chang, Gee-Chen; Tsai, Ting-Fen; Tsai, Shih-Feng; Liu, Hui-Ping; Wu, Yi-Cheng; Chen, Ya-Ting; Huang, Shiu-Feng; Chen, Yi-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1852</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1540-1549</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) gene mutations are strongly assocd. with lung adenocarcinoma and favorable response to EGFR tyrosine kinase inhibitor.  The mutated EGFR proteins (EGFRs) are hyper-phosphorylated and refractory to receptor down-regulation.  To address the discrepancy between hyper-phosphorylation and lack of down-regulation of mutant EGFRs, we have examd. the expression of EGFR neg. regulators in non-small cell lung cancer (NSCLC) cell lines.  We found that NSCLC cell lines expressing mutant EGFRs often had low expression of various neg. regulators for EGFR.  Among them, tumor suppressor CD82 was up-regulated by wild type (WT) EGFR but down-regulated by mutant EGFRs.  Reconstitution of CD82 exerted stronger suppressive effects on mutant EGFRs than on WT EGFR.  Active exportation of CD82 through the exosome was one of the mechanisms involved in achieving the overall CD82 down-regulation in mutant EGFR-expressing lung cancer cell lines.  Over-expression of mutant EGFR protein frequently occurred in the lung cancer tissues of mutant EGFR-transgenic mice and also assocd. with CD82 down-regulation.  Immunoblot analyses on the tumor tissues from 23 lung adenocarcinoma patients (12 with WT EGFR, and 11 with mutant EGFRs) also identified significantly stronger down-regulation of CD82 in tumors with mutant EGFRs than WT.  Our data indicate that CD82 down-regulation could be a crit. step involved in the EGFR over-expression and the stronger tumorigenic activity triggered by EGFR mutations.  Up-regulation of the CD82 level may become a promising new treatment strategy for lung adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4mbUaenzXarVg90H21EOLACvtfcHk0lhIb9GZju4pBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnt1ektrs%253D&md5=aefe17f2112db5b488181860181ba61d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2015.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2015.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%2BH.%26aulast%3DChou%26aufirst%3DH.%2BC.%26aulast%3DFu%26aufirst%3DY.%2BN.%26aulast%3DYeh%26aufirst%3DC.%2BL.%26aulast%3DCheng%26aufirst%3DH.%2BW.%26aulast%3DChang%26aufirst%3DI.%2BC.%26aulast%3DLiu%26aufirst%3DK.%2BJ.%26aulast%3DChang%26aufirst%3DG.%2BC.%26aulast%3DTsai%26aufirst%3DT.%2BF.%26aulast%3DTsai%26aufirst%3DS.%2BF.%26aulast%3DLiu%26aufirst%3DH.%2BP.%26aulast%3DWu%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BT.%26aulast%3DHuang%26aufirst%3DS.%2BF.%26aulast%3DChen%26aufirst%3DY.%2BR.%26atitle%3DEGFR%2520over-expression%2520in%2520non-small%2520cell%2520lung%2520cancers%2520harboring%2520EGFR%2520mutations%2520is%2520associated%2520with%2520marked%2520down-regulation%2520of%2520CD82%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2015%26volume%3D1852%26issue%3D7%26spage%3D1540%26epage%3D1549%26doi%3D10.1016%2Fj.bbadis.2015.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabian, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggs, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzfeld, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelias, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J.</span></span> <span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1038/nbt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&issue=3&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors&doi=10.1038%2Fnbt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0lhIb9GZju4pBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26issue%3D3%26spage%3D329%26epage%3D336%26doi%3D10.1038%2Fnbt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marathe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleczka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacokinetics and in vitro metabolism of BMS-690514, a potent inhibitor of EGFR and VEGFR2</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3579</span>– <span class="NLM_lpage">3593</span>, <span class="refDoi"> DOI: 10.1002/jps.22099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1002%2Fjps.22099" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=3579-3593&issue=8&author=P.+Maratheauthor=Y.+Tangauthor=B.+Sleczkaauthor=D.+Rodriguesauthor=A.+Gavaiauthor=T.+Wongauthor=L.+Christopherauthor=H.+Zhang&title=Preclinical+pharmacokinetics+and+in+vitro+metabolism+of+BMS-690514%2C+a+potent+inhibitor+of+EGFR+and+VEGFR2&doi=10.1002%2Fjps.22099"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fjps.22099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22099%26sid%3Dliteratum%253Aachs%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DSleczka%26aufirst%3DB.%26aulast%3DRodrigues%26aufirst%3DD.%26aulast%3DGavai%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DT.%26aulast%3DChristopher%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DPreclinical%2520pharmacokinetics%2520and%2520in%2520vitro%2520metabolism%2520of%2520BMS-690514%252C%2520a%2520potent%2520inhibitor%2520of%2520EGFR%2520and%2520VEGFR2%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26issue%3D8%26spage%3D3579%26epage%3D3593%26doi%3D10.1002%2Fjps.22099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hickinson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinowska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speake, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trigwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosios, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlaam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, D.</span></span> <span> </span><span class="NLM_article-title">AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: a unique agent for simultaneous ERBB receptor blockade in cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1169</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-09-2353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1158%2F1078-0432.CCR-09-2353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=20145185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=1159-1169&issue=4&author=D.+M.+Hickinsonauthor=T.+Klinowskaauthor=G.+Speakeauthor=J.+Vincentauthor=C.+Trigwellauthor=J.+Andertonauthor=S.+Beckauthor=G.+Marshallauthor=S.+Davenportauthor=R.+Callisauthor=E.+Millsauthor=K.+Grosiosauthor=P.+Smithauthor=B.+Barlaamauthor=R.+W.+Wilkinsonauthor=D.+Ogilvie&title=AZD8931%2C+an+equipotent%2C+reversible+inhibitor+of+signaling+by+epidermal+growth+factor+receptor%2C+ERBB2+%28HER2%29%2C+and+ERBB3%3A+a+unique+agent+for+simultaneous+ERBB+receptor+blockade+in+cancer&doi=10.1158%2F1078-0432.CCR-09-2353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer</span></div><div class="casAuthors">Hickinson, D. Mark; Klinowska, Teresa; Speake, Georgina; Vincent, John; Trigwell, Cath; Anderton, Judith; Beck, Sarah; Marshall, Gayle; Davenport, Sara; Callis, Rowena; Mills, Elizabeth; Grosios, Konstantina; Smith, Paul; Barlaam, Bernard; Wilkinson, Robert W.; Ogilvie, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1159-1169</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To test the hypothesis that simultaneous, equipotent inhibition of epidermal growth factor receptor (EGFR; erbB1), erbB2 (human epidermal growth factor receptor 2), and erbB3 receptor signaling, using the novel small-mol. inhibitor AZD8931, will deliver broad antitumor activity in vitro and in vivo.  Exptl. Design: A range of assays was used to model erbB family receptor signaling in homodimers and heterodimers, including in vitro evaluation of erbB kinase activity, erbB receptor phosphorylation, proliferation in cells, and in vivo testing in a human tumor xenograft panel, with ex vivo evaluation of erbB phosphorylation and downstream biomarkers.  Gefitinib and lapatinib were used to compare the pharmacol. profile of AZD8931 with other erbB family inhibitors.  Results: In vitro, AZD8931 showed equipotent, reversible inhibition of EGFR (IC50, 4 nmol/L), erbB2 (IC50, 3 nmol/L), and erbB3 (IC50, 4 nmol/L) phosphorylation in cells.  In proliferation assays, AZD8931 was significantly more potent than gefitinib or lapatinib in specific squamous cell carcinoma of the head and neck and non-small cell lung carcinoma cell lines.  In vivo, AZD8931 inhibited xenograft growth in a range of models while significantly affecting EGFR, erbB2, and erbB3 phosphorylation and downstream signaling pathways, apoptosis, and proliferation.  Conclusions: AZD8931 has a unique pharmacol. profile providing equipotent inhibition of EGFR, erbB2, and erbB3 signaling and showing greater antitumor activity than agents with a narrower spectrum of erbB receptor inhibition in specific preclin. models.  AZD8931 provides the opportunity to investigate whether simultaneous inhibition of erbB receptor signaling could be of utility in the clinic, particularly in the majority of solid tumors that do not overexpress erbB2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLhqWjVY8lNLVg90H21EOLACvtfcHk0liTgBd6uc_NJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGiur8%253D&md5=44b67f704bfdc9db519d40dabc7d457f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-2353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-2353%26sid%3Dliteratum%253Aachs%26aulast%3DHickinson%26aufirst%3DD.%2BM.%26aulast%3DKlinowska%26aufirst%3DT.%26aulast%3DSpeake%26aufirst%3DG.%26aulast%3DVincent%26aufirst%3DJ.%26aulast%3DTrigwell%26aufirst%3DC.%26aulast%3DAnderton%26aufirst%3DJ.%26aulast%3DBeck%26aufirst%3DS.%26aulast%3DMarshall%26aufirst%3DG.%26aulast%3DDavenport%26aufirst%3DS.%26aulast%3DCallis%26aufirst%3DR.%26aulast%3DMills%26aufirst%3DE.%26aulast%3DGrosios%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DBarlaam%26aufirst%3DB.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DOgilvie%26aufirst%3DD.%26atitle%3DAZD8931%252C%2520an%2520equipotent%252C%2520reversible%2520inhibitor%2520of%2520signaling%2520by%2520epidermal%2520growth%2520factor%2520receptor%252C%2520ERBB2%2520%2528HER2%2529%252C%2520and%2520ERBB3%253A%2520a%2520unique%2520agent%2520for%2520simultaneous%2520ERBB%2520receptor%2520blockade%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26issue%3D4%26spage%3D1159%26epage%3D1169%26doi%3D10.1158%2F1078-0432.CCR-09-2353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zejnullahu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gale, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifshits, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naumov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Althaus, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymach, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jänne, P. A.</span></span> <span> </span><span class="NLM_article-title">PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">11924</span>– <span class="NLM_lpage">11932</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-1885</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1158%2F0008-5472.CAN-07-1885" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=11924-11932&issue=24&author=J.+A.+Engelmanauthor=K.+Zejnullahuauthor=C.+M.+Galeauthor=E.+Lifshitsauthor=A.+J.+Gonzalesauthor=T.+Shimamuraauthor=F.+Zhaoauthor=P.+W.+Vincentauthor=G.+N.+Naumovauthor=J.+E.+Bradnerauthor=I.+W.+Althausauthor=L.+Gandhiauthor=G.+I.+Shapiroauthor=J.+M.+Nelsonauthor=J.+V.+Heymachauthor=M.+Meyersonauthor=K.+K.+Wongauthor=P.+A.+J%C3%A4nne&title=PF00299804%2C+an+irreversible+pan-ERBB+inhibitor%2C+is+effective+in+lung+cancer+models+with+EGFR+and+ERBB2+mutations+that+are+resistant+to+gefitinib&doi=10.1158%2F0008-5472.CAN-07-1885"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-1885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-1885%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DGale%26aufirst%3DC.%2BM.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DA.%2BJ.%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DVincent%26aufirst%3DP.%2BW.%26aulast%3DNaumov%26aufirst%3DG.%2BN.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DAlthaus%26aufirst%3DI.%2BW.%26aulast%3DGandhi%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DNelson%26aufirst%3DJ.%2BM.%26aulast%3DHeymach%26aufirst%3DJ.%2BV.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26atitle%3DPF00299804%252C%2520an%2520irreversible%2520pan-ERBB%2520inhibitor%252C%2520is%2520effective%2520in%2520lung%2520cancer%2520models%2520with%2520EGFR%2520and%2520ERBB2%2520mutations%2520that%2520are%2520resistant%2520to%2520gefitinib%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D24%26spage%3D11924%26epage%3D11932%26doi%3D10.1158%2F0008-5472.CAN-07-1885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curwen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickinson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elvin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carragher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plé, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bermingham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdgate, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequin, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costello, G. F.</span></span> <span> </span><span class="NLM_article-title">Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530</span>. <i>Mol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.molonc.2009.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1016%2Fj.molonc.2009.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=19393585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslKnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=248-261&issue=3&author=T.+P.+Greenauthor=M.+Fennellauthor=R.+Whittakerauthor=J.+Curwenauthor=V.+Jacobsauthor=J.+Allenauthor=A.+Logieauthor=J.+Hargreavesauthor=D.+M.+Hickinsonauthor=R.+W.+Wilkinsonauthor=P.+Elvinauthor=B.+Boyerauthor=N.+Carragherauthor=P.+A.+Pl%C3%A9author=A.+Berminghamauthor=G.+A.+Holdgateauthor=W.+H.+Wardauthor=L.+F.+Hennequinauthor=B.+R.+Daviesauthor=G.+F.+Costello&title=Preclinical+anticancer+activity+of+the+potent%2C+oral+Src+inhibitor+AZD0530&doi=10.1016%2Fj.molonc.2009.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530</span></div><div class="casAuthors">Green, Tim P.; Fennell, Mike; Whittaker, Robin; Curwen, Jon; Jacobs, Vivien; Allen, Jack; Logie, Armelle; Hargreaves, Judith; Hickinson, D. Mark; Wilkinson, Robert W.; Elvin, Paul; Boyer, Brigitte; Carragher, Neil; Ple, Patrick A.; Bermingham, Alun; Holdgate, Geoffrey A.; Ward, Walter H. J.; Hennequin, Laurent F.; Davies, Barry R.; Costello, Gerard F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">248-261</span>CODEN:
                <span class="NLM_cas:coden">MOONC3</span>;
        ISSN:<span class="NLM_cas:issn">1574-7891</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">AZD0530, an orally available Src inhibitor, demonstrated potent antimigratory and anti-invasive effects in vitro, and inhibited metastasis in a murine model of bladder cancer.  Antiproliferative activity of AZD0530 in vitro varied between cell lines (IC50 0.2 -> 10 μM).  AZD0530 inhibited tumor growth in 4/10 xenograft models tested and dynamically inhibited in vivo phosphorylation of Src substrates paxillin and FAK in both growth-inhibition-resistant and -sensitive xenografts.  The activity of AZD0530 in NBT-II bladder cancer cells in vitro was consistent with inhibition of cell migration and stabilization of cell-cell adhesion.  These data suggest a dominant anti-invasive pharmacol. for AZD0530 that may limit tumor progression in a range of cancers.  AZD0530 is currently in Phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAbzKlSDQyObVg90H21EOLACvtfcHk0liKCpThTNnUuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslKnsL0%253D&md5=4c2ec94fde22bbec401009e106bb6caf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.molonc.2009.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molonc.2009.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DT.%2BP.%26aulast%3DFennell%26aufirst%3DM.%26aulast%3DWhittaker%26aufirst%3DR.%26aulast%3DCurwen%26aufirst%3DJ.%26aulast%3DJacobs%26aufirst%3DV.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DLogie%26aufirst%3DA.%26aulast%3DHargreaves%26aufirst%3DJ.%26aulast%3DHickinson%26aufirst%3DD.%2BM.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DElvin%26aufirst%3DP.%26aulast%3DBoyer%26aufirst%3DB.%26aulast%3DCarragher%26aufirst%3DN.%26aulast%3DPl%25C3%25A9%26aufirst%3DP.%2BA.%26aulast%3DBermingham%26aufirst%3DA.%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DWard%26aufirst%3DW.%2BH.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DDavies%26aufirst%3DB.%2BR.%26aulast%3DCostello%26aufirst%3DG.%2BF.%26atitle%3DPreclinical%2520anticancer%2520activity%2520of%2520the%2520potent%252C%2520oral%2520Src%2520inhibitor%2520AZD0530%26jtitle%3DMol.%2520Oncol.%26date%3D2009%26volume%3D3%26issue%3D3%26spage%3D248%26epage%3D261%26doi%3D10.1016%2Fj.molonc.2009.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torrance, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Discafani, C. M.</span></span> <span> </span><span class="NLM_article-title">Combinatorial chemoprevention of intestinal neoplasia</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1024</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1038/79534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1038%2F79534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10973323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslSju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1024-1028&issue=9&author=C.+J.+Torranceauthor=P.+E.+Jacksonauthor=E.+Montgomeryauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=A.+Wissnerauthor=M.+Nunesauthor=P.+Frostauthor=C.+M.+Discafani&title=Combinatorial+chemoprevention+of+intestinal+neoplasia&doi=10.1038%2F79534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial chemoprevention of intestinal neoplasia</span></div><div class="casAuthors">Torrance, Christopher J.; Jackson, Peta E.; Montgomery, Elizabeth; Kinzler, Kenneth W.; Vogelstein, Bert; Wissner, Allan; Nunes, Maria; Frost, Philip; Discafani, Carolyn M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1024-1028</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A combination of two drugs afforded remarkable protection from intestinal neoplasia in APCMin/+ mice, a murine model of human familial adenomatous polyposis (FAP).  One of the drugs was sulindac, a prototypical non-steroidal anti-inflammatory drug with established chemopreventive activity.  The second drug was EKB569, a newly developed, irreversible inhibitor of the epidermal growth factor receptor kinase.  Although 100% of the untreated APCMin/+ mice developed -20 polyps, nearly half the mice treated with these two agents developed no polyps at all.  These results suggest a powerful strategy for the chemoprevention of human colonic neoplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoysAYwWewtCrVg90H21EOLACvtfcHk0liKCpThTNnUuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslSju7g%253D&md5=2b1da2bdcd72fec51856ff25643efd4c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F79534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F79534%26sid%3Dliteratum%253Aachs%26aulast%3DTorrance%26aufirst%3DC.%2BJ.%26aulast%3DJackson%26aufirst%3DP.%2BE.%26aulast%3DMontgomery%26aufirst%3DE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DNunes%26aufirst%3DM.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DDiscafani%26aufirst%3DC.%2BM.%26atitle%3DCombinatorial%2520chemoprevention%2520of%2520intestinal%2520neoplasia%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26issue%3D9%26spage%3D1024%26epage%3D1028%26doi%3D10.1038%2F79534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gendreau, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keast, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakes, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentzien, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cancilla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aftab, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Costa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joly, A. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3713</span>– <span class="NLM_lpage">3723</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-2590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1158%2F1078-0432.CCR-06-2590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=17575237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFCqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=3713-3723&issue=12&author=S.+B.+Gendreauauthor=R.+Venturaauthor=P.+Keastauthor=A.+D.+Lairdauthor=F.+M.+Yakesauthor=W.+Zhangauthor=F.+Bentzienauthor=B.+Cancillaauthor=J.+Lutmanauthor=F.+Chuauthor=L.+Jackmanauthor=Y.+Shiauthor=P.+Yuauthor=J.+Wangauthor=D.+T.+Aftabauthor=C.+T.+Jaegerauthor=S.+M.+Meyerauthor=A.+De+Costaauthor=K.+Engellauthor=J.+Chenauthor=J.+F.+Martiniauthor=A.+H.+Joly&title=Inhibition+of+the+T790M+gatekeeper+mutant+of+the+epidermal+growth+factor+receptor+by+EXEL-7647&doi=10.1158%2F1078-0432.CCR-06-2590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the T790M Gatekeeper Mutant of the Epidermal Growth Factor Receptor by EXEL-7647</span></div><div class="casAuthors">Gendreau, Steven B.; Ventura, Richard; Keast, Paul; Laird, A. Douglas; Yakes, F. Michael; Zhang, Wentao; Bentzien, Frauke; Cancilla, Belinda; Lutman, Jeffery; Chu, Felix; Jackman, Lisa; Shi, Yongchang; Yu, Peiwen; Wang, Jing; Aftab, Dana T.; Jaeger, Christopher T.; Meyer, Stephanie M.; De Costa, Anushka; Engell, Kelly; Chen, Jason; Martini, Jean-Francois; Joly, Alison H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3713-3723</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Agents inhibiting the epidermal growth factor receptor (EGFR) have shown clin. benefit in a subset of non-small cell lung cancer patients expressing amplified or mutationally activated EGFR.  However, responsive patients can relapse as a result of selection for EGFR gene mutations that confer resistance to ATP competitive EGFR inhibitors, such as erlotinib and gefitinib.  We describe here the activity of EXEL-7647 (XL647), a novel spectrum-selective kinase inhibitor with potent activity against the EGF and vascular endothelial growth factor receptor tyrosine kinase families, against both wild-type (WT) and mutant EGFR in vitro and in vivo.  Exptl. DESIGN: The activity of EGFR inhibitors against WT and mutant EGFRs and their effect on downstream signal transduction was examd. in cellular assays and in vivo using A431 and MDA-MB-231 (WT EGFR) and H1975 (L858R and T790M mutant EGFR) xenograft tumors.  RESULTS: EXEL-7647 shows potent and long-lived inhibition of the WT EGFR in vivo.  In addn., EXEL-7647 inhibits cellular proliferation and EGFR pathway activation in the erlotinib-resistant H1975 cell line that harbors a double mutation (L858R and T790M) in the EGFR gene.  In vivo efficacy studies show that EXEL-7647 substantially inhibited the growth of H1975 xenograft tumors and reduced both tumor EGFR signaling and tumor vessel d.  Addnl., EXEL-7647, in contrast to erlotinib, substantially inhibited the growth and vascularization of MDA-MB-231 xenografts, a model which is more reliant on signaling through vascular endothelial growth factor receptors.  CONCLUSIONS: These studies provide a preclin. basis for clin. trials of XL647 in solid tumors and in patients bearing tumors that are resistant to existing EGFR-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZI1xZ23d5TLVg90H21EOLACvtfcHk0lhcSQDPdrzdwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFCqu7s%253D&md5=f9684468d8e04df2f1a46b33966fa513</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2590%26sid%3Dliteratum%253Aachs%26aulast%3DGendreau%26aufirst%3DS.%2BB.%26aulast%3DVentura%26aufirst%3DR.%26aulast%3DKeast%26aufirst%3DP.%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBentzien%26aufirst%3DF.%26aulast%3DCancilla%26aufirst%3DB.%26aulast%3DLutman%26aufirst%3DJ.%26aulast%3DChu%26aufirst%3DF.%26aulast%3DJackman%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAftab%26aufirst%3DD.%2BT.%26aulast%3DJaeger%26aufirst%3DC.%2BT.%26aulast%3DMeyer%26aufirst%3DS.%2BM.%26aulast%3DDe%2BCosta%26aufirst%3DA.%26aulast%3DEngell%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DMartini%26aufirst%3DJ.%2BF.%26aulast%3DJoly%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520the%2520T790M%2520gatekeeper%2520mutant%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520by%2520EXEL-7647%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26issue%3D12%26spage%3D3713%26epage%3D3723%26doi%3D10.1158%2F1078-0432.CCR-06-2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klaeger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinzlmeir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polzer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinecke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruprecht, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzoldt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zecha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoof, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depaolini, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuchtinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueckert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huenges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garz, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zolg, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vooder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preissner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahne, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tõnisson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götze, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiche, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greif, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Médard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeremias, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiekermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuster, B.</span></span> <span> </span><span class="NLM_article-title">The target landscape of clinical kinase drugs</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>358</i></span> (<span class="NLM_issue">6367</span>), <span class="NLM_elocation-id">eaan4368</span> <span class="refDoi"> DOI: 10.1126/science.aan4368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1126%2Fscience.aan4368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=29191878" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2017&issue=6367&author=S.+Klaegerauthor=S.+Heinzlmeirauthor=M.+Wilhelmauthor=H.+Polzerauthor=B.+Vickauthor=P.+A.+Koenigauthor=M.+Reineckeauthor=B.+Ruprechtauthor=S.+Petzoldtauthor=C.+Mengauthor=J.+Zechaauthor=K.+Reiterauthor=H.+Qiaoauthor=D.+Helmauthor=H.+Kochauthor=M.+Schoofauthor=G.+Canevariauthor=E.+Casaleauthor=S.+R.+Depaoliniauthor=A.+Feuchtingerauthor=Z.+Wuauthor=T.+Schmidtauthor=L.+Rueckertauthor=W.+Beckerauthor=J.+Huengesauthor=A.+K.+Garzauthor=B.+O.+Gohlkeauthor=D.+P.+Zolgauthor=G.+Kayserauthor=T.+Vooderauthor=R.+Preissnerauthor=H.+Hahneauthor=N.+T%C3%B5nissonauthor=K.+Kramerauthor=K.+G%C3%B6tzeauthor=F.+Bassermannauthor=J.+Schleglauthor=H.+C.+Ehrlichauthor=S.+Aicheauthor=A.+Walchauthor=P.+A.+Greifauthor=S.+Schneiderauthor=E.+R.+Felderauthor=J.+Rulandauthor=G.+M%C3%A9dardauthor=I.+Jeremiasauthor=K.+Spiekermannauthor=B.+Kuster&title=The+target+landscape+of+clinical+kinase+drugs&doi=10.1126%2Fscience.aan4368"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.aan4368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aan4368%26sid%3Dliteratum%253Aachs%26aulast%3DKlaeger%26aufirst%3DS.%26aulast%3DHeinzlmeir%26aufirst%3DS.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DPolzer%26aufirst%3DH.%26aulast%3DVick%26aufirst%3DB.%26aulast%3DKoenig%26aufirst%3DP.%2BA.%26aulast%3DReinecke%26aufirst%3DM.%26aulast%3DRuprecht%26aufirst%3DB.%26aulast%3DPetzoldt%26aufirst%3DS.%26aulast%3DMeng%26aufirst%3DC.%26aulast%3DZecha%26aufirst%3DJ.%26aulast%3DReiter%26aufirst%3DK.%26aulast%3DQiao%26aufirst%3DH.%26aulast%3DHelm%26aufirst%3DD.%26aulast%3DKoch%26aufirst%3DH.%26aulast%3DSchoof%26aufirst%3DM.%26aulast%3DCanevari%26aufirst%3DG.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DDepaolini%26aufirst%3DS.%2BR.%26aulast%3DFeuchtinger%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DT.%26aulast%3DRueckert%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DHuenges%26aufirst%3DJ.%26aulast%3DGarz%26aufirst%3DA.%2BK.%26aulast%3DGohlke%26aufirst%3DB.%2BO.%26aulast%3DZolg%26aufirst%3DD.%2BP.%26aulast%3DKayser%26aufirst%3DG.%26aulast%3DVooder%26aufirst%3DT.%26aulast%3DPreissner%26aufirst%3DR.%26aulast%3DHahne%26aufirst%3DH.%26aulast%3DT%25C3%25B5nisson%26aufirst%3DN.%26aulast%3DKramer%26aufirst%3DK.%26aulast%3DG%25C3%25B6tze%26aufirst%3DK.%26aulast%3DBassermann%26aufirst%3DF.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DEhrlich%26aufirst%3DH.%2BC.%26aulast%3DAiche%26aufirst%3DS.%26aulast%3DWalch%26aufirst%3DA.%26aulast%3DGreif%26aufirst%3DP.%2BA.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DFelder%26aufirst%3DE.%2BR.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DM%25C3%25A9dard%26aufirst%3DG.%26aulast%3DJeremias%26aufirst%3DI.%26aulast%3DSpiekermann%26aufirst%3DK.%26aulast%3DKuster%26aufirst%3DB.%26atitle%3DThe%2520target%2520landscape%2520of%2520clinical%2520kinase%2520drugs%26jtitle%3DScience%26date%3D2017%26volume%3D358%26issue%3D6367%26doi%3D10.1126%2Fscience.aan4368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asquith, C. R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffuid, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrice, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tizzard, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alamillo-Ferrer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koshlap, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crona, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">Design and evaluation of novel 4-anilinoquinolines and quinazolines as EGFR inhibitors in lung cancer and chordoma</span>. <i>BioRxiv</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">545525</span>, <span class="refDoi"> DOI: 10.1101/54552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1101%2F54552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=545525&author=C.+R.+M.+Asquithauthor=K.+A.+Maffuidauthor=T.+Laitinenauthor=C.+D.+Torriceauthor=G.+J.+Tizzardauthor=C.+Alamillo-Ferrerauthor=K.+M.+Koshlapauthor=D.+J.+Cronaauthor=W.+J.+Zuercher&title=Design+and+evaluation+of+novel+4-anilinoquinolines+and+quinazolines+as+EGFR+inhibitors+in+lung+cancer+and+chordoma&doi=10.1101%2F54552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1101%2F54552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F54552%26sid%3Dliteratum%253Aachs%26aulast%3DAsquith%26aufirst%3DC.%2BR.%2BM.%26aulast%3DMaffuid%26aufirst%3DK.%2BA.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DTorrice%26aufirst%3DC.%2BD.%26aulast%3DTizzard%26aufirst%3DG.%2BJ.%26aulast%3DAlamillo-Ferrer%26aufirst%3DC.%26aulast%3DKoshlap%26aufirst%3DK.%2BM.%26aulast%3DCrona%26aufirst%3DD.%2BJ.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DDesign%2520and%2520evaluation%2520of%2520novel%25204-anilinoquinolines%2520and%2520quinazolines%2520as%2520EGFR%2520inhibitors%2520in%2520lung%2520cancer%2520and%2520chordoma%26jtitle%3DBioRxiv%26date%3D2019%26spage%3D545525%26doi%3D10.1101%2F54552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asquith, C.
R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godoi, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">East, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tizzard, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dornsife, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">Identification and optimization of 4-anilinoquinolines as inhibitors of cyclin G associated kinase</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1002%2Fcmdc.201700663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=29072804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKhurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=48-66&issue=1&author=C.%0AR.+M.+Asquithauthor=T.+Laitinenauthor=J.+M.+Bennettauthor=P.+H.+Godoiauthor=M.+P.+Eastauthor=G.+J.+Tizzardauthor=L.+M.+Gravesauthor=G.+L.+Johnsonauthor=R.+E.+Dornsifeauthor=C.+I.+Wellsauthor=J.+M.+Elkinsauthor=T.+M.+Willsonauthor=W.+J.+Zuercher&title=Identification+and+optimization+of+4-anilinoquinolines+as+inhibitors+of+cyclin+G+associated+kinase&doi=10.1002%2Fcmdc.201700663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase</span></div><div class="casAuthors">Asquith, Christopher R. M.; Laitinen, Tuomo; Bennett, James M.; Godoi, Paulo H.; East, Michael P.; Tizzard, Graham J.; Graves, Lee M.; Johnson, Gary L.; Dornsife, Ronna E.; Wells, Carrow I.; Elkins, Jonathan M.; Willson, Timothy M.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-66</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">4-Anilinoquinolines were identified as potent and narrow-spectrum inhibitors of the cyclin G assocd. kinase (GAK), an important regulator of viral and bacterial entry into host cells.  Optimization of the 4-anilino group and the 6,7-quinoline substituents produced GAK inhibitors with nanomolar activity, over 50 000-fold selectivity relative to other members of the numb-assocd. kinase (NAK) subfamily, and a compd. (6,7-dimethoxy-N-(3,4,5-trimethoxyphenyl)quinolin-4-amine; I) with a narrow-spectrum kinome profile.  These compds. may be useful tools to explore the therapeutic potential of GAK in prevention of a broad range of infectious and systemic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVCmCJJ-T_rrVg90H21EOLACvtfcHk0lh_it131Rn4Hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKhurfJ&md5=4ea89909e674ef29c37e78fbe7622a68</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700663%26sid%3Dliteratum%253Aachs%26aulast%3DAsquith%26aufirst%3DC.%2BR.%2BM.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DGodoi%26aufirst%3DP.%2BH.%26aulast%3DEast%26aufirst%3DM.%2BP.%26aulast%3DTizzard%26aufirst%3DG.%2BJ.%26aulast%3DGraves%26aufirst%3DL.%2BM.%26aulast%3DJohnson%26aufirst%3DG.%2BL.%26aulast%3DDornsife%26aufirst%3DR.%2BE.%26aulast%3DWells%26aufirst%3DC.%2BI.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DIdentification%2520and%2520optimization%2520of%25204-anilinoquinolines%2520as%2520inhibitors%2520of%2520cyclin%2520G%2520associated%2520kinase%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26issue%3D1%26spage%3D48%26epage%3D66%26doi%3D10.1002%2Fcmdc.201700663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asquith, C. R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuzzi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crona, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewry, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">East, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godoi, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrice, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earp, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">SGC-GAK-1: A chemical probe for cyclin G associated kinase (GAK)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2830</span>– <span class="NLM_lpage">2836</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01213</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01213" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFCrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2830-2836&issue=5&author=C.+R.+M.+Asquithauthor=B.+T.+Bergerauthor=J.+Wanauthor=J.+M.+Bennettauthor=S.+J.+Capuzziauthor=D.+J.+Cronaauthor=D.+H.+Drewryauthor=M.+P.+Eastauthor=J.+M.+Elkinsauthor=O.+Fedorovauthor=P.+H.+Godoiauthor=D.+M.+Hunterauthor=S.+Knappauthor=S.+M%C3%BCllerauthor=C.+D.+Torriceauthor=C.+I.+Wellsauthor=H.+S.+Earpauthor=T.+M.+Willsonauthor=W.+J.+Zuercher&title=SGC-GAK-1%3A+A+chemical+probe+for+cyclin+G+associated+kinase+%28GAK%29&doi=10.1021%2Facs.jmedchem.8b01213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK)</span></div><div class="casAuthors">Asquith, Christopher R. M.; Berger, Benedict-Tilman; Wan, Jing; Bennett, James M.; Capuzzi, Stephen J.; Crona, Daniel J.; Drewry, David H.; East, Michael P.; Elkins, Jonathan M.; Fedorov, Oleg; Godoi, Paulo H.; Hunter, Debra M.; Knapp, Stefan; Muller, Susanne; Torrice, Chad D.; Wells, Carrow I.; Earp, H. Shelton; Willson, Timothy M.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2830-2836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe SGC-GAK-1 (11), a potent, selective, and cell-active inhibitor of cyclin G-assocd. kinase (GAK), together with a structurally related neg. control SGC-GAK-1N (14).  11 Was highly selective in an in vitro kinome-wide screen, but cellular engagement assays defined RIPK2 as a collateral target.  We identified 18 as a potent RIPK2 inhibitor lacking GAK activity.  Together, this chem. probe set can be used to interrogate GAK cellular biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo59Ri_VO0xCLVg90H21EOLACvtfcHk0lj7kgvrozbj3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFCrtr4%253D&md5=95b6a31e3df7d87fb129d0814dc81bad</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01213%26sid%3Dliteratum%253Aachs%26aulast%3DAsquith%26aufirst%3DC.%2BR.%2BM.%26aulast%3DBerger%26aufirst%3DB.%2BT.%26aulast%3DWan%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DCapuzzi%26aufirst%3DS.%2BJ.%26aulast%3DCrona%26aufirst%3DD.%2BJ.%26aulast%3DDrewry%26aufirst%3DD.%2BH.%26aulast%3DEast%26aufirst%3DM.%2BP.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DGodoi%26aufirst%3DP.%2BH.%26aulast%3DHunter%26aufirst%3DD.%2BM.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DTorrice%26aufirst%3DC.%2BD.%26aulast%3DWells%26aufirst%3DC.%2BI.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DSGC-GAK-1%253A%2520A%2520chemical%2520probe%2520for%2520cyclin%2520G%2520associated%2520kinase%2520%2528GAK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D5%26spage%3D2830%26epage%3D2836%26doi%3D10.1021%2Facs.jmedchem.8b01213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drewry, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ali, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axtman, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuzzi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ettmayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gileadi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luecking, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaelides, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muratov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saikatendu, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span> <span> </span><span class="NLM_article-title">Progress towards a public chemogenomic set for protein kinases and a call for contributions</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">8</span>), <span class="NLM_elocation-id">e0181585</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0181585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1371%2Fjournal.pone.0181585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=28767711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFWktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&issue=8&author=D.+H.+Drewryauthor=C.+I.+Wellsauthor=D.+M.+Andrewsauthor=R.+Angellauthor=H.+Al-Aliauthor=A.+D.+Axtmanauthor=S.+J.+Capuzziauthor=J.+M.+Elkinsauthor=P.+Ettmayerauthor=M.+Frederiksenauthor=O.+Gileadiauthor=N.+Grayauthor=A.+Hooperauthor=S.+Knappauthor=S.+Lauferauthor=U.+Lueckingauthor=M.+Michaelidesauthor=S.+M%C3%BCllerauthor=E.+Muratovauthor=R.+A.+Dennyauthor=K.+S.+Saikatenduauthor=D.+K.+Treiberauthor=W.+J.+Zuercherauthor=T.+M.+Willson&title=Progress+towards+a+public+chemogenomic+set+for+protein+kinases+and+a+call+for+contributions&doi=10.1371%2Fjournal.pone.0181585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Progress towards a public chemogenomic set for protein kinases and a call for contributions</span></div><div class="casAuthors">Drewry, David H.; Wells, Carrow I.; Andrews, David M.; Angell, Richard; Al-Ali, Hassan; Axtman, Alison D.; Capuzzi, Stephen J.; Elkins, Jonathan M.; Ettmayer, Peter; Frederiksen, Mathias; Gileadi, Opher; Gray, Nathanael; Hooper, Alice; Knapp, Stefan; Laufer, Stefan; Luecking, Ulrich; Michaelides, Michael; Muller, Susanne; Muratov, Eugene; Aldrin, Denny R.; Saikatendu, Kumar S.; Treiber, Daniel K.; Zuercher, William J.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0181585/1-e0181585/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Protein kinases are highly tractable targets for drug discovery.  However, the biol. function and therapeutic potential of the majority of the 500+ human protein kinases remains unknown.  We have developed phys. and virtual collections of small mol. inhibitors, which we call chemogenomic sets, that are designed to inhibit the catalytic function of almost half the human protein kinases.  In this manuscript we share our progress towards generation of a comprehensive kinase chemogenomic set (KCGS), release kinome profiling data of a large inhibitor set (Published Kinase Inhibitor Set 2 (PKIS2)), and outline a process through which the community can openly collaborate to create a KCGS that probes the full complement of human protein kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpozOiNZl51XbVg90H21EOLACvtfcHk0lj7kgvrozbj3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFWktL0%253D&md5=9c27ba5cd21da43d30ce485ffa0e1675</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0181585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0181585%26sid%3Dliteratum%253Aachs%26aulast%3DDrewry%26aufirst%3DD.%2BH.%26aulast%3DWells%26aufirst%3DC.%2BI.%26aulast%3DAndrews%26aufirst%3DD.%2BM.%26aulast%3DAngell%26aufirst%3DR.%26aulast%3DAl-Ali%26aufirst%3DH.%26aulast%3DAxtman%26aufirst%3DA.%2BD.%26aulast%3DCapuzzi%26aufirst%3DS.%2BJ.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DEttmayer%26aufirst%3DP.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DGileadi%26aufirst%3DO.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DHooper%26aufirst%3DA.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DS.%26aulast%3DLuecking%26aufirst%3DU.%26aulast%3DMichaelides%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DMuratov%26aufirst%3DE.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DSaikatendu%26aufirst%3DK.%2BS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DProgress%2520towards%2520a%2520public%2520chemogenomic%2520set%2520for%2520protein%2520kinases%2520and%2520a%2520call%2520for%2520contributions%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26issue%3D8%26doi%3D10.1371%2Fjournal.pone.0181585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pawar, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sos, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rode, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heynck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Otterlo, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4-anilinoquinolines as potent inhibitors of epidermal growth factor receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2892</span>– <span class="NLM_lpage">2901</span>, <span class="refDoi"> DOI: 10.1021/jm901877j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901877j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2892-2901&author=V.+G.+Pawarauthor=M.+L.+Sosauthor=H.+B.+Rodeauthor=M.+Rabillerauthor=S.+Heynckauthor=W.+A.+van+Otterloauthor=R.+K.+Thomasauthor=D.+Rauh&title=Synthesis+and+biological+evaluation+of+4-anilinoquinolines+as+potent+inhibitors+of+epidermal+growth+factor+receptor&doi=10.1021%2Fjm901877j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm901877j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901877j%26sid%3Dliteratum%253Aachs%26aulast%3DPawar%26aufirst%3DV.%2BG.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DRode%26aufirst%3DH.%2BB.%26aulast%3DRabiller%26aufirst%3DM.%26aulast%3DHeynck%26aufirst%3DS.%26aulast%3Dvan%2BOtterlo%26aufirst%3DW.%2BA.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26aulast%3DRauh%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204-anilinoquinolines%2520as%2520potent%2520inhibitors%2520of%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2892%26epage%3D2901%26doi%3D10.1021%2Fjm901877j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kaitlyn A.  Maffuid</span>, <span class="hlFld-ContribAuthor ">Maria  Koyioni</span>, <span class="hlFld-ContribAuthor ">Chad D.  Torrice</span>, <span class="hlFld-ContribAuthor ">William A.  Murphy</span>, <span class="hlFld-ContribAuthor ">Heemaja K.  Mewada</span>, <span class="hlFld-ContribAuthor ">Panayiotis A.  Koutentis</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Crona</span>, <span class="hlFld-ContribAuthor ">Christopher R.M.  Asquith</span>. </span><span class="cited-content_cbyCitation_article-title">Design and evaluation of 1,2,3-dithiazoles and fused 1,2,4-dithiazines as anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>43 </em>, 128078. <a href="https://doi.org/10.1016/j.bmcl.2021.128078" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128078%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bevaluation%252Bof%252B1%25252C2%25252C3-dithiazoles%252Band%252Bfused%252B1%25252C2%25252C4-dithiazines%252Bas%252Banti-cancer%252Bagents%26aulast%3DMaffuid%26aufirst%3DKaitlyn%2BA.%26date%3D2021%26volume%3D43%26spage%3D128078" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prateek  Pathak</span>, <span class="hlFld-ContribAuthor ">Hrvoje  Rimac</span>, <span class="hlFld-ContribAuthor ">Maria  Grishina</span>, <span class="hlFld-ContribAuthor ">Amita  Verma</span>, <span class="hlFld-ContribAuthor ">Vladimir  Potemkin</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid Quinazoline 1,3,5‐Triazines as Epidermal Growth Factor Receptor (EGFR) Inhibitors with Anticancer Activity: Design, Synthesis, and Computational Study. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , 822-838. <a href="https://doi.org/10.1002/cmdc.202000646" title="DOI URL">https://doi.org/10.1002/cmdc.202000646</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000646&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000646%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DHybrid%252BQuinazoline%252B1%25252C3%25252C5%2525E2%252580%252590Triazines%252Bas%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252B%252528EGFR%252529%252BInhibitors%252Bwith%252BAnticancer%252BActivity%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BComputational%252BStudy%26aulast%3DPathak%26aufirst%3DPrateek%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D5%26spage%3D822%26epage%3D838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Belén  Martinez-Gualda</span>, <span class="hlFld-ContribAuthor ">Sirle  Saul</span>, <span class="hlFld-ContribAuthor ">Mathy  Froeyen</span>, <span class="hlFld-ContribAuthor ">Dominique  Schols</span>, <span class="hlFld-ContribAuthor ">Piet  Herdewijn</span>, <span class="hlFld-ContribAuthor ">Shirit  Einav</span>, <span class="hlFld-ContribAuthor ">Steven  De Jonghe</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-phenyl- and 3-N-piperidinyl-isothiazolo[4,3-b]pyridines as highly potent inhibitors of cyclin G-associated kinase. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>213 </em>, 113158. <a href="https://doi.org/10.1016/j.ejmech.2021.113158" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113158</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113158%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-phenyl-%252Band%252B3-N-piperidinyl-isothiazolo%25255B4%25252C3-b%25255Dpyridines%252Bas%252Bhighly%252Bpotent%252Binhibitors%252Bof%252Bcyclin%252BG-associated%252Bkinase%26aulast%3DMartinez-Gualda%26aufirst%3DBel%25C3%25A9n%26date%3D2021%26volume%3D213%26spage%3D113158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ting  Guo</span>, <span class="hlFld-ContribAuthor ">Shutao  Ma</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Discovery of Multitargeted Tyrosine Kinase Inhibitors as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (4)
                                     , 600-620. <a href="https://doi.org/10.1002/cmdc.202000658" title="DOI URL">https://doi.org/10.1002/cmdc.202000658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000658%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDiscovery%252Bof%252BMultitargeted%252BTyrosine%252BKinase%252BInhibitors%252Bas%252BAnticancer%252BAgents%26aulast%3DGuo%26aufirst%3DTing%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D4%26spage%3D600%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher  Asquith</span>, <span class="hlFld-ContribAuthor ">Graham  Tizzard</span>. </span><span class="cited-content_cbyCitation_article-title">6-Bromo-N-(3-(difluoromethyl)phenyl)quinolin-4-amine. </span><span class="cited-content_cbyCitation_journal-name">Molbank</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (4)
                                     , M1161. <a href="https://doi.org/10.3390/M1161" title="DOI URL">https://doi.org/10.3390/M1161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/M1161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2FM1161%26sid%3Dliteratum%253Aachs%26jtitle%3DMolbank%26atitle%3D6-Bromo-N-%2525283-%252528difluoromethyl%252529phenyl%252529quinolin-4-amine%26aulast%3DAsquith%26aufirst%3DChristopher%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D4%26spage%3DM1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sirle  Saul</span>, <span class="hlFld-ContribAuthor ">Szu-Yuan  Pu</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>, <span class="hlFld-ContribAuthor ">Shirit  Einav</span>, <span class="hlFld-ContribAuthor ">Christopher R.M.  Asquith</span>. </span><span class="cited-content_cbyCitation_article-title">Potent antiviral activity of novel multi-substituted 4-anilinoquin(az)olines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (16)
                                     , 127284. <a href="https://doi.org/10.1016/j.bmcl.2020.127284" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127284</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127284%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotent%252Bantiviral%252Bactivity%252Bof%252Bnovel%252Bmulti-substituted%252B4-anilinoquin%252528az%252529olines%26aulast%3DSaul%26aufirst%3DSirle%26date%3D2020%26volume%3D30%26issue%3D16%26spage%3D127284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R. M.  Asquith</span>, <span class="hlFld-ContribAuthor ">Graham J.  Tizzard</span>, <span class="hlFld-ContribAuthor ">James M.  Bennett</span>, <span class="hlFld-ContribAuthor ">Carrow I.  Wells</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Elkins</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Willson</span>, <span class="hlFld-ContribAuthor ">Antti  Poso</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Water Network in Cyclin G‐Associated Kinase (GAK) with 4‐Anilino‐quin(az)oline Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (13)
                                     , 1200-1215. <a href="https://doi.org/10.1002/cmdc.202000150" title="DOI URL">https://doi.org/10.1002/cmdc.202000150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000150%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTargeting%252Bthe%252BWater%252BNetwork%252Bin%252BCyclin%252BG%2525E2%252580%252590Associated%252BKinase%252B%252528GAK%252529%252Bwith%252B4%2525E2%252580%252590Anilino%2525E2%252580%252590quin%252528az%252529oline%252BInhibitors%26aulast%3DAsquith%26aufirst%3DChristopher%2BR.%2BM.%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D13%26spage%3D1200%26epage%3D1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Selvaraj  Shyamsivappan</span>, <span class="hlFld-ContribAuthor ">Raju  Vivek</span>, <span class="hlFld-ContribAuthor ">Arjunan  Saravanan</span>, <span class="hlFld-ContribAuthor ">Thangaraj  Arasakumar</span>, <span class="hlFld-ContribAuthor ">Thangaraj  Suresh</span>, <span class="hlFld-ContribAuthor ">Shunmuganarayanan  Athimoolam</span>, <span class="hlFld-ContribAuthor ">Palathurai Subramaniam  Mohan</span>. </span><span class="cited-content_cbyCitation_article-title">A novel 8-nitro quinoline-thiosemicarbazone analogues induces G1/S & G2/M phase cell cycle arrest and apoptosis through ROS mediated mitochondrial pathway. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>97 </em>, 103709. <a href="https://doi.org/10.1016/j.bioorg.2020.103709" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.103709</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.103709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.103709%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DA%252Bnovel%252B8-nitro%252Bquinoline-thiosemicarbazone%252Banalogues%252Binduces%252BG1%25252FS%252B%252526%252BG2%25252FM%252Bphase%252Bcell%252Bcycle%252Barrest%252Band%252Bapoptosis%252Bthrough%252BROS%252Bmediated%252Bmitochondrial%252Bpathway%26aulast%3DShyamsivappan%26aufirst%3DSelvaraj%26date%3D2020%26volume%3D97%26spage%3D103709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R. M.  Asquith</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>, <span class="hlFld-ContribAuthor ">Carrow I.  Wells</span>, <span class="hlFld-ContribAuthor ">Graham J.  Tizzard</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>. </span><span class="cited-content_cbyCitation_article-title">New Insights into 4-Anilinoquinazolines as Inhibitors of Cardiac Troponin I–Interacting Kinase (TNNi3K). </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (7)
                                     , 1697. <a href="https://doi.org/10.3390/molecules25071697" title="DOI URL">https://doi.org/10.3390/molecules25071697</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25071697&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25071697%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DNew%252BInsights%252Binto%252B4-Anilinoquinazolines%252Bas%252BInhibitors%252Bof%252BCardiac%252BTroponin%252BI%2525E2%252580%252593Interacting%252BKinase%252B%252528TNNi3K%252529%26aulast%3DAsquith%26aufirst%3DChristopher%2BR.%2BM.%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D7%26spage%3D1697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R. M.  Asquith</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>, <span class="hlFld-ContribAuthor ">James M.  Bennett</span>, <span class="hlFld-ContribAuthor ">Carrow I.  Wells</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Elkins</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>, <span class="hlFld-ContribAuthor ">Graham J.  Tizzard</span>, <span class="hlFld-ContribAuthor ">Antti  Poso</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Analysis of the 4‐Anilinoquin(az)oline Kinase Inhibition Profiles of GAK/SLK/STK10 Using Quantitative Structure‐Activity Relationships. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2020,</strong> <em>15 </em>
                                    (1)
                                     , 26-49. <a href="https://doi.org/10.1002/cmdc.201900521" title="DOI URL">https://doi.org/10.1002/cmdc.201900521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900521%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%252Band%252BAnalysis%252Bof%252Bthe%252B4%2525E2%252580%252590Anilinoquin%252528az%252529oline%252BKinase%252BInhibition%252BProfiles%252Bof%252BGAK%25252FSLK%25252FSTK10%252BUsing%252BQuantitative%252BStructure%2525E2%252580%252590Activity%252BRelationships%26aulast%3DAsquith%26aufirst%3DChristopher%2BR.%2BM.%26date%3D2020%26date%3D2019%26volume%3D15%26issue%3D1%26spage%3D26%26epage%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher  Asquith</span>, <span class="hlFld-ContribAuthor ">Graham  Tizzard</span>. </span><span class="cited-content_cbyCitation_article-title">6-Bromo-N-(2-methyl-2H-benzo[d][1,2,3]triazol-5-yl)quinolin-4-amine. </span><span class="cited-content_cbyCitation_journal-name">Molbank</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (4)
                                     , M1087. <a href="https://doi.org/10.3390/M1087" title="DOI URL">https://doi.org/10.3390/M1087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/M1087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2FM1087%26sid%3Dliteratum%253Aachs%26jtitle%3DMolbank%26atitle%3D6-Bromo-N-%2525282-methyl-2H-benzo%25255Bd%25255D%25255B1%25252C2%25252C3%25255Dtriazol-5-yl%252529quinolin-4-amine%26aulast%3DAsquith%26aufirst%3DChristopher%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D4%26spage%3DM1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R. M.  Asquith</span>, <span class="hlFld-ContribAuthor ">James M.  Bennett</span>, <span class="hlFld-ContribAuthor ">Lianyong  Su</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Elkins</span>, <span class="hlFld-ContribAuthor ">Julie E.  Pickett</span>, <span class="hlFld-ContribAuthor ">Carrow I.  Wells</span>, <span class="hlFld-ContribAuthor ">Zengbiao  Li</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Willson</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>. </span><span class="cited-content_cbyCitation_article-title">Towards the Development of an In vivo Chemical Probe for Cyclin G Associated Kinase (GAK). </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (22)
                                     , 4016. <a href="https://doi.org/10.3390/molecules24224016" title="DOI URL">https://doi.org/10.3390/molecules24224016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24224016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24224016%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DTowards%252Bthe%252BDevelopment%252Bof%252Ban%252BIn%252Bvivo%252BChemical%252BProbe%252Bfor%252BCyclin%252BG%252BAssociated%252BKinase%252B%252528GAK%252529%26aulast%3DAsquith%26aufirst%3DChristopher%2BR.%2BM.%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D22%26spage%3D4016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María Ayelén  Carabajal</span>, <span class="hlFld-ContribAuthor ">Christopher R. M.  Asquith</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>, <span class="hlFld-ContribAuthor ">Graham J.  Tizzard</span>, <span class="hlFld-ContribAuthor ">Lucía  Yim</span>, <span class="hlFld-ContribAuthor ">Analía  Rial</span>, <span class="hlFld-ContribAuthor ">José A.  Chabalgoity</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>, <span class="hlFld-ContribAuthor ">Eleonora  García Véscovi</span>. </span><span class="cited-content_cbyCitation_article-title">Quinazoline-Based Antivirulence Compounds Selectively Target
              Salmonella
              PhoP/PhoQ Signal Transduction System. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2019,</strong> <em>64 </em>
                                    (1)
                                     <a href="https://doi.org/10.1128/AAC.01744-19" title="DOI URL">https://doi.org/10.1128/AAC.01744-19</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.01744-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.01744-19%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DQuinazoline-Based%252BAntivirulence%252BCompounds%252BSelectively%252BTarget%252BSalmonella%252BPhoP%25252FPhoQ%252BSignal%252BTransduction%252BSystem%26aulast%3DCarabajal%26aufirst%3DMar%25C3%25ADa%2BAyel%25C3%25A9n%26date%3D2019%26date%3D2019%26volume%3D64%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R. M.  Asquith</span>, <span class="hlFld-ContribAuthor ">Kaitlyn A.  Maffuid</span>, <span class="hlFld-ContribAuthor ">Tuomo  Laitinen</span>, <span class="hlFld-ContribAuthor ">Chad D.  Torrice</span>, <span class="hlFld-ContribAuthor ">Graham J.  Tizzard</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Crona</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting an EGFR Water Network with 4‐Anilinoquin(az)oline Inhibitors for Chordoma. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (19)
                                     , 1693-1700. <a href="https://doi.org/10.1002/cmdc.201900428" title="DOI URL">https://doi.org/10.1002/cmdc.201900428</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900428%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DTargeting%252Ban%252BEGFR%252BWater%252BNetwork%252Bwith%252B4%2525E2%252580%252590Anilinoquin%252528az%252529oline%252BInhibitors%252Bfor%252BChordoma%26aulast%3DAsquith%26aufirst%3DChristopher%2BR.%2BM.%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D19%26spage%3D1693%26epage%3D1700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R.M.  Asquith</span>, <span class="hlFld-ContribAuthor ">Neil  Fleck</span>, <span class="hlFld-ContribAuthor ">Chad D.  Torrice</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Crona</span>, <span class="hlFld-ContribAuthor ">Christoph  Grundner</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (18)
                                     , 2695-2699. <a href="https://doi.org/10.1016/j.bmcl.2019.07.012" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.012%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAnti-tubercular%252Bactivity%252Bof%252Bnovel%252B4-anilinoquinolines%252Band%252B4-anilinoquinazolines%26aulast%3DAsquith%26aufirst%3DChristopher%2BR.M.%26date%3D2019%26volume%3D29%26issue%3D18%26spage%3D2695%26epage%3D2699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher R.M.  Asquith</span>, <span class="hlFld-ContribAuthor ">Daniel K.  Treiber</span>, <span class="hlFld-ContribAuthor ">William J.  Zuercher</span>. </span><span class="cited-content_cbyCitation_article-title">Utilizing comprehensive and mini-kinome panels to optimize the selectivity of quinoline inhibitors for cyclin G associated kinase (GAK). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (14)
                                     , 1727-1731. <a href="https://doi.org/10.1016/j.bmcl.2019.05.025" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.05.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.05.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.05.025%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DUtilizing%252Bcomprehensive%252Band%252Bmini-kinome%252Bpanels%252Bto%252Boptimize%252Bthe%252Bselectivity%252Bof%252Bquinoline%252Binhibitors%252Bfor%252Bcyclin%252BG%252Bassociated%252Bkinase%252B%252528GAK%252529%26aulast%3DAsquith%26aufirst%3DChristopher%2BR.M.%26date%3D2019%26volume%3D29%26issue%3D14%26spage%3D1727%26epage%3D1731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/medium/jm-2019-003508_0006.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00350&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/medium/jm-2019-003508_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Previously reported inhibitors of GAK and EGFR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00350&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/medium/jm-2019-003508_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design strategy for GAK/EGFR inhibitors: (A) Erlotinib docked in GAK (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y8D">4Y8D</a>) and (B) <b>3</b> docked in GAK (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y8D">4Y8D</a>) and (C) lapatinib docked in EGFR (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XKK">1XKK</a>) and (D) <b>15</b> docked in EGFR (pdb <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XKK">1XKK</a>) demonstrating the hydrophobic pocket (see <a href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf" class="ext-link">SI</a> for detailed images).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00350&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/medium/jm-2019-003508_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Procedure</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00350&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/medium/jm-2019-003508_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Western blot of p-EGFR (Y1068) and EGFR: Lane 1, untreated; lane 2, <b>7</b> (10 μM); lane 3, <b>7</b>(1 μM); lane 4, <b>8</b> (10 μM); lane 5, <b>8</b> (1 μM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-9/acs.jmedchem.9b00350/20190502/images/large/jm-2019-003508_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b00350&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i24">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04732" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04732" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 21 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">George, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bresson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Froelich, S.</span></span> <span> </span><span class="NLM_article-title">Chordomas: A review</span>. <i>Neurosurg Clin N Am.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>26</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">437</span>– <span class="NLM_lpage">452</span>, <span class="refDoi"> DOI: 10.1016/j.nec.2015.03.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1016%2Fj.nec.2015.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=26141362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FgtVCquw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2015&pages=437-452&issue=3&author=B.+Georgeauthor=D.+Bressonauthor=P.+Hermanauthor=S.+Froelich&title=Chordomas%3A+A+review&doi=10.1016%2Fj.nec.2015.03.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Chordomas: A Review</span></div><div class="casAuthors">George Bernard; Bresson Damien; Herman Philippe; Froelich Sebastien</div><div class="citationInfo"><span class="NLM_cas:title">Neurosurgery clinics of North America</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">437-52</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Chordomas (CHs) are tumors with benign histopathology but exhibit aggressive clinical behavior with invasive and metastatic potential.  CHs are challenging tumors to treat, and there are still many questions especially about their optimum treatment.  Radical resection at first presentation should be applied on all CHs.  Complementary proton therapy irrespective of the quality of resection is now routinely proposed even if its efficacy is not clearly demonstrated in case of incomplete resection.  The future of CH treatment is certainly related to a better understanding of the molecular biology and oncogenesis of CHs and consequently to the development of efficient targeted chemotherapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRtS4GCfwaGPsyail4HZd-ifW6udTcc2eZalPfl1ru99bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FgtVCquw%253D%253D&md5=634ae823545d5798180ad85108ac6782</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.nec.2015.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nec.2015.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DGeorge%26aufirst%3DB.%26aulast%3DBresson%26aufirst%3DD.%26aulast%3DHerman%26aufirst%3DP.%26aulast%3DFroelich%26aufirst%3DS.%26atitle%3DChordomas%253A%2520A%2520review%26jtitle%3DNeurosurg%2520Clin%2520N%2520Am.%26date%3D2015%26volume%3D26%26issue%3D3%26spage%3D437%26epage%3D452%26doi%3D10.1016%2Fj.nec.2015.03.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ferraresi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nuzzo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoccali, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marandino, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidiri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salducca, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeuli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giannarelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cognetti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biagini, R.</span></span> <span> </span><span class="NLM_article-title">Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">22</span>, <span class="refDoi"> DOI: 10.1186/1471-2407-10-22</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1186%2F1471-2407-10-22" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=20109225" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A280%3ADC%252BC3c7js1Citw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=22&author=V.+Ferraresiauthor=C.+Nuzzoauthor=C.+Zoccaliauthor=F.+Marandinoauthor=A.+Vidiriauthor=N.+Salduccaauthor=M.+Zeuliauthor=D.+Giannarelliauthor=F.+Cognettiauthor=R.+Biagini&title=Chordoma%3A+clinical+characteristics%2C+management+and+prognosis+of+a+case+series+of+25+patients&doi=10.1186%2F1471-2407-10-22"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Chordoma: clinical characteristics, management and prognosis of a case series of 25 patients</span></div><div class="casAuthors">Ferraresi Virginia; Nuzzo Carmen; Zoccali Carmine; Marandino Ferdinando; Vidiri Antonello; Salducca Nicola; Zeuli Massimo; Giannarelli Diana; Cognetti Francesco; Biagini Roberto</div><div class="citationInfo"><span class="NLM_cas:title">BMC cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">22</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Adequate surgery still remains the only curative treatment of chordoma.  Interesting clinical data on advanced disease with molecularly targeted therapies were reported.  METHODS:  We described the clinical outcome of a series of chordoma patients followed at Regina Elena National Cancer Centre of Rome from 2004 to 2008.  RESULTS:  Twenty-five consecutive patients with sacral (11 patients), spine (13 patients), and skull base (1 patient) chordoma went to our observation.  Six patients (24%) had primary disease, 14(56%) a recurrent disease, and 5(20%) a metastatic spreading.  Surgery was the primary option for treatment in 22 out of 25 patients.  Surgical margins were wide in 5 (23%) and intralesional in 17(77%) patients; 3 out of 4 in-house treated patients obtained wide margins.  After first surgery, radiotherapy (protons or high-energy photons) were delivered to 3 patients.  One out of the 5 patients with wide margins is still without evidence of disease at 20 months from surgery; 2 patients died without evidence of disease after 3 and 36 months from surgery.  Sixteen out of 17 (94%) patients with intralesional margins underwent local progression at a median time of 18 months with a 2-year local progression-free survival of 47%.  The 5-year metastasis-free survival rate was 78.3%.  Seventeen patients with locally advanced and/or metastatic disease expressing platelet-derived growth factor receptor (PDGFR) beta were treated with imatinib mesylate.  A RECIST stabilization of the disease was the best response observed in all treated cases.  Pain relief with reduction in analgesics use was obtained in 6 out of 11 (54%) symptomatic patients.  The 5- and 10-year survival rates of the entire series of patients were 76.7 and 59.7%, respectively.  CONCLUSIONS:  Despite progress of surgical techniques and the results obtained with targeted therapy, more effort is needed for better disease control.  Specific experience of the multi-disciplinary therapeutic team is, however, essential to succeed in improving patients' outcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkUT6DwQ4W4sve_zCu79I8fW6udTcc2eZalPfl1ru99bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7js1Citw%253D%253D&md5=4da42f86bedeb116a909fbac99b4c334</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-10-22&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-10-22%26sid%3Dliteratum%253Aachs%26aulast%3DFerraresi%26aufirst%3DV.%26aulast%3DNuzzo%26aufirst%3DC.%26aulast%3DZoccali%26aufirst%3DC.%26aulast%3DMarandino%26aufirst%3DF.%26aulast%3DVidiri%26aufirst%3DA.%26aulast%3DSalducca%26aufirst%3DN.%26aulast%3DZeuli%26aufirst%3DM.%26aulast%3DGiannarelli%26aufirst%3DD.%26aulast%3DCognetti%26aufirst%3DF.%26aulast%3DBiagini%26aufirst%3DR.%26atitle%3DChordoma%253A%2520clinical%2520characteristics%252C%2520management%2520and%2520prognosis%2520of%2520a%2520case%2520series%2520of%252025%2520patients%26jtitle%3DBMC%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D22%26doi%3D10.1186%2F1471-2407-10-22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akhavan-Sigari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohde, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abili, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostertag, H.</span></span> <span> </span><span class="NLM_article-title">Expression of PDGFR-α, EGFR and c-MET in spinal chordoma: a series of 52 patients</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=24510991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A280%3ADC%252BC2cvjsFyjsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=623-630&issue=2&author=R.+Akhavan-Sigariauthor=M.+Gaabauthor=V.+Rohdeauthor=M.+Abiliauthor=H.+Ostertag&title=Expression+of+PDGFR-%CE%B1%2C+EGFR+and+c-MET+in+spinal+chordoma%3A+a+series+of+52+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of PDGFR-α, EGFR and c-MET in spinal chordoma: a series of 52 patients</span></div><div class="casAuthors">Akhavan-Sigari Reza; Gaab Michael Robert; Rohde Veit; Abili Mehdi; Ostertag Helmut</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">623-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIM:  To investigate the expression of platelet-derived growth factor (PDGF) receptor-A (PDGFRα), epidermal growth factor receptor (EGFR) and c-Met in spinal chordoma.  To the authors' knowledge, little is known regarding the prognostic significance of receptor tyrosine kinase in spinal chordoma.  MATERIALS AND METHODS:  Using immunohistochemical techniques, the authors investigated PDGFR-α, EGFR and c-MET expression in 52 primary and 104 recurrent lesions, and compared these data with clinicopathological parameters.  RESULTS:  PDGFR-α, EGFR and c-MET were found to be expressed in 75.0%, 83% and 77% of primary, and in 97.0% of recurrent lesions in all investigated receptor tyrosine kinases.  Higher PDGFR-α and c-MET expression was found to be correlated with younger patient age.  Lesions with a higher expression of PDGFR-α demonstrated significantly higher EGFR scores in both primary and recurrent lesions compared to those with lower PDGFR-α expression.  In recurrent lesions, higher c-MET expression was found to be associated with significantly better prognosis than those with lower c-MET expression (p=0.033).  Lesions with a higher level of PDGFR-α expression were found to have significantly poorer prognosis than those with lower PDGFR-α expression (p=0.024).  Those patients with lower EGFR expression were found to have significantly better prognosis than those with higher EGFR expression (p=0.005).  CONCLUSION:  In the current study, c-MET expression in patients with spinal chordoma was found to be correlated with a younger patient age and a favorable prognosis.  Patients with a higher level of PDGFR-α and EGFR expression were found to have a significantly poorer prognosis than those with lower PDGFR-α and EGFR expression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQszQcW9x3M6uWhZTslLrfffW6udTcc2eZHzTN8z0vZRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cvjsFyjsg%253D%253D&md5=742c76c9ca2f9ea58e6273bf3dc5c2a3</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAkhavan-Sigari%26aufirst%3DR.%26aulast%3DGaab%26aufirst%3DM.%26aulast%3DRohde%26aufirst%3DV.%26aulast%3DAbili%26aufirst%3DM.%26aulast%3DOstertag%26aufirst%3DH.%26atitle%3DExpression%2520of%2520PDGFR-%25CE%25B1%252C%2520EGFR%2520and%2520c-MET%2520in%2520spinal%2520chordoma%253A%2520a%2520series%2520of%252052%2520patients%26jtitle%3DAnticancer%2520Res.%26date%3D2014%26volume%3D34%26issue%3D2%26spage%3D623%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magnaghi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salom, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cozzi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amboldi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballinari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamborini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gasparri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montagnoli, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raddrizzani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somaschini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bosotti, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orrenius, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozzi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sommer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stacchiotti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacchi, A.</span></span> <span> </span><span class="NLM_article-title">Afatinib is a new therapeutic approach in chordoma with a unique ability to target EGFR and Brachyury</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">603</span>– <span class="NLM_lpage">613</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-17-0324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1158%2F1535-7163.MCT-17-0324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=29237806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslKks7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2018&pages=603-613&issue=3&author=P.+Magnaghiauthor=B.+Salomauthor=L.+Cozziauthor=N.+Amboldiauthor=D.+Ballinariauthor=E.+Tamboriniauthor=F.+Gasparriauthor=A.+Montagnoliauthor=L.+Raddrizzaniauthor=A.+Somaschiniauthor=R.+Bosottiauthor=C.+Orreniusauthor=F.+Bozziauthor=S.+Pilottiauthor=A.+Galvaniauthor=J.+Sommerauthor=S.+Stacchiottiauthor=A.+Isacchi&title=Afatinib+is+a+new+therapeutic+approach+in+chordoma+with+a+unique+ability+to+target+EGFR+and+Brachyury&doi=10.1158%2F1535-7163.MCT-17-0324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury</span></div><div class="casAuthors">Magnaghi, Paola; Salom, Barbara; Cozzi, Liviana; Amboldi, Nadia; Ballinari, Dario; Tamborini, Elena; Gasparri, Fabio; Montagnoli, Alessia; Raddrizzani, Laura; Somaschini, Alessio; Bosotti, Roberta; Orrenius, Christian; Bozzi, Fabio; Pilotti, Silvana; Galvani, Arturo; Sommer, Josh; Stacchiotti, Silvia; Isacchi, Antonella</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">603-613</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Chordomas are rare bone tumors with no approved therapy.  These tumors express several activated tyrosine kinase receptors, which prompted attempts to treat patients with tyrosine kinase inhibitors.  Although clin. benefit was obsd. in phase II clin. trials with imatinib and sorafenib, and sporadically also with EGFR inhibitors, therapies evaluated to date have shown modest activity.  With the goal of identifying new drugs with immediate therapeutic potential for chordoma patients, we collected clin. approved drugs and other advanced inhibitors of MET, PDGFRβ, and EGFR tyrosine kinases, and assessed their antiproliferative activity against a panel of chordoma cell lines.  Chordoma cell lines were not responsive to MET and PDGFRβ inhibitors.  U-CH1 and UM-Chor1 were sensitive to all EGFR inhibitors, whereas the remaining cell lines were generally insensitive to these drugs.  Afatinib was the only EGFR inhibitor with activity across the chordoma panel.  We then investigated the mol. mechanisms behind the responses obsd. and found that the antiproliferative IC50s correlate with the unique ability of afatinib to promote degrdn. of EGFR and brachyury, an embryonic transcription factor considered a key driver of chordoma.  Afatinib displayed potent antitumor efficacy in U-CH1, SF8894, CF322, and CF365 chordoma tumor models in vivo.  In the panel analyzed, high EGFR phosphorylation and low AXL and STK33 expression correlated with higher sensitivity to afatinib and deserve further investigation as potential biomarkers of response.  These data support the use of afatinib in clin. trials and provide the rationale for the upcoming European phase II study on afatinib in advanced chordoma.  Mol Cancer Ther; 17(3); 603-13. ©2017 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrafQ0pTf5v_rVg90H21EOLACvtfcHk0lj-6XGsPDYd0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslKks7o%253D&md5=aecd84582cdf6f90be677bf8ca076b1f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-17-0324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-17-0324%26sid%3Dliteratum%253Aachs%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DSalom%26aufirst%3DB.%26aulast%3DCozzi%26aufirst%3DL.%26aulast%3DAmboldi%26aufirst%3DN.%26aulast%3DBallinari%26aufirst%3DD.%26aulast%3DTamborini%26aufirst%3DE.%26aulast%3DGasparri%26aufirst%3DF.%26aulast%3DMontagnoli%26aufirst%3DA.%26aulast%3DRaddrizzani%26aufirst%3DL.%26aulast%3DSomaschini%26aufirst%3DA.%26aulast%3DBosotti%26aufirst%3DR.%26aulast%3DOrrenius%26aufirst%3DC.%26aulast%3DBozzi%26aufirst%3DF.%26aulast%3DPilotti%26aufirst%3DS.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DSommer%26aufirst%3DJ.%26aulast%3DStacchiotti%26aufirst%3DS.%26aulast%3DIsacchi%26aufirst%3DA.%26atitle%3DAfatinib%2520is%2520a%2520new%2520therapeutic%2520approach%2520in%2520chordoma%2520with%2520a%2520unique%2520ability%2520to%2520target%2520EGFR%2520and%2520Brachyury%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2018%26volume%3D17%26issue%3D3%26spage%3D603%26epage%3D613%26doi%3D10.1158%2F1535-7163.MCT-17-0324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siu, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzevick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettegowda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hann, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallia, G. L.</span></span> <span> </span><span class="NLM_article-title">Erlotinib inhibits growth of a patient-derived chordoma xenograft</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span> (<span class="NLM_issue">11</span>), <span class="NLM_elocation-id">e78895</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0078895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1371%2Fjournal.pone.0078895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=24260133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVGmsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&issue=11&author=I.+M.+Siuauthor=J.+Ruzevickauthor=Q.+Zhaoauthor=N.+Connisauthor=Y.+Jiaoauthor=C.+Bettegowdaauthor=X.+Xiaauthor=P.+C.+Burgerauthor=C.+L.+Hannauthor=G.+L.+Gallia&title=Erlotinib+inhibits+growth+of+a+patient-derived+chordoma+xenograft&doi=10.1371%2Fjournal.pone.0078895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Erlotinib inhibits growth of a patient-derived chordoma xenograft</span></div><div class="casAuthors">Siu, I.-Mei; Ruzevick, Jacob; Zhao, Qi; Connis, Nick; Jiao, Yuchen; Bettegowda, Chetan; Xia, Xuewei; Burger, Peter C.; Hann, Christine L.; Gallia, Gary L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e78895/1-e78895/8, 8 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Chordomas are rare primary bone tumors that occur along the neuraxis.  Primary treatment is surgery, often followed by radiotherapy.  Treatment options for patients with recurrence are limited and, notably, there are no FDA approved therapeutic agents.  Development of therapeutic options has been limited by the paucity of preclin. model systems.  We have established and previously reported the initial characterization of the first patient-derived chordoma xenograft model.  In this study, we further characterize this model and demonstrate that it continues to resemble the original patient tumor histol. and immunohistochem., maintains nuclear expression of brachyury, and is highly concordant with the original patient tumor by whole genome genotyping.  Pathway anal. of this xenograft demonstrates activation of epidermal growth factor receptor (EGFR).  In vitro studies demonstrate that two small mol. inhibitors of EGFR, erlotinib and gefitinib, inhibit proliferation of the chordoma cell line U-CH 1.  We further demonstrate that erlotinib significantly inhibits chordoma growth in vivo.  Evaluation of tumors post-treatment reveals that erlotinib reduces phosphorylation of EGFR.  This is the first demonstration of antitumor activity in a patient-derived chordoma xenograft model and these findings support further evaluation of EGFR inhibitors in this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhQhcJFI7M7LVg90H21EOLACvtfcHk0lj-6XGsPDYd0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVGmsLc%253D&md5=15b6a4f4591f1067eab75b5c624e2783</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0078895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0078895%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DI.%2BM.%26aulast%3DRuzevick%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DConnis%26aufirst%3DN.%26aulast%3DJiao%26aufirst%3DY.%26aulast%3DBettegowda%26aufirst%3DC.%26aulast%3DXia%26aufirst%3DX.%26aulast%3DBurger%26aufirst%3DP.%2BC.%26aulast%3DHann%26aufirst%3DC.%2BL.%26aulast%3DGallia%26aufirst%3DG.%2BL.%26atitle%3DErlotinib%2520inhibits%2520growth%2520of%2520a%2520patient-derived%2520chordoma%2520xenograft%26jtitle%3DPLoS%2520One%26date%3D2013%26volume%3D8%26issue%3D11%26doi%3D10.1371%2Fjournal.pone.0078895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheipl, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottone, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorgensen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewry, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turlais, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leite, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leithner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüderlein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guppy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amary, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tirabosco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strauss, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pillay, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, A. M.</span></span> <span> </span><span class="NLM_article-title">EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen</span>. <i>J. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>239</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.1002/path.4729</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1002%2Fpath.4729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=27102572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVWmu7rI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=239&publication_year=2016&pages=320-334&issue=3&author=S.+Scheiplauthor=M.+Barnardauthor=L.+Cottoneauthor=M.+Jorgensenauthor=D.+H.+Drewryauthor=W.+J.+Zuercherauthor=F.+Turlaisauthor=H.+Yeauthor=A.+P.+Leiteauthor=J.+A.+Smithauthor=A.+Leithnerauthor=P.+M%C3%B6llerauthor=S.+Br%C3%BCderleinauthor=N.+Guppyauthor=F.+Amaryauthor=R.+Tiraboscoauthor=S.+J.+Straussauthor=N.+Pillayauthor=A.+M.+Flanagan&title=EGFR+inhibitors+identified+as+a+potential+treatment+for+chordoma+in+a+focused+compound+screen&doi=10.1002%2Fpath.4729"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen</span></div><div class="casAuthors">Scheipl, Susanne; Barnard, Michelle; Cottone, Lucia; Jorgensen, Mette; Drewry, David H.; Zuercher, William J.; Turlais, Fabrice; Ye, Hongtao; Leite, Ana P.; Smith, James A.; Leithner, Andreas; Moeller, Peter; Bruederlein, Silke; Guppy, Naomi; Amary, Fernanda; Tirabosco, Roberto; Strauss, Sandra J.; Pillay, Nischalan; Flanagan, Adrienne M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pathology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">239</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">320-334</span>CODEN:
                <span class="NLM_cas:coden">JPTLAS</span>;
        ISSN:<span class="NLM_cas:issn">1096-9896</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Chordoma is a rare malignant bone tumor with a poor prognosis and limited therapeutic options.  We undertook a focused compd. screen (FCS) against 1097 compds. on three well-characterized chordoma cell lines; 154 compds. were selected from the single concn. screen (1 μm), based on their growth-inhibitory effect.  Their half-maximal effective concn. (EC50) values were detd. in chordoma cells and normal fibroblasts.  Twenty-seven of these compds. displayed chordoma selective cell kill and 21/27 (78%) were found to be EGFR/ERBB family inhibitors.  EGFR inhibitors in clin. development were then studied on an extended cell line panel of seven chordoma cell lines, four of which were sensitive to EGFR inhibition.  Sapitinib (AstraZeneca) emerged as the lead compd., followed by gefitinib (AstraZeneca) and erlotinib (Roche/Genentech).  The compds. were shown to induce apoptosis in the sensitive cell lines and suppressed phospho-EGFR and its downstream pathways in a dose-dependent manner.  Anal. of substituent patterns suggested that EGFR-inhibitors with small aniline substituents in the 4-position of the quinazoline ring were more effective than inhibitors with large substituents in that position.  Sapitinib showed significantly reduced tumor growth in two xenograft mouse models (U-CH1 xenograft and a patient-derived xenograft, SF8894).  One of the resistant cell lines (U-CH2) was shown to express high levels of phospho-MET, a known bypass signalling pathway to EGFR.  Neither amplifications (EGFR, ERBB2, MET) nor mutations in EGFR, ERBB2, ERBB4, PIK3CA, BRAF, NRAS, KRAS, PTEN, MET or other cancer gene hotspots were detected in the cell lines.  Our findings are consistent with the reported (p-)EGFR expression in the majority of clin. samples, and provide evidence for exploring the efficacy of EGFR inhibitors in the treatment of patients with chordoma and studying possible resistance mechanisms to these compds. in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTSrh0vHlqC7Vg90H21EOLACvtfcHk0ljYjtmOGQsdew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVWmu7rI&md5=23ee7d42400eed728dc6232154a7a338</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1002%2Fpath.4729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fpath.4729%26sid%3Dliteratum%253Aachs%26aulast%3DScheipl%26aufirst%3DS.%26aulast%3DBarnard%26aufirst%3DM.%26aulast%3DCottone%26aufirst%3DL.%26aulast%3DJorgensen%26aufirst%3DM.%26aulast%3DDrewry%26aufirst%3DD.%2BH.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26aulast%3DTurlais%26aufirst%3DF.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DLeite%26aufirst%3DA.%2BP.%26aulast%3DSmith%26aufirst%3DJ.%2BA.%26aulast%3DLeithner%26aufirst%3DA.%26aulast%3DM%25C3%25B6ller%26aufirst%3DP.%26aulast%3DBr%25C3%25BCderlein%26aufirst%3DS.%26aulast%3DGuppy%26aufirst%3DN.%26aulast%3DAmary%26aufirst%3DF.%26aulast%3DTirabosco%26aufirst%3DR.%26aulast%3DStrauss%26aufirst%3DS.%2BJ.%26aulast%3DPillay%26aufirst%3DN.%26aulast%3DFlanagan%26aufirst%3DA.%2BM.%26atitle%3DEGFR%2520inhibitors%2520identified%2520as%2520a%2520potential%2520treatment%2520for%2520chordoma%2520in%2520a%2520focused%2520compound%2520screen%26jtitle%3DJ.%2520Pathol.%26date%3D2016%26volume%3D239%26issue%3D3%26spage%3D320%26epage%3D334%26doi%3D10.1002%2Fpath.4729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenberg, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, L. E.</span></span> <span> </span><span class="NLM_article-title">Depletion of GAK/auxilin 2 inhibits receptor-mediated endocytosis and recruitment of both clathrin and clathrin adaptors</span>. <i>J. Cell Sci.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">4311</span>– <span class="NLM_lpage">4321</span>, <span class="refDoi"> DOI: 10.1242/jcs.02548</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1242%2Fjcs.02548" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=16155256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCgt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2005&pages=4311-4321&author=D.+W.+Leeauthor=X.+Zhaoauthor=F.+Zhangauthor=E.+Eisenbergauthor=L.+E.+Greene&title=Depletion+of+GAK%2Fauxilin+2+inhibits+receptor-mediated+endocytosis+and+recruitment+of+both+clathrin+and+clathrin+adaptors&doi=10.1242%2Fjcs.02548"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of GAK/auxilin 2 inhibits receptor-mediated endocytosis and recruitment of both clathrin and clathrin adaptors</span></div><div class="casAuthors">Lee, Dong-won; Zhao, Xiaohong; Zhang, Fang; Eisenberg, Evan; Greene, Lois E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4311-4321</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">Cyclin G-assocd. kinase (GAK/auxilin 2), the ubiquitous form of the neuronal-specific protein auxilin 1, is an essential cofactor for the Hsc70-dependent uncoating of clathrin-coated vesicles.  We have now investigated the effect of knocking down GAK in HeLa cells by vector-based small hairpin RNA.  Functionally, depletion of GAK caused a marked decrease in internalization of both transferrin and epidermal growth factor and altered mannose 6-phosphate receptor trafficking, but had little effect on the recycling of transferrin receptor back to the plasma membrane.  Structurally, depletion of GAK caused a marked redn. in perinuclear clathrin assocd. with the trans-Golgi network and in the no. of clathrin-coated pits on the plasma membrane, and reduced clathrin exchange on the few clathrin-coated pits that remained.  Surprisingly, while clathrin depletion does not prevent adaptors from assembling on the membrane, depletion of GAK caused a dramatic redn. in AP2 and epsin on the plasma membrane and AP1 and GGA at the trans-Golgi network.  A similar effect was caused by expression of a dominant neg. Hsp70 mutant.  These results suggest that GAK, in conjunction with Hsc70, not only uncoats clathrin-coated vesicles and induces clathrin exchange on clathrin-coated pits, but also mediates binding of clathrin and adaptors to the plasma membrane and the trans-Golgi network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8IvRfVSaZT7Vg90H21EOLACvtfcHk0ljYjtmOGQsdew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCgt7fK&md5=0172190491cf9b908e705e434b763d60</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1242%2Fjcs.02548&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fjcs.02548%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DEisenberg%26aufirst%3DE.%26aulast%3DGreene%26aufirst%3DL.%2BE.%26atitle%3DDepletion%2520of%2520GAK%252Fauxilin%25202%2520inhibits%2520receptor-mediated%2520endocytosis%2520and%2520recruitment%2520of%2520both%2520clathrin%2520and%2520clathrin%2520adaptors%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2005%26volume%3D118%26spage%3D4311%26epage%3D4321%26doi%3D10.1242%2Fjcs.02548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeh, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, G. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. R.</span></span> <span> </span><span class="NLM_article-title">EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82</span>. <i>Biochim. Biophys. Acta, Mol. Basis Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>1852</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">1540</span>– <span class="NLM_lpage">1549</span>, <span class="refDoi"> DOI: 10.1016/j.bbadis.2015.04.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1016%2Fj.bbadis.2015.04.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=25912735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnt1ektrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1852&publication_year=2015&pages=1540-1549&issue=7&author=C.+H.+Yangauthor=H.+C.+Chouauthor=Y.+N.+Fuauthor=C.+L.+Yehauthor=H.+W.+Chengauthor=I.+C.+Changauthor=K.+J.+Liuauthor=G.+C.+Changauthor=T.+F.+Tsaiauthor=S.+F.+Tsaiauthor=H.+P.+Liuauthor=Y.+C.+Wuauthor=Y.+T.+Chenauthor=S.+F.+Huangauthor=Y.+R.+Chen&title=EGFR+over-expression+in+non-small+cell+lung+cancers+harboring+EGFR+mutations+is+associated+with+marked+down-regulation+of+CD82&doi=10.1016%2Fj.bbadis.2015.04.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82</span></div><div class="casAuthors">Yang, Chi-Hwa; Chou, Hsiao-Chin; Fu, Yu-Ning; Yeh, Chi-Ling; Cheng, Hui-Wen; Chang, Il-Chi; Liu, Ko-Jiunn; Chang, Gee-Chen; Tsai, Ting-Fen; Tsai, Shih-Feng; Liu, Hui-Ping; Wu, Yi-Cheng; Chen, Ya-Ting; Huang, Shiu-Feng; Chen, Yi-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Basis of Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">1852</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1540-1549</span>CODEN:
                <span class="NLM_cas:coden">BBADEX</span>;
        ISSN:<span class="NLM_cas:issn">0925-4439</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Epidermal growth factor receptor (EGFR) gene mutations are strongly assocd. with lung adenocarcinoma and favorable response to EGFR tyrosine kinase inhibitor.  The mutated EGFR proteins (EGFRs) are hyper-phosphorylated and refractory to receptor down-regulation.  To address the discrepancy between hyper-phosphorylation and lack of down-regulation of mutant EGFRs, we have examd. the expression of EGFR neg. regulators in non-small cell lung cancer (NSCLC) cell lines.  We found that NSCLC cell lines expressing mutant EGFRs often had low expression of various neg. regulators for EGFR.  Among them, tumor suppressor CD82 was up-regulated by wild type (WT) EGFR but down-regulated by mutant EGFRs.  Reconstitution of CD82 exerted stronger suppressive effects on mutant EGFRs than on WT EGFR.  Active exportation of CD82 through the exosome was one of the mechanisms involved in achieving the overall CD82 down-regulation in mutant EGFR-expressing lung cancer cell lines.  Over-expression of mutant EGFR protein frequently occurred in the lung cancer tissues of mutant EGFR-transgenic mice and also assocd. with CD82 down-regulation.  Immunoblot analyses on the tumor tissues from 23 lung adenocarcinoma patients (12 with WT EGFR, and 11 with mutant EGFRs) also identified significantly stronger down-regulation of CD82 in tumors with mutant EGFRs than WT.  Our data indicate that CD82 down-regulation could be a crit. step involved in the EGFR over-expression and the stronger tumorigenic activity triggered by EGFR mutations.  Up-regulation of the CD82 level may become a promising new treatment strategy for lung adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4mbUaenzXarVg90H21EOLACvtfcHk0lgL1hNn6izu3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnt1ektrs%253D&md5=aefe17f2112db5b488181860181ba61d</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bbadis.2015.04.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbadis.2015.04.020%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DC.%2BH.%26aulast%3DChou%26aufirst%3DH.%2BC.%26aulast%3DFu%26aufirst%3DY.%2BN.%26aulast%3DYeh%26aufirst%3DC.%2BL.%26aulast%3DCheng%26aufirst%3DH.%2BW.%26aulast%3DChang%26aufirst%3DI.%2BC.%26aulast%3DLiu%26aufirst%3DK.%2BJ.%26aulast%3DChang%26aufirst%3DG.%2BC.%26aulast%3DTsai%26aufirst%3DT.%2BF.%26aulast%3DTsai%26aufirst%3DS.%2BF.%26aulast%3DLiu%26aufirst%3DH.%2BP.%26aulast%3DWu%26aufirst%3DY.%2BC.%26aulast%3DChen%26aufirst%3DY.%2BT.%26aulast%3DHuang%26aufirst%3DS.%2BF.%26aulast%3DChen%26aufirst%3DY.%2BR.%26atitle%3DEGFR%2520over-expression%2520in%2520non-small%2520cell%2520lung%2520cancers%2520harboring%2520EGFR%2520mutations%2520is%2520associated%2520with%2520marked%2520down-regulation%2520of%2520CD82%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Basis%2520Dis.%26date%3D2015%26volume%3D1852%26issue%3D7%26spage%3D1540%26epage%3D1549%26doi%3D10.1016%2Fj.bbadis.2015.04.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fabian, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggs, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atteridge, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azimioara, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benedetti, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciceri, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edeen, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Floyd, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grotzfeld, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrgard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insko, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelias, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milanov, Z. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Velasco, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wodicka, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarrinkar, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockhart, D. J.</span></span> <span> </span><span class="NLM_article-title">A small molecule-kinase interaction map for clinical kinase inhibitors</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">336</span>, <span class="refDoi"> DOI: 10.1038/nbt1068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1038%2Fnbt1068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=15711537" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=329-336&issue=3&author=M.+A.+Fabianauthor=W.+H.+Biggsauthor=D.+K.+Treiberauthor=C.+E.+Atteridgeauthor=M.+D.+Azimioaraauthor=M.+G.+Benedettiauthor=T.+A.+Carterauthor=P.+Ciceriauthor=P.+T.+Edeenauthor=M.+Floydauthor=J.+M.+Fordauthor=M.+Galvinauthor=J.+L.+Gerlachauthor=R.+M.+Grotzfeldauthor=S.+Herrgardauthor=D.+E.+Inskoauthor=M.+A.+Inskoauthor=A.+G.+Laiauthor=J.+M.+Leliasauthor=S.+A.+Mehtaauthor=Z.+V.+Milanovauthor=A.+M.+Velascoauthor=L.+M.+Wodickaauthor=H.+K.+Patelauthor=P.+P.+Zarrinkarauthor=D.+J.+Lockhart&title=A+small+molecule-kinase+interaction+map+for+clinical+kinase+inhibitors&doi=10.1038%2Fnbt1068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">A small molecule-kinase interaction map for clinical kinase inhibitors</span></div><div class="casAuthors">Fabian, Miles A.; Biggs, William H.; Treiber, Daniel K.; Atteridge, Corey E.; Azimioara, Mihai D.; Benedetti, Michael G.; Carter, Todd A.; Ciceri, Pietro; Edeen, Philip T.; Floyd, Mark; Ford, Julia M.; Galvin, Margaret; Gerlach, Jay L.; Grotzfeld, Robert M.; Herrgard, Sanna; Insko, Darren E.; Insko, Michael A.; Lai, Andiliy G.; Lelias, Jean-Michel; Mehta, Shamal A.; Milanov, Zdravko V.; Velasco, Anne Marie; Wodicka, Lisa M.; Patel, Hitesh K.; Zarrinkar, Patrick P.; Lockhart, David J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">329-336</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Kinase inhibitors show great promise as a new class of therapeutics.  Here the authors describe an efficient way to det. kinase inhibitor specificity by measuring binding of small mols. to the ATP site of kinases.  The authors have profiled 20 kinase inhibitors, including 16 that are approved drugs or in clin. development, against a panel of 119 protein kinases.  The authors find that specificity varies widely and is not strongly correlated with chem. structure or the identity of the intended target.  Many novel interactions were identified, including tight binding of the p38 inhibitor BIRB-796 to an imatinib-resistant variant of the ABL kinase, and binding of imatinib to the SRC-family kinase LCK.  The authors also show that mutations in the epidermal growth factor receptor (EGFR) found in gefitinib-responsive patients do not affect the binding affinity of gefitinib or erlotinib.  Our results represent a systematic small mol.-protein interaction map for clin. compds. across a large no. of related proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqA0vNmMOXrnrVg90H21EOLACvtfcHk0ljTIWibbv4b0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXitF2nt7w%253D&md5=6aedd5ceb8f77cd26ee50425dcec7bdf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnbt1068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt1068%26sid%3Dliteratum%253Aachs%26aulast%3DFabian%26aufirst%3DM.%2BA.%26aulast%3DBiggs%26aufirst%3DW.%2BH.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DAtteridge%26aufirst%3DC.%2BE.%26aulast%3DAzimioara%26aufirst%3DM.%2BD.%26aulast%3DBenedetti%26aufirst%3DM.%2BG.%26aulast%3DCarter%26aufirst%3DT.%2BA.%26aulast%3DCiceri%26aufirst%3DP.%26aulast%3DEdeen%26aufirst%3DP.%2BT.%26aulast%3DFloyd%26aufirst%3DM.%26aulast%3DFord%26aufirst%3DJ.%2BM.%26aulast%3DGalvin%26aufirst%3DM.%26aulast%3DGerlach%26aufirst%3DJ.%2BL.%26aulast%3DGrotzfeld%26aufirst%3DR.%2BM.%26aulast%3DHerrgard%26aufirst%3DS.%26aulast%3DInsko%26aufirst%3DD.%2BE.%26aulast%3DInsko%26aufirst%3DM.%2BA.%26aulast%3DLai%26aufirst%3DA.%2BG.%26aulast%3DLelias%26aufirst%3DJ.%2BM.%26aulast%3DMehta%26aufirst%3DS.%2BA.%26aulast%3DMilanov%26aufirst%3DZ.%2BV.%26aulast%3DVelasco%26aufirst%3DA.%2BM.%26aulast%3DWodicka%26aufirst%3DL.%2BM.%26aulast%3DPatel%26aufirst%3DH.%2BK.%26aulast%3DZarrinkar%26aufirst%3DP.%2BP.%26aulast%3DLockhart%26aufirst%3DD.%2BJ.%26atitle%3DA%2520small%2520molecule-kinase%2520interaction%2520map%2520for%2520clinical%2520kinase%2520inhibitors%26jtitle%3DNat.%2520Biotechnol.%26date%3D2005%26volume%3D23%26issue%3D3%26spage%3D329%26epage%3D336%26doi%3D10.1038%2Fnbt1068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marathe, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleczka, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodrigues, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Preclinical pharmacokinetics and in vitro metabolism of BMS-690514, a potent inhibitor of EGFR and VEGFR2</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>99</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">3579</span>– <span class="NLM_lpage">3593</span>, <span class="refDoi"> DOI: 10.1002/jps.22099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1002%2Fjps.22099" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2010&pages=3579-3593&issue=8&author=P.+Maratheauthor=Y.+Tangauthor=B.+Sleczkaauthor=D.+Rodriguesauthor=A.+Gavaiauthor=T.+Wongauthor=L.+Christopherauthor=H.+Zhang&title=Preclinical+pharmacokinetics+and+in+vitro+metabolism+of+BMS-690514%2C+a+potent+inhibitor+of+EGFR+and+VEGFR2&doi=10.1002%2Fjps.22099"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fjps.22099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22099%26sid%3Dliteratum%253Aachs%26aulast%3DMarathe%26aufirst%3DP.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DSleczka%26aufirst%3DB.%26aulast%3DRodrigues%26aufirst%3DD.%26aulast%3DGavai%26aufirst%3DA.%26aulast%3DWong%26aufirst%3DT.%26aulast%3DChristopher%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DPreclinical%2520pharmacokinetics%2520and%2520in%2520vitro%2520metabolism%2520of%2520BMS-690514%252C%2520a%2520potent%2520inhibitor%2520of%2520EGFR%2520and%2520VEGFR2%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2010%26volume%3D99%26issue%3D8%26spage%3D3579%26epage%3D3593%26doi%3D10.1002%2Fjps.22099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hickinson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klinowska, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speake, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trigwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davenport, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mills, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosios, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barlaam, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogilvie, D.</span></span> <span> </span><span class="NLM_article-title">AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor, ERBB2 (HER2), and ERBB3: a unique agent for simultaneous ERBB receptor blockade in cancer</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1159</span>– <span class="NLM_lpage">1169</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-09-2353</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1158%2F1078-0432.CCR-09-2353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=20145185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhvFGiur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=1159-1169&issue=4&author=D.+M.+Hickinsonauthor=T.+Klinowskaauthor=G.+Speakeauthor=J.+Vincentauthor=C.+Trigwellauthor=J.+Andertonauthor=S.+Beckauthor=G.+Marshallauthor=S.+Davenportauthor=R.+Callisauthor=E.+Millsauthor=K.+Grosiosauthor=P.+Smithauthor=B.+Barlaamauthor=R.+W.+Wilkinsonauthor=D.+Ogilvie&title=AZD8931%2C+an+equipotent%2C+reversible+inhibitor+of+signaling+by+epidermal+growth+factor+receptor%2C+ERBB2+%28HER2%29%2C+and+ERBB3%3A+a+unique+agent+for+simultaneous+ERBB+receptor+blockade+in+cancer&doi=10.1158%2F1078-0432.CCR-09-2353"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">AZD8931, an Equipotent, Reversible Inhibitor of Signaling by Epidermal Growth Factor Receptor, ERBB2 (HER2), and ERBB3: A Unique Agent for Simultaneous ERBB Receptor Blockade in Cancer</span></div><div class="casAuthors">Hickinson, D. Mark; Klinowska, Teresa; Speake, Georgina; Vincent, John; Trigwell, Cath; Anderton, Judith; Beck, Sarah; Marshall, Gayle; Davenport, Sara; Callis, Rowena; Mills, Elizabeth; Grosios, Konstantina; Smith, Paul; Barlaam, Bernard; Wilkinson, Robert W.; Ogilvie, Donald</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1159-1169</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: To test the hypothesis that simultaneous, equipotent inhibition of epidermal growth factor receptor (EGFR; erbB1), erbB2 (human epidermal growth factor receptor 2), and erbB3 receptor signaling, using the novel small-mol. inhibitor AZD8931, will deliver broad antitumor activity in vitro and in vivo.  Exptl. Design: A range of assays was used to model erbB family receptor signaling in homodimers and heterodimers, including in vitro evaluation of erbB kinase activity, erbB receptor phosphorylation, proliferation in cells, and in vivo testing in a human tumor xenograft panel, with ex vivo evaluation of erbB phosphorylation and downstream biomarkers.  Gefitinib and lapatinib were used to compare the pharmacol. profile of AZD8931 with other erbB family inhibitors.  Results: In vitro, AZD8931 showed equipotent, reversible inhibition of EGFR (IC50, 4 nmol/L), erbB2 (IC50, 3 nmol/L), and erbB3 (IC50, 4 nmol/L) phosphorylation in cells.  In proliferation assays, AZD8931 was significantly more potent than gefitinib or lapatinib in specific squamous cell carcinoma of the head and neck and non-small cell lung carcinoma cell lines.  In vivo, AZD8931 inhibited xenograft growth in a range of models while significantly affecting EGFR, erbB2, and erbB3 phosphorylation and downstream signaling pathways, apoptosis, and proliferation.  Conclusions: AZD8931 has a unique pharmacol. profile providing equipotent inhibition of EGFR, erbB2, and erbB3 signaling and showing greater antitumor activity than agents with a narrower spectrum of erbB receptor inhibition in specific preclin. models.  AZD8931 provides the opportunity to investigate whether simultaneous inhibition of erbB receptor signaling could be of utility in the clinic, particularly in the majority of solid tumors that do not overexpress erbB2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLhqWjVY8lNLVg90H21EOLACvtfcHk0lixoU9WXjnHmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhvFGiur8%253D&md5=44b67f704bfdc9db519d40dabc7d457f</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-2353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-2353%26sid%3Dliteratum%253Aachs%26aulast%3DHickinson%26aufirst%3DD.%2BM.%26aulast%3DKlinowska%26aufirst%3DT.%26aulast%3DSpeake%26aufirst%3DG.%26aulast%3DVincent%26aufirst%3DJ.%26aulast%3DTrigwell%26aufirst%3DC.%26aulast%3DAnderton%26aufirst%3DJ.%26aulast%3DBeck%26aufirst%3DS.%26aulast%3DMarshall%26aufirst%3DG.%26aulast%3DDavenport%26aufirst%3DS.%26aulast%3DCallis%26aufirst%3DR.%26aulast%3DMills%26aufirst%3DE.%26aulast%3DGrosios%26aufirst%3DK.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DBarlaam%26aufirst%3DB.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DOgilvie%26aufirst%3DD.%26atitle%3DAZD8931%252C%2520an%2520equipotent%252C%2520reversible%2520inhibitor%2520of%2520signaling%2520by%2520epidermal%2520growth%2520factor%2520receptor%252C%2520ERBB2%2520%2528HER2%2529%252C%2520and%2520ERBB3%253A%2520a%2520unique%2520agent%2520for%2520simultaneous%2520ERBB%2520receptor%2520blockade%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26issue%3D4%26spage%3D1159%26epage%3D1169%26doi%3D10.1158%2F1078-0432.CCR-09-2353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Engelman, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zejnullahu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gale, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lifshits, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzales, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naumov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Althaus, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, G. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heymach, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyerson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jänne, P. A.</span></span> <span> </span><span class="NLM_article-title">PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span> (<span class="NLM_issue">24</span>),  <span class="NLM_fpage">11924</span>– <span class="NLM_lpage">11932</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-1885</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1158%2F0008-5472.CAN-07-1885" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=11924-11932&issue=24&author=J.+A.+Engelmanauthor=K.+Zejnullahuauthor=C.+M.+Galeauthor=E.+Lifshitsauthor=A.+J.+Gonzalesauthor=T.+Shimamuraauthor=F.+Zhaoauthor=P.+W.+Vincentauthor=G.+N.+Naumovauthor=J.+E.+Bradnerauthor=I.+W.+Althausauthor=L.+Gandhiauthor=G.+I.+Shapiroauthor=J.+M.+Nelsonauthor=J.+V.+Heymachauthor=M.+Meyersonauthor=K.+K.+Wongauthor=P.+A.+J%C3%A4nne&title=PF00299804%2C+an+irreversible+pan-ERBB+inhibitor%2C+is+effective+in+lung+cancer+models+with+EGFR+and+ERBB2+mutations+that+are+resistant+to+gefitinib&doi=10.1158%2F0008-5472.CAN-07-1885"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-1885&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-1885%26sid%3Dliteratum%253Aachs%26aulast%3DEngelman%26aufirst%3DJ.%2BA.%26aulast%3DZejnullahu%26aufirst%3DK.%26aulast%3DGale%26aufirst%3DC.%2BM.%26aulast%3DLifshits%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DA.%2BJ.%26aulast%3DShimamura%26aufirst%3DT.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DVincent%26aufirst%3DP.%2BW.%26aulast%3DNaumov%26aufirst%3DG.%2BN.%26aulast%3DBradner%26aufirst%3DJ.%2BE.%26aulast%3DAlthaus%26aufirst%3DI.%2BW.%26aulast%3DGandhi%26aufirst%3DL.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26aulast%3DNelson%26aufirst%3DJ.%2BM.%26aulast%3DHeymach%26aufirst%3DJ.%2BV.%26aulast%3DMeyerson%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DK.%2BK.%26aulast%3DJ%25C3%25A4nne%26aufirst%3DP.%2BA.%26atitle%3DPF00299804%252C%2520an%2520irreversible%2520pan-ERBB%2520inhibitor%252C%2520is%2520effective%2520in%2520lung%2520cancer%2520models%2520with%2520EGFR%2520and%2520ERBB2%2520mutations%2520that%2520are%2520resistant%2520to%2520gefitinib%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26issue%3D24%26spage%3D11924%26epage%3D11932%26doi%3D10.1158%2F0008-5472.CAN-07-1885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Green, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fennell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curwen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Logie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hickinson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilkinson, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elvin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carragher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plé, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bermingham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holdgate, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennequin, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costello, G. F.</span></span> <span> </span><span class="NLM_article-title">Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530</span>. <i>Mol. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>3</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1016/j.molonc.2009.01.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1016%2Fj.molonc.2009.01.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=19393585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslKnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2009&pages=248-261&issue=3&author=T.+P.+Greenauthor=M.+Fennellauthor=R.+Whittakerauthor=J.+Curwenauthor=V.+Jacobsauthor=J.+Allenauthor=A.+Logieauthor=J.+Hargreavesauthor=D.+M.+Hickinsonauthor=R.+W.+Wilkinsonauthor=P.+Elvinauthor=B.+Boyerauthor=N.+Carragherauthor=P.+A.+Pl%C3%A9author=A.+Berminghamauthor=G.+A.+Holdgateauthor=W.+H.+Wardauthor=L.+F.+Hennequinauthor=B.+R.+Daviesauthor=G.+F.+Costello&title=Preclinical+anticancer+activity+of+the+potent%2C+oral+Src+inhibitor+AZD0530&doi=10.1016%2Fj.molonc.2009.01.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530</span></div><div class="casAuthors">Green, Tim P.; Fennell, Mike; Whittaker, Robin; Curwen, Jon; Jacobs, Vivien; Allen, Jack; Logie, Armelle; Hargreaves, Judith; Hickinson, D. Mark; Wilkinson, Robert W.; Elvin, Paul; Boyer, Brigitte; Carragher, Neil; Ple, Patrick A.; Bermingham, Alun; Holdgate, Geoffrey A.; Ward, Walter H. J.; Hennequin, Laurent F.; Davies, Barry R.; Costello, Gerard F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Oncology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">248-261</span>CODEN:
                <span class="NLM_cas:coden">MOONC3</span>;
        ISSN:<span class="NLM_cas:issn">1574-7891</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">AZD0530, an orally available Src inhibitor, demonstrated potent antimigratory and anti-invasive effects in vitro, and inhibited metastasis in a murine model of bladder cancer.  Antiproliferative activity of AZD0530 in vitro varied between cell lines (IC50 0.2 -> 10 μM).  AZD0530 inhibited tumor growth in 4/10 xenograft models tested and dynamically inhibited in vivo phosphorylation of Src substrates paxillin and FAK in both growth-inhibition-resistant and -sensitive xenografts.  The activity of AZD0530 in NBT-II bladder cancer cells in vitro was consistent with inhibition of cell migration and stabilization of cell-cell adhesion.  These data suggest a dominant anti-invasive pharmacol. for AZD0530 that may limit tumor progression in a range of cancers.  AZD0530 is currently in Phase II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAbzKlSDQyObVg90H21EOLACvtfcHk0lixoU9WXjnHmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslKnsL0%253D&md5=4c2ec94fde22bbec401009e106bb6caf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.molonc.2009.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molonc.2009.01.002%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DT.%2BP.%26aulast%3DFennell%26aufirst%3DM.%26aulast%3DWhittaker%26aufirst%3DR.%26aulast%3DCurwen%26aufirst%3DJ.%26aulast%3DJacobs%26aufirst%3DV.%26aulast%3DAllen%26aufirst%3DJ.%26aulast%3DLogie%26aufirst%3DA.%26aulast%3DHargreaves%26aufirst%3DJ.%26aulast%3DHickinson%26aufirst%3DD.%2BM.%26aulast%3DWilkinson%26aufirst%3DR.%2BW.%26aulast%3DElvin%26aufirst%3DP.%26aulast%3DBoyer%26aufirst%3DB.%26aulast%3DCarragher%26aufirst%3DN.%26aulast%3DPl%25C3%25A9%26aufirst%3DP.%2BA.%26aulast%3DBermingham%26aufirst%3DA.%26aulast%3DHoldgate%26aufirst%3DG.%2BA.%26aulast%3DWard%26aufirst%3DW.%2BH.%26aulast%3DHennequin%26aufirst%3DL.%2BF.%26aulast%3DDavies%26aufirst%3DB.%2BR.%26aulast%3DCostello%26aufirst%3DG.%2BF.%26atitle%3DPreclinical%2520anticancer%2520activity%2520of%2520the%2520potent%252C%2520oral%2520Src%2520inhibitor%2520AZD0530%26jtitle%3DMol.%2520Oncol.%26date%3D2009%26volume%3D3%26issue%3D3%26spage%3D248%26epage%3D261%26doi%3D10.1016%2Fj.molonc.2009.01.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torrance, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinzler, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vogelstein, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Discafani, C. M.</span></span> <span> </span><span class="NLM_article-title">Combinatorial chemoprevention of intestinal neoplasia</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>6</i></span> (<span class="NLM_issue">9</span>),  <span class="NLM_fpage">1024</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1038/79534</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1038%2F79534" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10973323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslSju7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1024-1028&issue=9&author=C.+J.+Torranceauthor=P.+E.+Jacksonauthor=E.+Montgomeryauthor=K.+W.+Kinzlerauthor=B.+Vogelsteinauthor=A.+Wissnerauthor=M.+Nunesauthor=P.+Frostauthor=C.+M.+Discafani&title=Combinatorial+chemoprevention+of+intestinal+neoplasia&doi=10.1038%2F79534"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Combinatorial chemoprevention of intestinal neoplasia</span></div><div class="casAuthors">Torrance, Christopher J.; Jackson, Peta E.; Montgomery, Elizabeth; Kinzler, Kenneth W.; Vogelstein, Bert; Wissner, Allan; Nunes, Maria; Frost, Philip; Discafani, Carolyn M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1024-1028</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">A combination of two drugs afforded remarkable protection from intestinal neoplasia in APCMin/+ mice, a murine model of human familial adenomatous polyposis (FAP).  One of the drugs was sulindac, a prototypical non-steroidal anti-inflammatory drug with established chemopreventive activity.  The second drug was EKB569, a newly developed, irreversible inhibitor of the epidermal growth factor receptor kinase.  Although 100% of the untreated APCMin/+ mice developed -20 polyps, nearly half the mice treated with these two agents developed no polyps at all.  These results suggest a powerful strategy for the chemoprevention of human colonic neoplasia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoysAYwWewtCrVg90H21EOLACvtfcHk0lhJEz1bdhjrJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslSju7g%253D&md5=2b1da2bdcd72fec51856ff25643efd4c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2F79534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F79534%26sid%3Dliteratum%253Aachs%26aulast%3DTorrance%26aufirst%3DC.%2BJ.%26aulast%3DJackson%26aufirst%3DP.%2BE.%26aulast%3DMontgomery%26aufirst%3DE.%26aulast%3DKinzler%26aufirst%3DK.%2BW.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DWissner%26aufirst%3DA.%26aulast%3DNunes%26aufirst%3DM.%26aulast%3DFrost%26aufirst%3DP.%26aulast%3DDiscafani%26aufirst%3DC.%2BM.%26atitle%3DCombinatorial%2520chemoprevention%2520of%2520intestinal%2520neoplasia%26jtitle%3DNat.%2520Med.%26date%3D2000%26volume%3D6%26issue%3D9%26spage%3D1024%26epage%3D1028%26doi%3D10.1038%2F79534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gendreau, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ventura, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keast, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laird, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yakes, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentzien, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cancilla, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lutman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aftab, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeger, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Costa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joly, A. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">3713</span>– <span class="NLM_lpage">3723</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-06-2590</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1158%2F1078-0432.CCR-06-2590" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=17575237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BD2sXmsFCqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=3713-3723&issue=12&author=S.+B.+Gendreauauthor=R.+Venturaauthor=P.+Keastauthor=A.+D.+Lairdauthor=F.+M.+Yakesauthor=W.+Zhangauthor=F.+Bentzienauthor=B.+Cancillaauthor=J.+Lutmanauthor=F.+Chuauthor=L.+Jackmanauthor=Y.+Shiauthor=P.+Yuauthor=J.+Wangauthor=D.+T.+Aftabauthor=C.+T.+Jaegerauthor=S.+M.+Meyerauthor=A.+De+Costaauthor=K.+Engellauthor=J.+Chenauthor=J.+F.+Martiniauthor=A.+H.+Joly&title=Inhibition+of+the+T790M+gatekeeper+mutant+of+the+epidermal+growth+factor+receptor+by+EXEL-7647&doi=10.1158%2F1078-0432.CCR-06-2590"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the T790M Gatekeeper Mutant of the Epidermal Growth Factor Receptor by EXEL-7647</span></div><div class="casAuthors">Gendreau, Steven B.; Ventura, Richard; Keast, Paul; Laird, A. Douglas; Yakes, F. Michael; Zhang, Wentao; Bentzien, Frauke; Cancilla, Belinda; Lutman, Jeffery; Chu, Felix; Jackman, Lisa; Shi, Yongchang; Yu, Peiwen; Wang, Jing; Aftab, Dana T.; Jaeger, Christopher T.; Meyer, Stephanie M.; De Costa, Anushka; Engell, Kelly; Chen, Jason; Martini, Jean-Francois; Joly, Alison H.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3713-3723</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Agents inhibiting the epidermal growth factor receptor (EGFR) have shown clin. benefit in a subset of non-small cell lung cancer patients expressing amplified or mutationally activated EGFR.  However, responsive patients can relapse as a result of selection for EGFR gene mutations that confer resistance to ATP competitive EGFR inhibitors, such as erlotinib and gefitinib.  We describe here the activity of EXEL-7647 (XL647), a novel spectrum-selective kinase inhibitor with potent activity against the EGF and vascular endothelial growth factor receptor tyrosine kinase families, against both wild-type (WT) and mutant EGFR in vitro and in vivo.  Exptl. DESIGN: The activity of EGFR inhibitors against WT and mutant EGFRs and their effect on downstream signal transduction was examd. in cellular assays and in vivo using A431 and MDA-MB-231 (WT EGFR) and H1975 (L858R and T790M mutant EGFR) xenograft tumors.  RESULTS: EXEL-7647 shows potent and long-lived inhibition of the WT EGFR in vivo.  In addn., EXEL-7647 inhibits cellular proliferation and EGFR pathway activation in the erlotinib-resistant H1975 cell line that harbors a double mutation (L858R and T790M) in the EGFR gene.  In vivo efficacy studies show that EXEL-7647 substantially inhibited the growth of H1975 xenograft tumors and reduced both tumor EGFR signaling and tumor vessel d.  Addnl., EXEL-7647, in contrast to erlotinib, substantially inhibited the growth and vascularization of MDA-MB-231 xenografts, a model which is more reliant on signaling through vascular endothelial growth factor receptors.  CONCLUSIONS: These studies provide a preclin. basis for clin. trials of XL647 in solid tumors and in patients bearing tumors that are resistant to existing EGFR-targeted therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZI1xZ23d5TLVg90H21EOLACvtfcHk0lhJEz1bdhjrJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXmsFCqu7s%253D&md5=f9684468d8e04df2f1a46b33966fa513</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-2590&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-2590%26sid%3Dliteratum%253Aachs%26aulast%3DGendreau%26aufirst%3DS.%2BB.%26aulast%3DVentura%26aufirst%3DR.%26aulast%3DKeast%26aufirst%3DP.%26aulast%3DLaird%26aufirst%3DA.%2BD.%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DBentzien%26aufirst%3DF.%26aulast%3DCancilla%26aufirst%3DB.%26aulast%3DLutman%26aufirst%3DJ.%26aulast%3DChu%26aufirst%3DF.%26aulast%3DJackman%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DAftab%26aufirst%3DD.%2BT.%26aulast%3DJaeger%26aufirst%3DC.%2BT.%26aulast%3DMeyer%26aufirst%3DS.%2BM.%26aulast%3DDe%2BCosta%26aufirst%3DA.%26aulast%3DEngell%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DMartini%26aufirst%3DJ.%2BF.%26aulast%3DJoly%26aufirst%3DA.%2BH.%26atitle%3DInhibition%2520of%2520the%2520T790M%2520gatekeeper%2520mutant%2520of%2520the%2520epidermal%2520growth%2520factor%2520receptor%2520by%2520EXEL-7647%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26issue%3D12%26spage%3D3713%26epage%3D3723%26doi%3D10.1158%2F1078-0432.CCR-06-2590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klaeger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinzlmeir, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilhelm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polzer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vick, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koenig, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinecke, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruprecht, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petzoldt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zecha, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reiter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helm, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoof, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casale, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depaolini, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feuchtinger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rueckert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huenges, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garz, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gohlke, B. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zolg, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kayser, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vooder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Preissner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hahne, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tõnisson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Götze, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassermann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlegl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aiche, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greif, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Médard, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeremias, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiekermann, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuster, B.</span></span> <span> </span><span class="NLM_article-title">The target landscape of clinical kinase drugs</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>358</i></span> (<span class="NLM_issue">6367</span>), <span class="NLM_elocation-id">eaan4368</span> <span class="refDoi"> DOI: 10.1126/science.aan4368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1126%2Fscience.aan4368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=29191878" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2017&issue=6367&author=S.+Klaegerauthor=S.+Heinzlmeirauthor=M.+Wilhelmauthor=H.+Polzerauthor=B.+Vickauthor=P.+A.+Koenigauthor=M.+Reineckeauthor=B.+Ruprechtauthor=S.+Petzoldtauthor=C.+Mengauthor=J.+Zechaauthor=K.+Reiterauthor=H.+Qiaoauthor=D.+Helmauthor=H.+Kochauthor=M.+Schoofauthor=G.+Canevariauthor=E.+Casaleauthor=S.+R.+Depaoliniauthor=A.+Feuchtingerauthor=Z.+Wuauthor=T.+Schmidtauthor=L.+Rueckertauthor=W.+Beckerauthor=J.+Huengesauthor=A.+K.+Garzauthor=B.+O.+Gohlkeauthor=D.+P.+Zolgauthor=G.+Kayserauthor=T.+Vooderauthor=R.+Preissnerauthor=H.+Hahneauthor=N.+T%C3%B5nissonauthor=K.+Kramerauthor=K.+G%C3%B6tzeauthor=F.+Bassermannauthor=J.+Schleglauthor=H.+C.+Ehrlichauthor=S.+Aicheauthor=A.+Walchauthor=P.+A.+Greifauthor=S.+Schneiderauthor=E.+R.+Felderauthor=J.+Rulandauthor=G.+M%C3%A9dardauthor=I.+Jeremiasauthor=K.+Spiekermannauthor=B.+Kuster&title=The+target+landscape+of+clinical+kinase+drugs&doi=10.1126%2Fscience.aan4368"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1126%2Fscience.aan4368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aan4368%26sid%3Dliteratum%253Aachs%26aulast%3DKlaeger%26aufirst%3DS.%26aulast%3DHeinzlmeir%26aufirst%3DS.%26aulast%3DWilhelm%26aufirst%3DM.%26aulast%3DPolzer%26aufirst%3DH.%26aulast%3DVick%26aufirst%3DB.%26aulast%3DKoenig%26aufirst%3DP.%2BA.%26aulast%3DReinecke%26aufirst%3DM.%26aulast%3DRuprecht%26aufirst%3DB.%26aulast%3DPetzoldt%26aufirst%3DS.%26aulast%3DMeng%26aufirst%3DC.%26aulast%3DZecha%26aufirst%3DJ.%26aulast%3DReiter%26aufirst%3DK.%26aulast%3DQiao%26aufirst%3DH.%26aulast%3DHelm%26aufirst%3DD.%26aulast%3DKoch%26aufirst%3DH.%26aulast%3DSchoof%26aufirst%3DM.%26aulast%3DCanevari%26aufirst%3DG.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DDepaolini%26aufirst%3DS.%2BR.%26aulast%3DFeuchtinger%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DSchmidt%26aufirst%3DT.%26aulast%3DRueckert%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DW.%26aulast%3DHuenges%26aufirst%3DJ.%26aulast%3DGarz%26aufirst%3DA.%2BK.%26aulast%3DGohlke%26aufirst%3DB.%2BO.%26aulast%3DZolg%26aufirst%3DD.%2BP.%26aulast%3DKayser%26aufirst%3DG.%26aulast%3DVooder%26aufirst%3DT.%26aulast%3DPreissner%26aufirst%3DR.%26aulast%3DHahne%26aufirst%3DH.%26aulast%3DT%25C3%25B5nisson%26aufirst%3DN.%26aulast%3DKramer%26aufirst%3DK.%26aulast%3DG%25C3%25B6tze%26aufirst%3DK.%26aulast%3DBassermann%26aufirst%3DF.%26aulast%3DSchlegl%26aufirst%3DJ.%26aulast%3DEhrlich%26aufirst%3DH.%2BC.%26aulast%3DAiche%26aufirst%3DS.%26aulast%3DWalch%26aufirst%3DA.%26aulast%3DGreif%26aufirst%3DP.%2BA.%26aulast%3DSchneider%26aufirst%3DS.%26aulast%3DFelder%26aufirst%3DE.%2BR.%26aulast%3DRuland%26aufirst%3DJ.%26aulast%3DM%25C3%25A9dard%26aufirst%3DG.%26aulast%3DJeremias%26aufirst%3DI.%26aulast%3DSpiekermann%26aufirst%3DK.%26aulast%3DKuster%26aufirst%3DB.%26atitle%3DThe%2520target%2520landscape%2520of%2520clinical%2520kinase%2520drugs%26jtitle%3DScience%26date%3D2017%26volume%3D358%26issue%3D6367%26doi%3D10.1126%2Fscience.aan4368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asquith, C. R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffuid, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrice, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tizzard, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alamillo-Ferrer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koshlap, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crona, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">Design and evaluation of novel 4-anilinoquinolines and quinazolines as EGFR inhibitors in lung cancer and chordoma</span>. <i>BioRxiv</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_fpage">545525</span>, <span class="refDoi"> DOI: 10.1101/54552</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1101%2F54552" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&pages=545525&author=C.+R.+M.+Asquithauthor=K.+A.+Maffuidauthor=T.+Laitinenauthor=C.+D.+Torriceauthor=G.+J.+Tizzardauthor=C.+Alamillo-Ferrerauthor=K.+M.+Koshlapauthor=D.+J.+Cronaauthor=W.+J.+Zuercher&title=Design+and+evaluation+of+novel+4-anilinoquinolines+and+quinazolines+as+EGFR+inhibitors+in+lung+cancer+and+chordoma&doi=10.1101%2F54552"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1101%2F54552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252F54552%26sid%3Dliteratum%253Aachs%26aulast%3DAsquith%26aufirst%3DC.%2BR.%2BM.%26aulast%3DMaffuid%26aufirst%3DK.%2BA.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DTorrice%26aufirst%3DC.%2BD.%26aulast%3DTizzard%26aufirst%3DG.%2BJ.%26aulast%3DAlamillo-Ferrer%26aufirst%3DC.%26aulast%3DKoshlap%26aufirst%3DK.%2BM.%26aulast%3DCrona%26aufirst%3DD.%2BJ.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DDesign%2520and%2520evaluation%2520of%2520novel%25204-anilinoquinolines%2520and%2520quinazolines%2520as%2520EGFR%2520inhibitors%2520in%2520lung%2520cancer%2520and%2520chordoma%26jtitle%3DBioRxiv%26date%3D2019%26spage%3D545525%26doi%3D10.1101%2F54552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asquith, C.
R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laitinen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godoi, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">East, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tizzard, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dornsife, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">Identification and optimization of 4-anilinoquinolines as inhibitors of cyclin G associated kinase</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1002%2Fcmdc.201700663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=29072804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVKhurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&pages=48-66&issue=1&author=C.%0AR.+M.+Asquithauthor=T.+Laitinenauthor=J.+M.+Bennettauthor=P.+H.+Godoiauthor=M.+P.+Eastauthor=G.+J.+Tizzardauthor=L.+M.+Gravesauthor=G.+L.+Johnsonauthor=R.+E.+Dornsifeauthor=C.+I.+Wellsauthor=J.+M.+Elkinsauthor=T.+M.+Willsonauthor=W.+J.+Zuercher&title=Identification+and+optimization+of+4-anilinoquinolines+as+inhibitors+of+cyclin+G+associated+kinase&doi=10.1002%2Fcmdc.201700663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and Optimization of 4-Anilinoquinolines as Inhibitors of Cyclin G Associated Kinase</span></div><div class="casAuthors">Asquith, Christopher R. M.; Laitinen, Tuomo; Bennett, James M.; Godoi, Paulo H.; East, Michael P.; Tizzard, Graham J.; Graves, Lee M.; Johnson, Gary L.; Dornsife, Ronna E.; Wells, Carrow I.; Elkins, Jonathan M.; Willson, Timothy M.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-66</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">4-Anilinoquinolines were identified as potent and narrow-spectrum inhibitors of the cyclin G assocd. kinase (GAK), an important regulator of viral and bacterial entry into host cells.  Optimization of the 4-anilino group and the 6,7-quinoline substituents produced GAK inhibitors with nanomolar activity, over 50 000-fold selectivity relative to other members of the numb-assocd. kinase (NAK) subfamily, and a compd. (6,7-dimethoxy-N-(3,4,5-trimethoxyphenyl)quinolin-4-amine; I) with a narrow-spectrum kinome profile.  These compds. may be useful tools to explore the therapeutic potential of GAK in prevention of a broad range of infectious and systemic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVCmCJJ-T_rrVg90H21EOLACvtfcHk0li-8ylKeuCNpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVKhurfJ&md5=4ea89909e674ef29c37e78fbe7622a68</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700663%26sid%3Dliteratum%253Aachs%26aulast%3DAsquith%26aufirst%3DC.%2BR.%2BM.%26aulast%3DLaitinen%26aufirst%3DT.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DGodoi%26aufirst%3DP.%2BH.%26aulast%3DEast%26aufirst%3DM.%2BP.%26aulast%3DTizzard%26aufirst%3DG.%2BJ.%26aulast%3DGraves%26aufirst%3DL.%2BM.%26aulast%3DJohnson%26aufirst%3DG.%2BL.%26aulast%3DDornsife%26aufirst%3DR.%2BE.%26aulast%3DWells%26aufirst%3DC.%2BI.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DIdentification%2520and%2520optimization%2520of%25204-anilinoquinolines%2520as%2520inhibitors%2520of%2520cyclin%2520G%2520associated%2520kinase%26jtitle%3DChemMedChem%26date%3D2018%26volume%3D13%26issue%3D1%26spage%3D48%26epage%3D66%26doi%3D10.1002%2Fcmdc.201700663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asquith, C. R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuzzi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crona, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewry, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">East, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godoi, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunter, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torrice, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Earp, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">SGC-GAK-1: A chemical probe for cyclin G associated kinase (GAK)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">2830</span>– <span class="NLM_lpage">2836</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01213</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01213" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFCrtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2830-2836&issue=5&author=C.+R.+M.+Asquithauthor=B.+T.+Bergerauthor=J.+Wanauthor=J.+M.+Bennettauthor=S.+J.+Capuzziauthor=D.+J.+Cronaauthor=D.+H.+Drewryauthor=M.+P.+Eastauthor=J.+M.+Elkinsauthor=O.+Fedorovauthor=P.+H.+Godoiauthor=D.+M.+Hunterauthor=S.+Knappauthor=S.+M%C3%BCllerauthor=C.+D.+Torriceauthor=C.+I.+Wellsauthor=H.+S.+Earpauthor=T.+M.+Willsonauthor=W.+J.+Zuercher&title=SGC-GAK-1%3A+A+chemical+probe+for+cyclin+G+associated+kinase+%28GAK%29&doi=10.1021%2Facs.jmedchem.8b01213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">SGC-GAK-1: A Chemical Probe for Cyclin G Associated Kinase (GAK)</span></div><div class="casAuthors">Asquith, Christopher R. M.; Berger, Benedict-Tilman; Wan, Jing; Bennett, James M.; Capuzzi, Stephen J.; Crona, Daniel J.; Drewry, David H.; East, Michael P.; Elkins, Jonathan M.; Fedorov, Oleg; Godoi, Paulo H.; Hunter, Debra M.; Knapp, Stefan; Muller, Susanne; Torrice, Chad D.; Wells, Carrow I.; Earp, H. Shelton; Willson, Timothy M.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2830-2836</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We describe SGC-GAK-1 (11), a potent, selective, and cell-active inhibitor of cyclin G-assocd. kinase (GAK), together with a structurally related neg. control SGC-GAK-1N (14).  11 Was highly selective in an in vitro kinome-wide screen, but cellular engagement assays defined RIPK2 as a collateral target.  We identified 18 as a potent RIPK2 inhibitor lacking GAK activity.  Together, this chem. probe set can be used to interrogate GAK cellular biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo59Ri_VO0xCLVg90H21EOLACvtfcHk0lh6V-1o9RU3jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFCrtr4%253D&md5=95b6a31e3df7d87fb129d0814dc81bad</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01213%26sid%3Dliteratum%253Aachs%26aulast%3DAsquith%26aufirst%3DC.%2BR.%2BM.%26aulast%3DBerger%26aufirst%3DB.%2BT.%26aulast%3DWan%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DJ.%2BM.%26aulast%3DCapuzzi%26aufirst%3DS.%2BJ.%26aulast%3DCrona%26aufirst%3DD.%2BJ.%26aulast%3DDrewry%26aufirst%3DD.%2BH.%26aulast%3DEast%26aufirst%3DM.%2BP.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DGodoi%26aufirst%3DP.%2BH.%26aulast%3DHunter%26aufirst%3DD.%2BM.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DTorrice%26aufirst%3DC.%2BD.%26aulast%3DWells%26aufirst%3DC.%2BI.%26aulast%3DEarp%26aufirst%3DH.%2BS.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DSGC-GAK-1%253A%2520A%2520chemical%2520probe%2520for%2520cyclin%2520G%2520associated%2520kinase%2520%2528GAK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26issue%3D5%26spage%3D2830%26epage%3D2836%26doi%3D10.1021%2Facs.jmedchem.8b01213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drewry, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, C. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Ali, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Axtman, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capuzzi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ettmayer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gileadi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luecking, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michaelides, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muratov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denny, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saikatendu, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treiber, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span> <span> </span><span class="NLM_article-title">Progress towards a public chemogenomic set for protein kinases and a call for contributions</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">8</span>), <span class="NLM_elocation-id">e0181585</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0181585</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=10.1371%2Fjournal.pone.0181585" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=28767711" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFWktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&issue=8&author=D.+H.+Drewryauthor=C.+I.+Wellsauthor=D.+M.+Andrewsauthor=R.+Angellauthor=H.+Al-Aliauthor=A.+D.+Axtmanauthor=S.+J.+Capuzziauthor=J.+M.+Elkinsauthor=P.+Ettmayerauthor=M.+Frederiksenauthor=O.+Gileadiauthor=N.+Grayauthor=A.+Hooperauthor=S.+Knappauthor=S.+Lauferauthor=U.+Lueckingauthor=M.+Michaelidesauthor=S.+M%C3%BCllerauthor=E.+Muratovauthor=R.+A.+Dennyauthor=K.+S.+Saikatenduauthor=D.+K.+Treiberauthor=W.+J.+Zuercherauthor=T.+M.+Willson&title=Progress+towards+a+public+chemogenomic+set+for+protein+kinases+and+a+call+for+contributions&doi=10.1371%2Fjournal.pone.0181585"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Progress towards a public chemogenomic set for protein kinases and a call for contributions</span></div><div class="casAuthors">Drewry, David H.; Wells, Carrow I.; Andrews, David M.; Angell, Richard; Al-Ali, Hassan; Axtman, Alison D.; Capuzzi, Stephen J.; Elkins, Jonathan M.; Ettmayer, Peter; Frederiksen, Mathias; Gileadi, Opher; Gray, Nathanael; Hooper, Alice; Knapp, Stefan; Laufer, Stefan; Luecking, Ulrich; Michaelides, Michael; Muller, Susanne; Muratov, Eugene; Aldrin, Denny R.; Saikatendu, Kumar S.; Treiber, Daniel K.; Zuercher, William J.; Willson, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e0181585/1-e0181585/20</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Protein kinases are highly tractable targets for drug discovery.  However, the biol. function and therapeutic potential of the majority of the 500+ human protein kinases remains unknown.  We have developed phys. and virtual collections of small mol. inhibitors, which we call chemogenomic sets, that are designed to inhibit the catalytic function of almost half the human protein kinases.  In this manuscript we share our progress towards generation of a comprehensive kinase chemogenomic set (KCGS), release kinome profiling data of a large inhibitor set (Published Kinase Inhibitor Set 2 (PKIS2)), and outline a process through which the community can openly collaborate to create a KCGS that probes the full complement of human protein kinases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpozOiNZl51XbVg90H21EOLACvtfcHk0lh6V-1o9RU3jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFWktL0%253D&md5=9c27ba5cd21da43d30ce485ffa0e1675</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0181585&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0181585%26sid%3Dliteratum%253Aachs%26aulast%3DDrewry%26aufirst%3DD.%2BH.%26aulast%3DWells%26aufirst%3DC.%2BI.%26aulast%3DAndrews%26aufirst%3DD.%2BM.%26aulast%3DAngell%26aufirst%3DR.%26aulast%3DAl-Ali%26aufirst%3DH.%26aulast%3DAxtman%26aufirst%3DA.%2BD.%26aulast%3DCapuzzi%26aufirst%3DS.%2BJ.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DEttmayer%26aufirst%3DP.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DGileadi%26aufirst%3DO.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DHooper%26aufirst%3DA.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DLaufer%26aufirst%3DS.%26aulast%3DLuecking%26aufirst%3DU.%26aulast%3DMichaelides%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DMuratov%26aufirst%3DE.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DSaikatendu%26aufirst%3DK.%2BS.%26aulast%3DTreiber%26aufirst%3DD.%2BK.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26atitle%3DProgress%2520towards%2520a%2520public%2520chemogenomic%2520set%2520for%2520protein%2520kinases%2520and%2520a%2520call%2520for%2520contributions%26jtitle%3DPLoS%2520One%26date%3D2017%26volume%3D12%26issue%3D8%26doi%3D10.1371%2Fjournal.pone.0181585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pawar, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sos, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rode, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heynck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Otterlo, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4-anilinoquinolines as potent inhibitors of epidermal growth factor receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2892</span>– <span class="NLM_lpage">2901</span>, <span class="refDoi"> DOI: 10.1021/jm901877j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901877j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2892-2901&author=V.+G.+Pawarauthor=M.+L.+Sosauthor=H.+B.+Rodeauthor=M.+Rabillerauthor=S.+Heynckauthor=W.+A.+van+Otterloauthor=R.+K.+Thomasauthor=D.+Rauh&title=Synthesis+and+biological+evaluation+of+4-anilinoquinolines+as+potent+inhibitors+of+epidermal+growth+factor+receptor&doi=10.1021%2Fjm901877j"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm901877j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901877j%26sid%3Dliteratum%253Aachs%26aulast%3DPawar%26aufirst%3DV.%2BG.%26aulast%3DSos%26aufirst%3DM.%2BL.%26aulast%3DRode%26aufirst%3DH.%2BB.%26aulast%3DRabiller%26aufirst%3DM.%26aulast%3DHeynck%26aufirst%3DS.%26aulast%3Dvan%2BOtterlo%26aufirst%3DW.%2BA.%26aulast%3DThomas%26aufirst%3DR.%2BK.%26aulast%3DRauh%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204-anilinoquinolines%2520as%2520potent%2520inhibitors%2520of%2520epidermal%2520growth%2520factor%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2892%26epage%3D2901%26doi%3D10.1021%2Fjm901877j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y8D" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y8D','PDB','4Y8D'); return false;">PDB: 4Y8D</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XKK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1XKK','PDB','1XKK'); return false;">PDB: 1XKK</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i20"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00350">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_55347"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.9b00350">10.1021/acs.jmedchem.9b00350</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures for the synthesis of intermediates together with biological data and associated errors, NMR conformation, and molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_001.pdf">jm9b00350_si_001.pdf (8.0 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b00350/suppl_file/jm9b00350_si_002.csv">jm9b00350_si_002.csv (3.59 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b00350&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b00350%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-9" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b00350" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677a5d180a783d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
